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Abstract 
The canonical Wnt pathway is a vitally important signalling pathway that plays an important role in 
cell proliferation, differentiation and fate decisions in embryonic development and in the 
maintenance of adult tissues. The twelve Armadillo (ARM) repeat-containing protein β-catenin acts 
as the signal transducer in this pathway and is continuously degraded in the cytosol by the β-catenin 
destruction complex (BDC). Upon receiving the Wnt signal the BDC is inactivated, allowing β-catenin 
to accumulate in the cytosol and be transported to the nucleus where it binds to the TCF/LEF family 
of transcription factors, inducing the expression of cell cycle promotor genes. 
In this Thesis I describe investigations into the roles of leucine-rich repeat kinase 2 (LRRK2) and the 
transcription factor TCF7L2 within this signalling pathway. LRRK2 is a large multi-domain protein 
with strong links to Parkinson’s disease and suggested to play a role in inactivating the BDC in 
response to the Wnt signal. A recent paper proposed that the previously uncharacterised regions of 
LRRK2 contain a series of tandem repeat sub-domains. I began an investigation into these sub-
domains but I was unable to produce soluble protein constructs despite the use of a range of 
common techniques, and so I was forced to conclude this project early. 
The main body of this thesis focuses on the interaction between the intrinsically disordered TCF7L2 
and the repeat protein β-catenin, a very long interface of approximately 4800 Å2 that spans from the 
third to the eleventh ARM repeat of β-catenin and residues 12 to 50 of TCF7L2, as determined by X-
ray crystal structures. First, a fluorescence reporter system for the binding interaction was 
developed and used to determine the kinetic rate constants for the association and dissociation of 
the wild-type construct using stopped-flow fluorescence spectroscopy and time-dependent 
fluorescence spectroscopy. It was found that association of TCF7L2 and β-catenin was rapid (7.3 ± 
0.1 x107 M-1s-1) with only a single phase was observed, whereas dissociation was biphasic and slow 
(5.7 ± 0.4 x10-4 s-1, 15.2 ± 2.8 x10-4 s-1). Using either of these two dissociation rate constants the 
calculated Kd value obtained is much lower than the values previously reported in the literature (8 ± 
1 / 20 ± 2 pM compared with 16 nM). 
This reporter system was then used to investigate the striking variability between three crystal 
structures previously obtained for the TCF7L2-β-catenin complex, in which different regions of 
TCF7L2 show different elements of secondary structure. Mutational analysis revealed that the 
interface residues on TCF7L2 identified in these structures make little or no contribution to the 
overall binding affinity, pointing to a transient nature of these contact in solution and suggesting 
that the observed differences between the structures are due to differences in crystal packing. 
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Further experiments into the effect of osmolarity on the binding equilibrium and kinetics supported 
this conclusion and suggest a change in the association/dissociation mechanism as a function of ionic 
strength. 
Lastly, further mutational analysis of TCF7L2 revealed two regions that contribute particularly 
strongly to the binding kinetics, suggesting that TCF7L2-β-catenin assembly proceeds via a two-site 
avidity mechanism. Some of the most destabilising variants display two additional dissociation 
phases, indicating the presence of an alternative dissociation pathway that is inaccessible to the 
wild-type.  
In summary, the results presented here provide insights into the kinetics of molecular recognition of 
a long intrinsically disordered region with an extended repeat protein surface, a process shown to 
involve multiple routes with multiple steps in each. 
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Abbreviations 
Ax    absorbency at x nm wavelength 
aa    amino acid 
ABA    abscisic acid 
ABAR    putative ABA receptor 
ACTR    activator for thyroid hormone and retinoid receptor 
AD    subdomain of p53 
Aha    azidohomoalanine 
AMD    age-related macular degeneration 
ANK    ankyrin 
amp    ampicillin 
APC    adenomatous polyposis coli 
ARM    armadillo 
ATP    adenosine triphosphate 
BCA    bicinchoninic acid 
BDC    β-catenin destruction complex 
cAMP    cyclic adenosine monophosphate 
CBP    CREB binding protein 
CD    circular dichroism 
CDK    cyclin-dependent kinase 
CK1α/γ    casein kinase 1α/γ 
COR    C-terminal of ROC 
CREB    cAMP response element-binding protein 
CRISPR    clustered regularly interspaced short palindromic repeats 
CuAAC    copper-catalysed azide-alkyne cycloaddition 
d.p.    decimal place 
DsbC    disulfide bond isomerase C 
DMSO    dimethylsulfoxide 
DTT    1,4-dithiothreitol 
εx    extinction coefficient at x nm wavelength 
E. coli    Escherichia coli 
EDTA    ethylenediaminetetraactetic acid 
ELISA    enzyme-linked immunosorbent assay 
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FG Nup    phenylalanine-glycine nucleoporin 
FIH    factor-inhibiting hypoxia-inducible factor 
FITC    fluorescein 4-isothiocyanate 
Fz    frizzled 
GSK3β    glycogen synthase kinase 3β 
GST    glutathione S-transferase 
HEAT huntingtin, elongation factor 3, protein phosphatase 2A, and the 
yeast kinase, TOR1 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HDX-MS   hydrogen-deuterium exchange mass spectroscopy 
HIF    hypoxia inducible factor 
HPV E7    human papillomavirus E7 
IDP    intrinsically disordered protein 
IDR    intrinsically disordered region 
IPTG    isopropyl β-D-1 thiogalactopyranoside 
kan    kanamycin 
LRP    LDL (low-density lipoprotein) receptor-related protein 
LRR    leucine-rich repeat 
LRRK2    leucine-rich repeat kinase 2 
MAPKKK   mitogen-activated protein kinase kinase kinase 
Mcl-1    induced myeloid leukemia cell differentiation protein 
MCS    multiple cloning site 
MES    2-(N-morpholino)ethanesulfonic acid 
MoRFs    molecular recognition features 
MPP+    1-methyl-4-phenylpyridinium 
MPTP    1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
Mw    molecular weight 
MWC    Monod-Wyman-Changeux 
NADPH    reduced nicotinamide adenine dinucleotide phosphate 
NCBD    nuclear co-activator binding domain 
NCL    native chemical ligation 
NDSB    non-detergent sulfobetaine 
NMR    nuclear magnetic resonance 
NPC    nuclear pore complex 
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NTA    nitrilotriacetic acid 
OD600    optical density at 600 nm wavelength 
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
PD    Parkinson’s disease 
PDB    Protein Data Bank 
PEG    polyethylene glycol 
PMT    photomultiplier tube 
PNK    polynucleotide kinase 
PP2A    protein phosphatase 2A 
PTM    post-transcriptional modificiation 
PUMA    p53 upregulated modulator of apoptosis 
ras    rat sarcoma gene family 
Rb    retinoblastoma tumor suppressor 
RCM    ring-closing metathesis 
RTH    round-the-horn 
ROC    ras of complex proteins 
RVD    repeat-variable diresidue 
SAX    small angle X-ray scattering 
SDM    site-directed mutagenesis 
SDS    sodium dodecylsulfate 
SEC    size exclusion chromatography 
SOAR1    suppressor of the ABAR-overexpressor 1 
SOC    super optimised broth with catabolite repression 
SPPS    solid-phase peptide synthesis 
θx    ellipticity at x nm wavelength 
TAZ    transcriptional adapter zinc finger 
TALE    transcription activator-like effector 
TALEN    TALE nuclease 
TCF7L2    transcription factor 7-like 2 
TFE    2,2,2-trifluoroethanol 
TLE    transducing-like enhancer of split 
Tm    melting temperature 
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TMAO    trimethylamine N-oxide 
Tris    tris(hydroxymethyl)aminomethane 
VEGF    vascular endothelial growth factor 
WD40    tryptophan-aspartic acid-40 
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 Chapter 1 – Introduction 
1.1 Tandem Repeat Proteins 
Repeat protein is the term used to describe any protein that contains some repeated element of 
sequence and/or structure, with the current estimate being that 14% of all proteins contain 
segments of duplicated sequence (Marcotte et al., 1999). Generally the more complex an organism, 
the greater proportion of their genome will encode for proteins containing repeating structure, with 
25% of human proteins containing repeat motifs (Marcotte et al., 1999). This is likely a result of gene 
duplication, and the subsequent diversification of function, as a facilitator of evolution. This also 
explains why eukaryotic repeat proteins tend to be larger, containing more repeats, than those seen 
in prokaryotes (Heringa, 1998). 
 More often than not, discussion of repeat proteins refers to tandem repeat proteins i.e. proteins 
containing tandem repeats of a small structural motif that stack together to form elongated 
structures which are distinct from “typical” globular proteins (Javadi and Itzhaki, 2013). Typically 
tandem repeats form highly symmetrical linear arrays, which are either structurally open and 
superhelical, referred to as solenoids or superhelices (Kobe and Kajava, 2000), or circularly closed 
(Blaber and Lee, 2012). 
1.1.1 Tandem Repeat Families 
There are currently twenty different classes of repeat protein (Kobe and Kajava, 2000), but this study 
will focus on four families in particular: three linear repeat families; Ankyrin (ANK), Armadillo (ARM) 
and Leucine-Rich Repeat (LRR), and circularly closed WD40 repeat family. The properties of these 
four families are summarised in Table 1-1. 
The ankyrin (ANK) repeat is one of the most common structure repeat motifs seen in nature 
(Mosavi, Minor and Peng, 2002). First identified in the signalling proteins Saccharomyces Cdc10 and 
Drosophila Notch (Breeden and Nasmyth, 1987), the family is named for the human protein, ankyrin 
(Lux, John and Bennett, 1990). The motif comprises two antiparallel α-helices, linked by a β-turn, 
with an unstructured loop of variable length connecting adjoining repeats which stack to form a 
nearly linear structure with little curvature (see Figure 1-1a). Typically only four to six repeats are 
seen in nature making the eponymous ankyrin protein somewhat unusual, containing 24 of these 
repeats (Mosavi et al., 2004).  
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repeats seen in 
natural proteins 








LRR 20-305 strand-turn-helix 
Open or 
closed 
LxxLxLxxNxLxx…xLxxLxx6 Up to 28 
WD40 407 β-propeller8 Closed 
xvxsvxldgxxlasgsxDxti 
kvWDxxxGxClxtlxgH8 
4-16 (typically 7) 
*Capitalisation indicates residue is highly conserved, lower case indicates some degree of conservation, 
x indicates no significant conservation and … indicates variable repeat length. 
1 (Lux, John and Bennett, 1990); 2 (Mosavi, Minor and Peng, 2002); 3 (Peifer, Berg and Reynolds, 1994); 
4 (Andrade et al., 2001); 5 (Kobe and Kajava, 2001); 6 (Bella et al., 2008); 7 (Neer et al., 1994); 8 (Li and 
Roberts, 2001) 
The armadillo (ARM) repeat is another ubiquitous repeat family that has been observed in all 
eukaryotic domains of life (Peifer, Berg and Reynolds, 1994). The family’s name derives from the 
gene name for the Drosophila analogue of the human protein, β-catenin, which is named armadillo 
after the appearance of the Drosophila embryos when this gene is mutated (Coates, 2003). The ARM 
repeat comprises three α-helices arranged in a triangular pattern, with the third helix resting on top 
of the first causing a twist which results in its iconic superhelix of helices structure (see Figure 1-1b) 
(Huber, Nelson and Weis, 1997). 
The leucine-rich repeat (LRR) motif is named for its unusually high leucine content (Takahashi, 
Takahashi and Putnam, 1985). This repeat comprises a β-strand-turn-helix motif, where the type of 
helix can vary between proteins. Most commonly it is an α-helix, although 310-helices and π-helices 
have been observed (Enkhbayar et al., 2003). These repeats stack together to form an α/β 
horseshoe fold, with the β-strands coming together to form a parallel β-sheet on the concave 
surface and the helices on the convex face (see Figure 1-1c), the type and pattern of the helices 
determining the curvature of the solenoid structure (Kobe and Deisenhofer, 1994). Although the LRR 
proteins seen in nature do not contain enough repeats for this to be observed, given enough 
repeats, the structure could form an open superhelix or be circularly closed (similar to β-barrel 
proteins) and even the hypothetical β-Möbius Strip (Enkhbayar et al., 2003).  
The WD40 repeat is different from the other three as it always forms a circularly closed structure. It 
is also distinguished by having a generally lower level of conservation in its primary consensus 
sequence with the exception of its namesake tryptophan-aspartic acid dipeptide motif (Neer et al., 
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Chapter 1 – Introduction 3 
 
1994; Li and Roberts, 2001). The motif comprises a four-stranded β-propeller, where four β-strands 
form an anti-parallel β-sheet which is twisted such that the first and fourth strand lie almost 
perpendicular to each other. Typically four to eight of these β-propellers come together to form a 
circularly closed structure (the most common being the seven-bladed β-propeller), with first strand 
forming a parallel β-barrel on the concave face. It is also common for the first (or last) repeat to be 
non-contiguously formed, with β-strands being contributed from both the N- and C-terminal parts of 
the domain, as demonstrated in Figure 1-1d. 
1.1.2 Biophysical Properties of Tandem Repeat Proteins  
Tandem repeat proteins are characterised by their simple architecture, which results in them 
forming fewer long-range interactions and more short-range interactions. For linear tandem repeat 
proteins, this often has the consequence that individual repeats tend not to be inherently stable and 
are dependent on their neighbouring repeats for stability (Mello and Barrick, 2004). This property 
actually makes them more amenable to biophysical studies of protein folding and unfolding. 
Figure 1-1 – The solenoid structures of tandem repeat proteins. Examples of proteins from the four repeat protein families 
discuss in this thesis: (A) the ANK subdomain of ankyrinR; (B) the ARM repeat region of β-catenin; (C) porcine ribonuclease 
inhibitor; and (D) the C-terminal WD40 domain of Tup1. Structures (A), (B), (C) and (D) were visualised in UCSF Chimera 
(Pettersen et al., 2004) using the PDB IDs 1N11 (Michaely, 2002), 2Z6H (Xing et al., 2008), 2BNH (Kobe and Deisenhofer, 
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For globular proteins, folding processes typically involve the whole structure moving through a 
diffuse transition state structure, in a concerted two-state mechanism (Fersht, 1997). Due to their 
modular nature, the folding of repeat proteins tends to be less concerted and more polarised, where 
it has been demonstrated that a subset of repeats are completely folded in the transition state 
whereas the rest are completely unfolded (Tang, Fersht and Itzhaki, 2003; Bradley and Barrick, 2006; 
Lowe and Itzhaki, 2007; Courtemanche and Barrick, 2008). 
Although in some proteins, individual repeats are capable of folding independently (like “beads-on-
a-string” (Ferreiro and Komives, 2007)), most fold with a high degree of cooperativity, being 
dependent on the inter-repeat interactions to provide stability. In the case of smaller repeat proteins 
(<150 amino acids), such as the four ankyrin repeat protein, myotrophin (Lowe and Itzhaki, 2007), 
folding resembles the concerted two-state folding seen for globular proteins, with only the folded 
and completely unfolded states populated at equilibrium (Ferreiro and Komives, 2007). 
Larger repeat proteins tend to have more complex folding mechanisms and typically do not exhibit 
two-state behaviour (Werbeck and Itzhaki, 2007; Javadi and Main, 2009). Cooperativity between 
repeats often results in the formation of stable subdomains leading to the population of 
intermediates or the potential for alternative parallel folding and unfolding pathways (Tang, Fersht 
and Itzhaki, 2003; Bradley and Barrick, 2006; Werbeck and Itzhaki, 2007; Tsytlonok et al., 2013). 
Due to their dependence on long-range contacts for stability, it is very difficult, even impossible in 
many cases, to dissect the contribution of individual parts of a globular protein give to its stability 
(Kloss, Courtemanche and Barrick, 2008). Conversely the modular nature of tandem repeat proteins 
makes it possible to deconvolute the contribution of individual repeats to overall protein stability by 
breaking them down into their smaller constituent parts (Rowling et al., 2015). The traditional 
technique of destabilisation of the folding intermediate can also be used. However this perturbation 
can potentially result in the population of alternative intermediates and rerouting the folding 
Figure 1-2 – Parallel unfolding pathway in PR65/A. The proposed multistep unfolding pathway of the giant 590 residue, 
15 HEAT repeat protein, PR65/A, involving a parallel pathway where repeats 3 to 10 and repeats 14 and 15 can unfold in 
independent events in either order. Reproduced from Tsytlonok et al. (2013). 
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pathway, as has been observed for a number of ANK repeat proteins (Lowe and Itzhaki, 2007; Tripp 
and Barrick, 2008; Werbeck et al., 2008; Tsytlonok et al., 2013; Hutton et al., 2015), as was predicted 
by in silico methods (Ferreiro et al., 2005).  
1.1.3 Natural and Artificial Functions of Tandem Repeat Proteins 
The formation of the stable extended structures seen in linear tandem repeat proteins provides 
nature with a number of selective advantages over globular proteins. The primary advantage is that 
this provides a larger surface area for protein-partner interactions (Grove, Cortajarena and Regan, 
2008). And because fewer residues are dedicated to protein topology, a greater degree of sequence 
variation is permissible within repeat protein families than in globular protein families, allowing a 
greater variety of unique binding surfaces to be presented for a given structural motif (see Table 1-
2). A larger surface area also allows for increased promiscuity, where a single protein is capable of 
binding multiple binding partners allowing them to serve multiple functions, e.g. LRRK2 (see Section 
1.4) or β-catenin (see Section 1.5), or act as hub proteins allowing cross-talk between different 
signalling pathways, e.g. SOAR1, which is thought to enable crosstalk between the PYR/PYL/RCAR- 
and CHLH/ABAR-mediated signalling pathways in plants (Jiang et al., 2014). 
Extended surface area is not the only way in which the unique properties of tandem repeat proteins 
can provide additional functionality. The inherent instability of the internal repeats can provide the 
flexibility necessary for molecular recognition. For example, IκBα contains two weakly folded ANK 
repeats that are essential for its ability to cause NF-κB to dissociate from DNA. Bergqvist et al. (2009) 
were able to demonstrate that stabilising these two repeats actually impaired this function. A similar 
thing was show for the HEAT-repeat protein, PR65/A binding to protein phosphatase 2A by 
Tsytlonok et al. (2013).  
Alternatively, partial unfolding or transient unfolding events as a result of low stability can be 
essential in facilitating post-transcriptional modifications (PTMs) to enable further functionality. Löw 
et al. (2009) showed that phosphorylation of the ANK repeat-containing tumour suppressor protein, 
p19INK4d, at S76 destabilises repeats 1 and 2 causing them to unfold and prevent binding to CDK4 and 
CDK6, acting as a molecular switch. This also has the effect of exposing K62 for ubiquitination and 
subsequent degradation, providing a regulatory mechanism. Another example would be asparagine 
β-hydroxylation of ANK repeats by FIH, which has been shown to stabilise ANK repeat domains (Kelly 
et al., 2009), including Notch (Coleman et al., 2007), Tankyrase-2 (Cockman et al., 2009) and IκBα 
(Devries et al., 2010). The data suggests that partial or complete unfolding of the domains is 
required for this process (Barrick, 2009) which would explain why Kelly et al. did not observe 
asparagine β-hydroxylation for all ANK repeat domain-containing proteins. 
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Table 1-2: Functions of tandem repeat proteins found in nature 
Family Biological Function Proteins 
ANK1 Transcription Factor Mbp1 (late G1 phase) 
Swi4 & 6 (late G1 phase) 






Regulation of muscle stress respeonse Ankrd2 
CARP 
DARP 
Polyadenylation Inhibition BARD1 
Chloroplast signal recognition particle cpSRP43 
Cell-cell adhesion Integrin linked kinase 
Tumor suppressor / cell cycle regulator INK4 family (p15INK4b, p16INK4a, p18INK4c & p19INK4d) 
53BP2 
Development / Cell-fate determination Myotrophin/V1 
Notch 
Cytoskeletal assembly and other 
structural functions 
MYPT1 (myosin phosphorylation) 
P85 (actin regulation) 
SHANK1 & 2 (postsynaptic density scaffolding) 
Ankyrin 
Poly(ADP-ribose) polymerase Tankyrase 
Signal transduction Tvl-1 
ARM2 Nuclear transport Importin family  
Cell-cell adhesion α-catenin 
β-catenin 
δ-catenin (p120) 
Wnt signalling pathway armadillo/β-catenin 
adenomatous polyposis coli (APC) 
Cytoskeletal assembly and other 
structural functions 
PF16/SPAG6 (sperm flagellum motility) 
Vesicular trafficking vac8p (transport to vacuole) 
RNA regulation Smg-GDS (mRNA quality control) 
Muscle regulation SMAP/KAP 
Light sensing and response (plants) PHOR1 
Gibberellin signalling ARC1 
Exocytosis Nd9p (membrane fusion) 
LRR3 RNA regulation RNase Inhibitor 
RNA1 (S. cerevisiae) 
RNA processing U2 snRNP A’ (splicing) 
Extracellular matrix binding Biglycan 
Decorin 
Fibromodulin 
Corneal transparency Lumican 
Bone morphogenesis Osteoinductive factor 
Cell-cell adhesion Platelet GP Ibα & V 
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Table 1-2 (cont.) 
Family Biological Function Protein 
LRR3 
(cont.) 
Bacterial virulence / invasiveness YopM (Y. pestis - bubonic plague) 
Internalin (L. monocytogenes – listeriosis) 
Development / Cell-fate determination Toll (embryo development) 
Chaoptin (photoreceptor-cell development) 
Cytoskeletal assembly and other 
structural functions 
Slit (axon development) 
Connectin (synapse development) 
Oligodendrocyte myelin GP (myelination) 
Immune response CD14 (bacterial lipopolysaccharide receptor) 
Receptor protein kinase Trk, TrkB & TrkC 
TMK1 





DNA repair RAD1 & 7 
DNA recombination DRT100 
Oncoprotein / Transcriptional Regulator CCR4 
Mitosis sds22 
Reticulated membrane p34 ribosome-binding protein 
Inflammation response Carboxypeptidase N 








RNA synthesis TATA box-binding protein associated factors 
RNA processing Tup1 
CstF 
Chromatin assembly CAF-1 
HIR1 & 2 
Vesicular trafficking coatomer 
COPα & β 
SEC13 




Arp2 & 3 





1 (Mosavi et al., 2004), 2 (Coates, 2003), 3 (Kobe and Deisenhofer, 1994), 4 (Li and Roberts, 2001) 
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The properties of tandem repeat proteins also lend themselves well for use as building blocks in the 
rational design of artificial proteins with novel functionality (Javadi and Itzhaki, 2013). Their simple, 
modular topology is unreliant on long range interactions for stability, instead depending on a few 
key residues for stability.  
Consensus sequences for these repeat protein families (such as those given in Table 1-1) are the 
results of millions of years of selective pressure on natural proteins and only through careful study of 
the different sequences of proteins within a family are we able to find them (Forrer et al., 2004). 
From the consensus sequence we have been able to identify the residues that are critical to stability 
and morphology and those that are important to molecular recognition and functionality. This has 
allowed us to modify natural proteins to improve stability without compromising function e.g. IκBα 
(Ferreiro and Komives, 2007).  
Similarly, it is possible to modify function without compromising stability, a prime example of this 
being the development of Transcription Activator-Like Effector Nucleases (TALENs) (reviewed (Sun 
and Zhao, 2013)). TALEs are a repeat protein family secreted by the bacterial plant pathogens of the 
genus Xanthomonas. Each 34 amino acid repeat contains a pair of residues, known as the repeat-
variable diresidue (RVD) which can recognise and bind to a specific base pair in dsDNA in a one-to-
one manner. Li et al. (2011) fused TALEs to a FokI DNA-cleavage domain to create TALENs, a gene 
editing tool akin to CRISPR/Cas9 or zinc-finger nucleases (reviewed by Yin, Kauffman and Anderson 
(2017)) 
Also from these consensus sequences, we have been able to create consensus-designed repeat 
sequences to use as building blocks in the design of artificial proteins with novel functionality. These 
consensus design proteins, created from near identical repeats, often demonstrate stability far 
higher than are seen for most globular and natural repeat proteins (Kohl et al., 2003) due to their 
highly optimised inter-repeat interactions. For example, full-consensus designed ankyrin repeat 
proteins (DARPins) of sufficient length cannot be fully unfolded, even at high temperatures in the 
presence of high concentrations of denaturants (Wetzel et al., 2008). However it is often the case 
that the stability is tuned by changing some of the consensus residues. 
These highly stable building blocks have been used to create novel proteins for various purposes 
(reviewed by Plückthun (2015)). Novel DARPins have been created for use in circumventing viral 
infection (Veesler et al., 2009), targeting breast cancer tumours (Theurillat et al., 2010) and there are 
currently DARPins in clinical trial for the treatment of AMD (Souied et al., 2014) (Phase III at time of 
writing) and targeting VEGF (Pre-clinical) (see www.molecularpartners.com).  
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Chapter 1 – Introduction 9 
 
The ANK repeat is not the only repeat motif for which a consensus designed repeat has been created 
and developed: consensus-designed tetratricopeptide repeat proteins (cTPRs) have been used to 
create functionalised smart gels and films (Grove et al., 2012 & 2013); and designed ARM repeat 
proteins are emerging as an effective alternative to monoclonal antibodies for peptide binding 
applications such as western blots (Varadamsetty et al., 2012). 
1.2 Intrinsically Disordered Proteins (IDPs) 
Intrinsically disordered proteins (IDPs) are a class of proteins which, as the name implies, are lacking 
in fixed tertiary (and often secondary) structure. In a field formally dominated by the structure-
function paradigm (born from the “lock-and-key” (Fischer, 1894) and later “induced fit” (Koshland, 
1958) models of enzyme catalysis), proteins that functioned without structure were seen as rare and 
obscure exceptions to the norm. It was not until the turn of the millennium that the hypothesis that 
such naturally flexible species could represent a new and unique class of proteins was postulated, as 
a result of being highlighted by a number of seminal papers (Wright and Dyson, 1999; Uversky, 
Gillespie and Fink, 2000; Dunker et al., 2001; Tompa, 2002). 
The structure-function paradigm represented a major barrier to this discovery. While the existence 
of proteins lacking in secondary structure has been known for many decades (Linderstrøm-Lang and 
Schellman, 1954), it was always assumed that they were an artefact of the experimental conditions 
and not the deliberate design of nature. Consequently, “natively denatured” proteins (Schweers et 
al., 1994) were rediscovered and renamed multiple times over the intervening years (Uversky (2011) 
lists 19 different terms used), making it difficult for past researchers to compare findings. Since then 
the terms IDP and IDR (intrinsically disordered region, denoting regions within larger, mostly 
structured proteins that have no defined structure) have become the naming convention, having 
established that function can arise from disorder. 
Additionally the properties of IDPs (discussed in Section 1.2.1) mean that many of the biophysical 
techniques used to characterise structured proteins either fail to report or misreport the properties 
of IDPs. IDPs are inherently more sensitive to degradation by proteases and so are underrepresented 
when purifying from cell homogenates, which are protease rich environments (Dyson and Wright, 
2005). Their disorder also either makes them unresolvable in crystal structures or often prevents 
them from crystallising in the first place. When the field of protein science is fixated on acquiring 
crystal structures in order to elucidate function, those that could not be seen were ignored. 
However, over the last two decades since the idea of functional disorder was established, a number 
of new techniques have been developed, as well as advancements in classical techniques, to help 
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identify and characterise this fascinating class of proteins. Techniques like nuclear magnetic 
resonance (NMR), small angle X-ray scattering (SAXS), circular dichroism (CD) and single molecule 
techniques have provided some insight into the partial or transient structures formed by IDPs 
(Tompa, 2011 & 2012; Gibbs and Showalter, 2015; Kumagai, DeMarco and Lopes, 2017). 
This new wave of structural data pertaining to IDPs has been collated into a database called DisProt 
(Sickmeier et al., 2007; Piovesan et al., 2017), an equivalent of the PDB (Berman et al., 2000; Rose et 
al., 2017) for the “unfoldome” (Uversky, 2010) i.e. proteins containing intrinsic disorder. From data 
repositories like DisProt, it has been possible to develop software tools such as PONDR-FIT (Xue et 
al., 2010) and MetaDisorder (Kozlowski and Bujnicki, 2012) to accurately predict regions of protein 
disorder, and with the aid of these tools it has been estimated that 10-35% of prokaryotic proteins 
and 15-45% of eukaryotic proteins contain disordered regions (>30 residues) (Tompa, 2012). 
1.2.1 Biophysical Properties of IDPs 
IDPs are defined by their lack of stable structure. It has been known for many decades that a 
protein’s structure is determined entirely by its sequence (Anfinsen, 1973), so therefore it follows 
that disorder must also be encoded at the sequence level. An early analysis of 275 natively folded 
and 91 natively unfolded proteins found that IDPs were enriched in Ala, Arg, Gln, Glu, Gly, Lys, Ser 
and Pro (so called “disorder-promoting” residues) and depleted Asn, Cys, Ile, Leu, Phe, Trp, Tyr and 
Figure 1-3 – Amino acid composition bias in IDPs. The amino acid composition of disordered proteins in comparison to 
ordered proteins, reproduced from Rani, Baruah and Biswas (2014). Group 1 consists of 9508 disordered proteins taken 
from the PDB for which the crystal structure contained at least 3 consecutive residues which were missing electron 
density i.e. were unresolved. Group 2 consists of 91 disordered proteins taken from DisProt (Release 6.02) for which 
there was total disorder, with no residues resolved in either crystal structures or NMR. Group 3 consists of 83 disordered 
proteins taken from the PDB for which there was less than 5% total secondary structure but contained at least 40 well 
defined residues in the crystal structure. 
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Val (so called “order-promoting” residues) with Asp, His, Met and Thr being ambiguous (Dunker et 
al., 2001). A recent, more exhaustive study of 1917 globular proteins and 9682 disordered proteins 
(disordered being defined more loosely, see paper) yielded similar results (see Figure 1-3) (Rani, 
Baruah and Biswas, 2014). Amino acid composition is by no means the only method of discovering 
intrinsic disorder in proteins and algorithms used in there detection use more than 50 different 
predictors of disorder (He et al., 2009), including net charge, 14 Å contact number, total 
Arg+Glu+Ser+Pro content, β-sheet propensity, total Cys+Phe+Tyr+Trp content, and flexibility.  
While it is broadly true that bulky, hydrophobic residues are disfavoured in IDPs and IDRs, they are 
very rarely excluded from IDPs and IDRs. Molecular recognition features (MoRFs) are typically 
enriched with hydrophobic and aromatic residues, particularly Phe and Tyr (Mohan et al., 2006). 
Moreover aromatic residues in MoRFs typically are directly involved in the binding interaction (Vacic 
et al., 2007). Consequently aromatic residues are sparse, but strategically placed in IDPs and IDRs to 
enable proper function (Fuxreiter, Tompa and Simon, 2007) (see Section 1.2.3). 
Lacking any fixed structure, IDPs and IDRs instead exist as diffuse ensembles of structures, with atom 
and backbone Ramachandran angles varying over time without a specific equilibrium value. While 
these “protein clouds” (Dunker and Uversky, 2010) are highly dynamic they are often well described 
by a fairly limited number of lower-energy conformations (Choy and Forman-Kay, 2001; Huang and 
Stultz, 2008). Consequently IDPs can form both extended regions with diffuse, poorly packed side 
chains (random coil-like, see Figure 1-4a) and partially collapsed, compacted regions (pre-molten 
globule-like, see Figure 1-4b) with noticeable secondary structure (molten globule-like) or a mixture 
(see Figure 1-4c) (Uversky and Dunker, 2010). 
Charge also plays a number of important roles in IDPs and IDRs as they tend to be enriched in 
charged residues. It is well understood from studies of polyglycine that the polypeptide backbone 
has an intrinsic preference for forming collapsed structures (Tran, Mao and Pappu, 2008) and this 
driving force has to be overcome in order for extended conformations to occur. The high density of 
charged residues (Uversky, Gillespie and Fink, 2000) is the counter driving force that can, by 
modulating the effects of both hydration and solute ion coordination (Bokor et al., 2005; Csizmók et 
al., 2005; Tompa et al., 2006), determine whether IDPs form molten globule-like, pre-molten 
globule-like or random coil-like structures (see Figure 1-4). Additionally Das and Pappu (2013) have 
shown that not only the number, but the distribution of charged residues has a significant impact on 
the structures adopted by disordered proteins and have developed a software tool, CIDER, to predict 
the effect that charge distribution has on the conformations adopted by IDPs (Holehouse et al., 
2017). Charge also has significant effect on IDP function, discussed in Sections 1.2.2 and 1.2.3. 
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Many IDPs fold upon binding to their specific protein partners (Wright and Dyson, 2009; Keppel, 
Howard and Weis, 2011), even adopting different conformation depending on which partner they 
are binding to (Karush, 1950; Kriwacki et al., 1996; Dunker et al., 2001). For example the c-terminal 
regulation domain of tumour suppresser p53, which is disordered in its free form, can form a short 
α-helix, a β-strand or two differently shaped coils, depending on whether it is bound to s100B(ββ) 
(PDB ID 1DT7, Rustandi, Baldisseri and Weber, 2000), sirtuin (PDB ID 1MA3, Avalos et al., 2002), 
cyclin A (PDB ID 1H26, Lowe et al., 2002) or the CBP bromo domain (PDB ID 1JSP, Mujtaba et al., 
2004) respectively.  
The flexibility of IDP also impacts its binding dynamics, their interactions with other protein partners 
tend to be high specificity/low affinity (Dunker et al., 2001) with affinities typically falling in the low 
micromolar to low nanomolar range (Dogan, Gianni and Jemth, 2014). This low affinity/high 
specificity binding arises through the higher entropic cost of the disorder-to-order transitions IDPs 
Figure 1-4 – IDP ensemble structures. Three examples of the ensembles of structures that IDPs adopt in solution. (A) is 
the ensemble (20 chains) adopted by thylakoid soluble phosphoprotein of 9 kDa (TSP9) as determined by solution NMR 
from PDB ID 2FFT (Song et al., 2006) and rendered using UCSF Chimera. (B) is the ensemble adopted by activator of 
thyroid and retinoid receptors (ACTR) reproduced from Keppel et al. (2011). (C) is the ensemble for amelogenin as 
generated by MODELLER reproduced from Kozlowski and Bujnicki, (2012). 
A B 
C 
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undergo on binding, compared to ordered proteins, which a recent computational study estimated 
at 1.0-1.5 kcal mol-1 per residue (Baxa et al., 2014). Yet IDP-folded protein complexes are typically 
only 2.5 kcal mol-1 weaker than folded-folded complexes (Teilum, Olsen and Kragelund, 2015), 
suggesting that the interactions of IDPs with folded partners is actually more efficient. This is not to 
say that IDPs are incapable of high affinity binding, affinities in the high to low picomolar range have 
been observed (S-peptide-S-protein, Kd ≈ 6 pM (Goldberg and Baldwin, 1998), PUMA BH3-Mcl1 , Kd ≈ 
100 pM (Rogers, Steward and Clarke, 2013)). This usually arises through “fuzzy” binding, where 
disorder is partially maintained and the entropy cost minimised, discussed in Section 1.2.2. 
Many factors within the cellular environment can affect IDP conformation. Factors such as salt 
concentration and pH have a significant impact on IDP conformation, particularly as a consequence 
of their high proportion of charged residues. Another factor that is important when comparing in 
vitro and in vivo studies is the effect of molecular crowding which can affect IDPs dramatically, many 
gaining significant partial structure in crowded environments. Some IDPs, such as α-synuclein 
(McNulty, Young and Pielak, 2006), remain completely unfolded in the crowded cellular environment 
(Szasz et al., 2011), whereas other proteins, such as bacterial protein FlgM (Dedmon et al., 2002), 
appear disordered in vitro, but are fully folded in their native cellular environments. 
As has already been noted (see Section 1.1.2), the ability of tandem repeat proteins to dynamically 
partially unfold provides an evolutionary advantage by facilitating regulation through PTMs. IDPs are 
no less amenable to PTMs where they can have a significant impact not only on their interactions 
with other proteins and ligands but can induce dramatic conformational changes (Bah and Forman-
Kay, 2016), leading complete folding (Bah et al., 2014), oligomerisation (Mitrea et al., 2014; Levine et 
al., 2015) and phase-separation (P. Li et al., 2012).  
1.2.2 Binding Modes of IDPs 
The inherent properties of IDPs and IDRs have some interesting effects on their ability to interact 
with other proteins and ligands as a given disordered region can contain any number of different 
MoRFs (Mohan et al., 2006; Vacic et al., 2007). This can either be in the form linear motifs in the 
protein sequence e.g. SLIMs (reviewed by Davey, Cyert and Moses (2015)), or secondary structural 
elements that are conformationally selected for or which fold upon binding (Wright and Dyson, 
2009). Consequently IDP binding can be promiscuous, where a single IDP can bind to more than one 
partner, such as p53 (described above) or the “Janus” Chaperones (Tompa and Kovacs, 2010), or 
several IDPs can bind to a single ordered (or disordered) partner e.g. β-catenin (tandem repeat 
protein) binding to TCF/LEF family transcription factors, E-cadherin, axin and adenomatous polyposis 
coli (APC) (all IDPs, described in more detail in Section 1.5). 
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Figure 1-5 – A portrait gallery of IDPs in complex. Reproduced from Uversky (2011a). Description taken from that paper: “A. 
MoRFs. a, α-MoRF, a complex between the botulinum neurotoxin (red helix) and its receptor (a blue cloud) (PDB ID: 2NM1); b, 
i-MoRF, a complex between an 18-mer cognate peptide derived from the α1 subunit of the nicotinic acetylcholine receptor 
from Torpedo californica (red helix) and α-cobratoxin (a blue cloud) (PDB ID: 1LXH). B. Wrappers. a, rat PP1 (blue cloud)  
complexed with mouse inhibitor-2 (red helices) (PDB ID: 2O8A); b, a complex between the paired domain from the Drosophila 
paired (prd) protein and DNA (PDB ID: 1PDN). C. Penetrator. Ribosomal protein s12 embedded into the rRNA (PDB ID: 1N34). 
D. Huggers. a, E. coli trp repressor dimer (PDB ID: 1ZT9); b, tetramerization domain of p53 (PDB ID: 1PES); c, tetramerization 
domain of p73 (PDB ID: 2WQI). E. Intertwined strings. a, dimeric coiled-coil, a basic coiled-coil protein from Eubacterium 
eligens ATCC 27750 (PDB ID: 3HNW); b, trimeric coiled-coil, salmonella trimeric autotransporter adhesin, SadA (PDB ID: 
2WPQ); c, tetrameric coiled-coil, the virion-associated protein P3 from Caulimovirus (PDB ID: 2O1J). F. Long cylindrical 
containers. a, pentameric coiled coil, side and top views of the assembly domain of cartilage oligomeric matrix protein (PDB 
ID: 1FBM); b, side and top views of the seven-helix coiled-coil, engineered version of the GCN4 leucine zipper (PDB ID: 2HY6). G. 
Connectors. a, human heat shock factor binding protein 1 (PDB ID: 3CI9); b, the bacterial cell division protein ZapA from 
Pseudomonas aeruginosa (PDB ID: 1W2E). H. Armature. a, side and top views of the envelope glycoprotein GP2 from Ebola 
virus (PDB ID: 2EBO); b, side and top views of a complex between the N- and C-terminal peptides derived from the membrane 
fusion protein of the Visna (PDB ID: 1JEK). I. Tweezers or forceps. A complex between c-Jun, c-Fos and DNA. Proteins are 
shown as red helices, whereas DNA is shown as a blue cloud (PDB ID: 1FOS). J. Grabbers. Structure of the complex between 
βPIX coiled coil (red helices) and Shank PDZ (blue cloud) (PDB ID: 3L4F). K. Tentacles. Structure of the hexameric molecular 
chaperone prefoldin from the archaeum Methanobacterium thermoautotrophicum (PDB ID: 1FXK). L. Pullers. Structure of the 
ClpB chaperone from Thermus thermophilus (PDB ID: 1QVR). M. Chameleons. The C-terminal fragment of p53 gains different 
types of secondary structure in complexes with four different binding partners, cyclinA (PDB ID: 1H26), sirtuin (PDB ID: 1MA3), 
CBP bromo domain (PDB ID: 1JSP), and s100B(ββ) (PDB ID: 1DT7). N. Stackers or β-arcs. a, stack of β-arches, β-amyloid; b, 
superpleated β-structure (Sup35p, Ure2P, α-synuclein); c, stack of β-solenoids (prion); d, stack of β-arch dimers (insulin); e, β-
solenoids. Modified from Kajava, Baxa and Steven (2010). O. Dynamic complexes. Schematic representation of the 
polyelectrostatic model of Sic1-Cdc4 interaction (Mittag et al., 2008). Schematic of an IDP (ribbon) interacting with a folded 
receptor (gray shape) through several distinct binding motifs and an ensemble of conformations (indicated by four 
representations of the interaction). The intrinsically disordered protein possesses positive and negative charges (depicted as 
blue and red circles, respectively) giving rise to a net charge ql, while the binding site in the receptor (light blue) has a charge 
qr. The effective distance <r> is between the binding site and the centre of mass of the intrinsically disordered protein. 
Reproduced from Mittag, Kay and Forman-Kay (2009). This figure is based on the data represented in Uversky (2011b).” 
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Due to their unique capacity to adjust their structures to any given binding partner, many of which 
are unattainable to ordered proteins, and ability to present virtually any MoRF, the vast array of 
structures IDPs have been observed adopting in complex should be unsurprising. Broadly, these can 
be divided into static complexes (Uversky, 2011b), where the IDP is ordered in complex (and can 
often be seen in X-ray crystal structures), and dynamic or “fuzzy” complexes, where the IDP retains a 
significant proportion (sometimes all) of its disorder whilst in complex (Borg et al., 2007; Sigalov, 
Zhuravleva and Orekhov, 2007; Mittag et al., 2008; Mittag, Kay and Forman-Kay, 2009). Uversky 
(2011b) has subdivided the static complexes into 14 subgroups: MoRFs, wrappers, chameleons, 
penetrators, huggers, intertwined strings, long cylindrical containers, connectors, armature, 
tweezers and forceps, grabbers, tentacles, pullers, and stackers or β-arcs (see Figure 1-5 and the 
paper). 
Mechanistically, IDP binding is equally varied, and recently Olsen, Teilum and Kragelund (2017) 
grouped them into four distinct modes of binding: Simple two-state binding, Avidity, Allovalency and 
Fuzzy binding. Simple two-state binding is, as the name implies, the simple case where binding can 
be approximated to single MoRF binding to a single receptor site on the binding partner (see Figure 
1-6a). This is the most frequent case for conformational selection (Wright and Dyson, 2009), where 
the IDP samples a range of structures but only binds to its partner when the right conformation is 
adopted. It can also be the case for folding on binding interactions, if the whole process is highly 
concerted, as is the case for PUMA binding to MCL-1 (Rogers, Wong and Clarke, 2014). 
Avidity arises when there are two or more independent MoRFs on the ligand IDP and an equal 
number of unique, complimentary receptor sites on the binding partner, which cannot exchange 
(see Figure 1-6b). In this model, the individual binding epitopes can bind separately to their cognate 
receptor sites and are separated by a disordered linker that ensures that once one site is bound the 
other epitopes are held close in space to their corresponding receptor sites. This behaviour greatly 
increases the probability of the subsequent binding events occurring after the first, lowering the 
entropic cost of binding more than one ligand, introducing cooperativity (Kitov and Bundle, 2003). 
However this disordered linker needs to be reasonably short otherwise the adjacent binding sites 
become decoupled and the effect is lost (Bobrovnik, 2007). Avidity was originally a term used to 
describe antibody-antigen binding, which Olsen, Teilum and Kragelund (2017) subsequently co-
opted to describe this particular mode of IDP binding (Crothers and Metzger, 1972). 
Allovalency is a concept originally developed by Klein, Pawson and Tyers (2003) and later expanded 
upon by Levchenko (2003) and Locasale (2008). Allovalency differs from avidity, as for avidity there 
are n unique matched epitope-receptor pairs, whereas as in allovalency, n (nearly) identical binding 
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epitopes compete for a single receptor site, which can only be occupied by a single epitope at a time 
Figure 1-6 – An illustration of the four different binding modes of IDPs. (A), (B), (C) and (D) are cartoon diagrams of 
simple two-state, avidity, allovalency and fuzzy binding respectively. The IDP ligand is shown in grey with its binding 
epitopes highlighted in blue and red, and its macromolecular receptor is shown in orange. For (C) the dashed grey circle 
represents the capture radius of the receptor and for (D) the white dots indicate the cluster of micro -receptors sites with 
which the IDP interacts. Reproduced from Olsen, Teilum and Kragelund (2017). 
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(see Figure 1-6c). The individual epitopes may have very low individual affinities for the binding site, 
but the presence of multiple epitopes held with a “capture radius” increases the overall affinity 
(Mittag et al., 2008). Unlike with simple two-state binding and avidity, allovalency often does not 
result in long-lived static complexes, combined with the array of adoptable structures inhibiting 
crystal packing, it is difficult to obtain crystal structures for allovalent complexes unless smaller 
fragments containing only a few epitopes are used (Xing et al., 2004) 
The definitive example of an allovalent complex is the complex formed by the cyclin-dependent 
kinase inhibitor Sic1 and its binding partner, the F-box protein Cdc4 (Klein, Pawson and Tyers, 2003; 
Borg et al., 2007; Mittag et al., 2008). Sic1 contains nine suboptimal binding epitopes for a single 
binding site on Cdc4, each of which can be “activated” by phosphorylation of either a serine or 
threonine residue within the epitope (Klein, Pawson and Tyers, 2003). In order to achieve its high 
affinity binding, at least six of the nine epitopes must be phosphorylated but which epitopes is 
entirely arbitrary (Nash et al., 2001; Borg et al., 2007; Mittag et al., 2008).  
The final binding mechanism proposed by Olsen et al. is fuzzy binding. Inspired by the mathematical 
term “fuzzy logic”, whereby the true answer to a question can be no (0), yes (1) or any value in 
between, the concept was first introduced by Tompa and Fuxreiter in 2008. Fuxreiter et al. would 
later describe fuzzy complexes as ‘protein complexes, where conformation heterogeneity of IDRs is 
retained and is required for function’ (Sharma et al., 2015), highlighting the key distinction between 
a fuzzy complex and non-specific interactions: that fuzzy complexes have a biological consequence. 
Mechanistically, fuzzy complexes are best described as an IDP-receptor complex comprised of a 
large number of smaller functional groups forming many transient interactions with a large number 
of micro-receptor sites. These functional groups can be any normally seen in proteins e.g. –OH, –CH3, 
–CO2-, –NH3+, –aromatic ring, etc., but the key is that these small interactions are individually weak 
and bind and unbind very rapidly, allowing the IDP to continue sampling a relatively large 
conformational space and reduce the entropy cost of binding. The earliest known example of 
fuzziness is the T cell receptor ζ-subunit recognising SIV pathogenicity factor Nef (Sigalov et al., 
2008). Fuzzy complexes in general cannot be captured in X-ray crystal structures and requires a 
combination of techniques such as SAXS, NMR, CD and hydrogen-deuterium exchange mass 
spectroscopy (HDX-MS) to obtain an accurate picture of the complex ensemble (Gógl et al., 2016; 
Peti et al., 2018). Moreover as only a single state is allowed in a crystal lattice, this can produce 
misleading artefacts. 
Independent from their mode of binding, Tompa and Csermely grouped IDPs into six broad 
functional classes, based on their mode of action: Assemblers, chaperones, display sites, effectors, 
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entropic chains and scavengers (Tompa, 2002, 2003; Tompa and Csermely, 2004). Chaperones aid 
the folding/reroute the misfolding of other macromolecules, and are often capable of binding many 
different macromolecules in a range of intermediate folded states. Intrinsic disorder provides 
chaperones the flexibility to adapt to the structure of different partially or misfolded targets as well 
as aiding solubility, increasing the “first-contact” radius (sometimes referred to as “flycasting”) 
and/or acting through entropic transfer (see Tompa and Csermely (2004)). Display sites act as 
recognition sites for other enzymes, usually for post-transcriptional modification and/or limited 
proteolysis. Effectors modulate the actions of other proteins, usually as an inhibitor or activator, 
typically by binding to them. Entropic chains are more loosely defined as any function that simply 
could not be performed by a protein with a well-defined compact structure such as spacer/linker 
regions, entropic gating and molecular springs. Scavengers bind, store and sometime neutralise 
small molecules. Where only a short and simple binding motif is required to bind the target small 
molecule, it is advantageous to have an extended, multivalent binding surface that can sample a 
large amount of space quickly to find and sequester the target. Finally assemblers use their intrinsic 
disorder to help coordinate and stabilise macromolecular complexes, either by acting as flexible 
linkers between structured binding domains, or in a similar mode to scavengers: presenting multiple 
binding motifs and sampling a large conformational space to locate the required complex 
components, as well as providing additional stabilisation to the holo-complex once assembled.  
1.2.3 IDPs in Physiological and Pathological Functions 
IDPs have been observed performing pretty much every role within cells (Xie et al., 2007a, 2007b, 
2007c; Sharma et al., 2015), but due to their high-specificity/low-affinity binding and their 
promiscuous one-to-many and many-to-one binding capabilities they are more often seen acting as 
interaction hubs in protein networks (Dunker et al., 2005; Uversky, Oldfield and Dunker, 2005; 
Haynes et al., 2006; Singh, Ganapathi and Dash, 2006). This presents a problem as hubs are central 
to normal function and signalling pathway cross-talk in all living organisms and disruption of hubs is 
frequently lethal (Jeong et al., 2001) or results in serious pathologies, particularly cancers and 
neurodegenerative diseases (Iakoucheva et al., 2002; Tompa, 2012). Some better known examples 
of IDP hubs in humans include p53 (cancer, Meek (2015)), α-synuclein and tau protein (Parkinson’s 
diasease and Alzheimer’s disease respectively, Moussaud et al. (2014)), myelin basic protein 
(multiple sclerosis, Zhou et al. (2017)) and BRCA1 and estrogen receptor α (breast cancer, Gaboriau 
et al. (2015) and Jahandoost, Farhanghian and Abbasi, (2017) respectively). 
As a consequence, the prevalence of intrinsic disorder in disease gave rise to the D2 concept 
(disorder in disorders), where it is suggested that disorder is prevalent in disorders precisely due to 
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the unusual properties of IDPs (Uversky, Oldfield and Dunker, 2008). In globular proteins, mutation 
that destabilise their folded structure results in their unfolding, leading to degradation before a 
mutant signal can be produced. However IDPs are biologically active in their disordered form 
(Hammoudeh et al., 2009), so mutation within IDRs are not immediately recognised by the 
proteasome (if at all), resulting in prolonged aberrant signalling, leading to disease. Additionally, as 
IDPs play key roles in regulation and signalling pathways, altered availability (either by over or 
underexpression) can also have pathological results (Babu et al., 2011). 
Table 1-3: Normal and pathological functions of IDPs in humans 
IDP or IDR 
Containing 
Protein 
Normal Function Associated Pathology in Humans 
p53 Tumour suppressor - activates DNA 
repair proteins, cell cycle arrest 
(G1/S checkpoint), angiogenesis 
inhibitor, initiator of apoptosis 
Tumour cell proliferation 
α-synuclein Synaptic vesicle trafficking (not 
well understood) 




Tumour suppressor - cell growth, 
proliferation, differentiation, and 
apoptosis, particularly embryo 
development 
Tumour initiation, cell progression, 
metastasis and invasiveness 
estrogen 
receptor α 
Estrogen sex hormone signalling Breast cancer in men and women; 
Gynecomastia in men; Estrogen Insensitivity 
Syndrome - Tall stature, osteoporosis and 
infertility in both men and women, 
abnormal development in puberty and 
many other problems in women 
Arf and Mdm2 Regulators of p53 (see p53) Delayed DNA break repair, chromosomal 




In the Measles virus: nucleocaspid 






Structuring the β-catenin 
destruction complex (see Section 
1.5.2) 
Aberrant Wnt signalling leading to 
colorectal cancers (see Section 1.5.2) 
BRCA1 Tumour suppressor - DNA damage 
signalling and repair, centrosome 






Regulation of smooth muscle 
contraction 
Loss of smooth muscle tone, essential for 
normal heart contractility 
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Table 1-3 (cont.) 
IDP or IDR 
Containing 
Protein 





Tumour cell proliferation 
XPA Scaffold for DNA nucleotide 
excision repair proteins 
Xerderma pigmentosum (hypersensitivity to 
UV, increasing skin cancer risk) 
tau protein Actin microtubule stabilisation Multiple tauopathies resulting in 
neurodegeneration, notably Alzheimer's 
disease 
Amyloid β As amyloid precursor protein: 
synapse formation, neural 
plasticity and iron export 
As amyloid β: Alzheimer's Disease 
Prion Proteins Unclear. Evidence for 
maintenance of long-term 
memory and stem cell renewal 
Assorted transmissible spongiform 
encephalopathies including Creutzfeldt-
Jakob disease (human "mad cow disease"), 
Gerstmann-Sträussler-Scheinker syndrome, 
fatal familial insomnia and Kuru 
IκBα Inhibits nuclear translocation of 




Formation of myelin sheaths in 
the nervous system 
Multiple sclerosis 
Strathmin Cytoskeletal regulation via 
inhibition of tubulin 
polymerisation 
Cancer - uncontrolled cell division through 
inability to prevent mitotic spindle assembly 
Huntingtin Unclear. Absence is embryonic 
lethal 
Huntington's disease 
PTEN Phosphorylase for PIP3 Numerous cancers, particularly prostate 
cancer in men 
Proteins listed have been pooled from papers cited in Section 1.2 
 What is more interesting is the range of functions IDPs are not typically observed performing. By 
analysing the Swiss-Prot database Xie et al. found that only in five major functional categories where 
IDPs were significantly under represented (Xie et al., 2007a), those being catalysis, transport, 
biosynthesis, metabolism and trans-membrane proteins. Even so it is possible to find examples of 
proteins performing these functions where intrinsic disorder is still essential to function.  
Retinaldehyde Dehydrogenase II (RalDH2) in a member of the NAD-dependant aldehyde 
dehydrogenase (ALDH) superfamily, which relies on intrinsic disorder for its function (Bordelon et al., 
2004). Unlike other members of this family (Liu et al., 1997; Steinmetz et al., 1997; Johansson et al., 
1998; Moore et al., 1998), the crystal structures of RalDH2 reveal that one wall of the catalytic 
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pocket is disordered (Lamb and Newcomer, 1999) and undergoes a disorder-to-order transition on 
substrate binding. Bordelon et al. (2004) were able to show through mutagenesis that this 
disordered region has an effect on catalysis beyond simple substrate binding affinity. They 
rationalise that because the primary substrate for RalDH2, retinal, is much larger the primary 
substrates of other members of the family, having a disordered wall instead of a rigidly structured 
one allows a gating mechanism. Rather than maintaining a large open pocket, the disordered region 
acts to exclude water and other aldehydes from the catalytic site as well adjusting to the optimal 
catalytic conformation once the correct substrate is bound. 
IDPs involved in transport often act as scavengers, where multiple short, simple binding motifs are 
arranged in tandem in an extended disordered region, acting as a multivalent binding surface that 
can sample a large amount of space quickly to find and sequester the target molecules (Tompa, 
2002, 2003). For example the 69-residue mitochondrial protein Cox17 plays a vital role in importing 
copper (I) ions into the mitochondria for the cytochrome-c oxidase complex (Terziyska et al., 2005a, 
2005b; Cobine, Pierrel and Winge, 2006). In the reducing environment of the cytoplasm Cox17 is 
disordered and capable of binding four copper (I) ions cooperatively (Abajian et al., 2004), however 
when Cox17 is imported into the highly oxidising intermembrane space it folds via the formation of 
disulfide bonds (Banci, Bertini, Ciofi-Baffoni, Janicka, et al., 2008; Banci et al., 2011). In its oxidised 
folded state Cox17 is only capable of binding one copper (I) ion transferring the other three to Cox11 
and Soc1 (Horng et al., 2004; Banci, Bertini, Ciofi-Baffoni, Hadjiloi, et al., 2008). 
IDPs and IDRs involved in biosynthetic and metabolic processes tend not to be involved directly in 
the synthetic machinery; instead they tend to be involved in complex assembly. Examples include 
the L7 and L12 ribosomal proteins which play a vital role in coordinating the translation factors; EF-
G, IF2 and RF3 in the bacteria 70S ribosome (Carlson et al., 2017). They also can act as modulators of 
biosynthetic machinery such as CP12 in chloroplasts, which acts as a light sensitive switch for the 
Calvin cycle (the carbon-capture cycle that assimilates CO2) (minireviewed by Gontero and Maberly 
(2012)). In the absence of light, the chloroplast environment is oxidising and CP12 forms a complex 
with the enzymes glyceraldehyde-3-phosphate dehydrogenase and phosphoribulokinase, inhibiting 
both (Wedel, Soll and Paap, 1997; Wedel and Soll, 1998). In the presence of light, ATP and NADPH 
are produced in the primary phase of photosynthesis, which turns the chloroplast into a reducing 
environment, CP12 becomes reduced, releasing the two enzymes to perform their function 
(Thieulin-Pardo et al., 2015). 
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Transmembrane proteins also tend to require structure for function, as they are anchored within a 
membrane. However one particularly well studied example of IDPs in transmembrane proteins are 
the phenylalanine-glycine repeat-containing nucleoporins (FG Nups) which line the inner surface of 
nuclear pore complexes (NPCs) (reviewed by Sakiyama, Panatala and Lim (2017)). The FG Nups form 
a bristly, sieve-like hydrogel that prevents the translocation of large non-specific macromolecules 
above ≈ 40 kDa while still being permeable to smaller molecules (Rout et al., 2003; Yamada et al., 
2010; Popken et al., 2015). Selective transport across the nuclear envelope is facilitated by the 
importin family of proteins, sometimes called karyopherins (which are ARM repeat proteins) (Chook 
and Süel, 2011). Importin β1 binds to cargo proteins containing a nuclear localisation signal and the 
Importin-cargo complex translocates through the NPC in what appears to be a diffusion process 
(Yang, Gelles and Musser, 2004) but is actually directionally regulated by Ran GTPase (Görlich et al., 
1996). It is still unclear precisely how this fast, selective, transport works mechanistically but a 
possible explanation is that importin β1 has approximately ten hydrophobic grooves which could 
potentially bind to FG repeats (Isgro and Schulten, 2005) in a manner somewhere between allovency 
and fuzzy binding (Schoch, Kapinos and Lim, 2012; Kapinos et al., 2014; Hough et al., 2015; Milles et 
al., 2015), where the effective capture radius of the complex is the entire inner pore (Olsen, Teilum 
and Kragelund, 2017). 
Figure 1-7 – Schematic model of a nuclear pore complex. The black strands represent the intrinsically disordered FG 
nucleoporin, Nsp1, within the pore of the nuclear pore complex. The green, blue and pink boxes contain stills taken from 
simulations of Nsp1 arranged in a ring array. Reproduced from Gamini et al. (2014). 
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Disregarding the “structure dictates function” paradigm, IDPs have the potential to function in ways 
that would be impossible for ordered proteins. One of the more interesting examples of unique 
functions of IDPs is the formation of membrane-less organelles, where soluble macromolecules 
undergo liquid-liquid phase separation (reviewed by Aumiller and Keating (2017)). The intrinsic 
properties of IDPs make them well-suited for the formation of membraneless organelles (reviewed 
by Uversky (2017a)). IDPs are conformationally flexible, capable of forming very elongated structures 
(Das and Pappu, 2013) and multivalent, allowing them to self-polymerise through disperse repeated 
units (e.g. alternating blocks of opposite charge (Nott et al., 2015) or complementary donor-
acceptor units, separated by flexible linkers (P. Li et al., 2012)) as well as recruit other proteins that 
facilitate the organelles function. They are amenable to many forms of post-transcriptional 
modification (Wang et al., 2014; Nott et al., 2015), which may induce dynamic compartmentalisation 
in response to environmental changes and other stimuli (e.g. changes in salinity, temperature or 
binding partner concentration). Membraneless organelles constitute a deep and complex emerging 
field that is not directly relevant to the rest of this thesis, but I have mentioned them here as a 
fascinating example of the unique functionality of intrinsic disorder in proteins. For a more in depth 
discussion, as well as an extensive list of examples, I recommend the reviews by Aumiller and 
Keating (2017) and Uversky (2017a, 2017b). 
1.3 The Canonical Wnt Signalling Pathway 
The canonical, β-catenin-dependant Wnt signalling pathway is one of three signalling pathways 
activated by the secreted glyco-/lipoproteins of the Wnt family (Port and Basler, 2010). The other 
two non-canonical (or β-catenin-independent) Wnt signalling pathways are the Wnt/PCP (planar cell 
polarity) pathway, which regulates cytoskeleton dynamics, and the Wnt/Ca2+ pathway, which 
regulates intracellular Ca2+ levels, act through G-protein coupled mechanisms (Gordon and Nusse, 
2006). These pathways are critical to the regulation of cell proliferation, differentiation and fate 
decisions in embryonic development and tissue homeostasis in adults (Logan and Nusse, 2004; 
Guder et al., 2006; Clevers and Nusse, 2012), particularly the canonical pathway for which deletion 
and continuous activation are both embryonic lethal (Logan and Nusse, 2004). The β-catenin-
independent pathways are not relevant to this Thesis and so will not be discussed further here, 
although excellent reviews have been written by Seifert and Mlodzik (2007) and Kohn and Moon 
(2005) respectively. 
In the absence of a Wnt signal, cytosolic β-catenin is continuously synthesised then sequestered and 
targeted for proteasomal degradation by a multi-protein complex called the β-catenin destruction 
complex (BDC) (MacDonald, Tamai and He, 2009). The BDC is comprised of five main proteins: two 
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Chapter 1 – Introduction 24 
 
structural proteins, Axin and adenomatous polyposis coli (APC), two kinases, glycogen synthase 
kinase 3β (GSK3β) and casein kinase 1α (CK1α) and a phosphatase, protein phosphatase 2A (PP2A). 
Here β-catenin is hyperphosphorylated at the N-terminal disordered region by the combined action 
of GSK3β and CK1α (both are required, Kimelman and Xu (2006)), allowing it to be recognised and 
ubiquitinated by the β-TrCP E3 ubiquitin ligase (Wu et al., 2003) and then subsequently degraded by 
the proteasome. 
Both Axin and APC are large proteins (862 and 2843 residues, respectively), containing large IDRs 
(residues 211-780 and 800-2843, respectively), which are critical to their function and to the activity 
of the BDC (Minde et al., 2011; Noutsou et al., 2011). Together these two proteins form a scaffold 
onto which the other components and β-catenin can bind. Axin and APC can both self-associate, APC 
can homodimerise via its N-terminal coiled-coil domain (residues 1-50) (Joslyn et al., 1993) and Axin 
can homo-oligomerise via its C-terminal DIX domain (residues 780-862) (Kishida et al., 1999), which 
can also hetero-oligomerise with other DIX domain-containing proteins (Wong et al., 2004). 
Additionally, Axin contains one APC-binding RGS domain (88-211) which can bind to one of three 
SAMP repeats in APC (Eklof Spink, Fridman and Weis, 2001). This multiplicity of binding allows APC 
and Axin to theoretically form an infinitely large network which could potentially be considered a 
membraneless organelle (Kunttas-Tatli, Roberts and McCartney, 2014) (see Figure 1.8). 
The IDR of Axin contains binding sites for all the members of the BDC required for β-catenin 
phosphorylation within its IDR (GSK3β and CK1α  and β-catenin itself, Xue et al. (2013)) yet it has 
been shown that APC is required for BDC function (McCartney and Näthke, 2008; Kunttas-Tatli, 
Roberts and McCartney, 2014). APC coordinates PP2A in the complex via an ARM repeat domain and 
also has eleven binding sites for β-catenin within its IDR (seven 20-mer motifs and four 15-mer 
motifs, Minde et al. (2011)), each of which has a lower affinity for β-catenin than Axin (Choi, Huber 
and Weis, 2006; Liu et al., 2006). However these eleven repeats can be phosphorylated by GSK3β 
and CK1α, which increases their affinities for β-catenin above that of Axin (Ha et al., 2004; Liu et al., 
2006), suggesting a mechanism of cycling β-catenin between Axin and APC through phosphorylation 
and dephosphorylation (by PP2A Ha et al. (2004)) of these repeats. It has been suggested that having 
this many binding repeats in a large IDR allows APC to operate as a scavenger for β-catenin (Minde 
et al., 2011), as well as playing a role in recruiting the β-TrCP ubiquitin E3 ligase, post β-catenin 
phosphorylation (Yang et al., 2006; V. S. W. Li et al., 2012).] 
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The APC-β-catenin interaction provides an interesting example of an IDR binding to an ordered 
partner. The eleven β-catenin binding motifs, modulated by phosphorylation, is reminiscent of the 




Figure 1-8 – Axin and APC in the β-catenin destruction complex. (A) and (B) show the positions of the domains of Axin 
and APC respectively, with the interaction partners for APC being highlighted in (B). (C) demonstrates the potential of Axin 
and APC to form an infinite network such as those seen in membraneless organelles. (A) and (B) were recreated from 
Noutsou et al. (2011) and Minde et al. (2011), respectively, and (C) was from Wikimedia commons. 
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sizes of the binding interfaces (8 residues for Sic1, >50 for APC) as well as the distance between 
repeats (<10 residues for Sic1, ≈100 for APC) suggests that APC-β-catenin binding does not follow 
the allovalency mechanism. Moreover currently unpublished work by Dr. P.J.E. Rowling in our 
research group suggests that β-catenin binding to an individual APC repeat follows a two-site avidity 
mechanism. 
When the Wnt signal is given, the Wnt ligand binds to the transmembrane Frizzled (Fz) receptor and 
a co-receptor, LRP5 or 6 (usually 6), initiating a multistep process that leads to the BDC becoming 
plasma membrane-bound and sequestered, effectively inactivating it (Taelman et al., 2010; Berwick 
and Harvey, 2012; Kim, Kim and Jho, 2013). This in turn leads to the accumulation of cytosolic β-
catenin which is then able to enter the nucleus and bind to and co-activate the TCF/LEF family of 
transcription factors, activating the transcription of the Wnt target genes (see Figure 1-9) 
(MacDonald, Tamai and He, 2009). 
The actual process of BDC inactivation and sequestration is not fully understood owing in large parts 
to the complexity and diversity of its regulation and crosstalk with other signalling pathways 
(reviewed by Kim, Kim and Jho (2013)). Three events are known to be important for this process: 
hyperphosphorylation of the intercellular region of LRP5/6 (Tamai et al., 2004), Dishevelled (Dvl)-
mediated clustering of Fz/LRP receptors at the plasma membrane (Zeng et al., 2008), and 
endocytosis of the Fz/LRP/BDC complex in multi-vesicular bodies (Taelman et al., 2010). 
LRP5 & LRP6 contain five PPP(S/T)P repeats in their cytosolic tail which creates a docking site for 
Axin, when all five are phosphorylated (Tamai et al., 2004). However a number of different studies 
have shown that many different kinases are capable of facilitating this step, thereby allowing 
modulation and crosstalk between multiple signalling pathways (Kim, Kim and Jho, 2013). These 
include membrane-bound CK1γ (Davidson et al., 2005), G-protein-coupled  receptor kinase (GRK) 
5/6 (Chen et al., 2009), the cyclin-Y-dependent kinase PFTK (Davidson and Niehrs, 2010), MAPKs 
(Davidson et al., 2009), and cytosolic GSK3β (Zeng et al., 2005). Additionally, it has been shown that 
Axin-bound GSK3β is also capable of phosphorylating the LRP5/6 cytosolic tail, providing a possible 
signal amplification method when combined with Fz/LRP clustering. 
The Dishevelled (Dvl) phosphoprotein plays a central role in both the canonical and the non-
canonical Wnt signalling pathways, being the protein that both relays the Wnt signal to the cytosolic 
BDC and facilitates its binding to FZ/LRP at the cell membrane (Schwarz-Romond, Metcalfe and 
Bienz, 2007). Like Axin, Dvl contains a DIX domain, which allows it to both homo-oligomerise, and 
hetero-oligomerise with other DIX domain containing proteins (Kishida et al., 1999; Wong et al., 
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2004), but Dvl also contains a PDZ domain, which can interact directly with the Fz receptor (Wong et 
al., 2003; Punchihewa et al., 2009). Precisely how Wnt stimulation induces a change in behaviour is 
complex and multifaceted but it is known to involve phosphorylation of Dvl by various kinases, 
including casein kinases, but not CK1α or γ (reviewed by Gao and Chen (2010) and Kim, Kim and Jho 
(2013)). 
Here we can see the multiple pathways involved in BDC membrane recruitment as well as a 
mechanism for the clustering of receptors at the membrane. Axin (and the rest of the BDC) is 
recruited to the Fz/LRP receptor complex either to the phosphorylated LRP5/6 cytosolic tail (Tamai 
et al., 2004) or to the intracellular domain of Fz using Dvl as an adaptor (Punchihewa et al., 2009), 
leaving the other site free to bind a second Axin. Through this mechanism, one can imagine a “daisy-
chaining” of receptors and Axin/Dvl hetero-oligomers, resulting in the clustering of receptors. 
Additionally, Dvl oligomers can bind multiple Fz/LRP receptor complexes with or without the 
presence of Axin providing another mode of receptor clustering. 
Finally, the aggregated Wnt/Fz/Dvl/BDC complexes are endocytosed into multi-vesicular bodies, a 
step which has been shown to be absolutely essential to Wnt signalling (Blitzer and Nusse, 2006; 
Yamamoto, Komekado and Kikuchi, 2006; Bilic et al., 2007) (see Figure 1-10). It is currently thought 
that this is a key step in inhibiting the activity of the BDC: physically excluding GSK3β from the 
Figure 1-9 – The canonical Wnt signalling pathway. The canonical Wnt signalling pathway in the absence (A) and presence 
(B) of the Wnt ligand. In (A), β-catenin is continuously phosphorylated by the BDC (APC, Axin, CK1α and GSK3β), tagging it 
for degradation by the proteasome. Upon receiving the Wnt signal (B) the BDC is recruited to the cell membrane, freeing 
β-catenin, which translocates to the nucleus where it co-activates the TCF/LEF family of the transcription factors. 
Reproduced from Kim, Kim and Jho (2013). 
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cytosol, preventing β-catenin degradation and thereby allowing it to accumulate (Niehrs and 
Acebron, 2010; Taelman et al., 2010). However this simplified model is made more complicated by 
recent findings of Cruciat et al. (2010) who reported that endocytosis of the Wnt/Fz/LRP receptor 
complex occurs at an earlier stage than initially thought. They suggest that acidification of the vesical 
lumen is required for LRP6 phosphorylation to occur and Axin recruitment to the Wnt/Fz/Dvl 
receptor complex. 
1.4 Leucine-rich Repeat Kinase 2 (LRRK2) 
1.4.1 LRRK2 as a Tandem Repeat Protein 
LRRK2 is a very large 2527 amino acid, multi-domain protein containing a ROC domain and a kinase 
domain in the middle, with an eponymous N-terminal LRR domain and a C-terminal WD40 repeat 
Figure 1-10 – The process of BDC inactivation. Niehrs and Acebron suggest that the correct order of events for is: 1) Wnt 
ligand binds to Fz/Dvl receptor; 2) Dvl-mediated receptor clustering; 3) First endocytosis and acidification of the lumen; 4) 
LRP phosphorylation and BDC recruitment; 5) Second endocytosis in the multi-vesicular body. Reproduced from Niehrs 
and Acebron (2010). 
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domain along with suggestions of outer unmapped repeat domains. However the crystal structure of 
full-length LRRK2 is currently unsolved and there is some debate as to the exact number and 
locations of these repeats. Cookson (2010) suggests that there are thirteen LRRs, six WD40 repeats 
and an unspecified number of other repeats, whereas Mills et al. (2012) predict via homology 
modelling fourteen LRRs and seven WD40 repeats as well as thirteen ARM repeats and seven ANK 
repeats (see Figure 1-11a & b). 
Figure 1-11 – The predicted structural domains of LRRK2. (A) and (B) are the linear arrangement of the domains of LRRK2 
as predicted by Cookson (2010) and Mills et al. (2012) respectively, reproduced from their respective papers. (C) is the 
structures of the repeat domains of LRRK2 as predicted by Mills et al. using homology modelling, with known PD-
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A significant number of mutations related to Parkinson’s disease (PD) have been identified, a 
number of which have been shown in vitro to increase LRRK2’s rate of phosphorylation and 
autophosphorylation (Tong et al., 2010; Yue and Lachenmayer, 2011). Some of these mutations fall 
outside the catalytic domains, within the proposed repeat domains. These include: A211V, E334K 
and K544E in the predicted ARM repeat domain; M712V, P755L and R793M in the ANK repeat 
domain; R1067Q, S1096C, I1122V, and S1228T in the LRR domain; and T2356I and G2385R in the 
WD40 repeat domain (Mills et al., 2012) (see Figure 1-11c). These proposed tandem repeat domains 
of LRRK2 are explored further in Chapter 3. 
1.4.2 LRRK2 and Parkinson’s Disease 
Parkinson’s disease (PD) is an idiopathic, neurodegenerative disease, resulting from the death of 
dopaminergic neurones in the substantia nigra region of the midbrain (Dauer and Przedborski, 
2003). The main symptoms are tremor at rest, bradykinesia, deteriorating to akinesia, rigidity and 
postural instability (Jankovic, 2008). In the later stages of the disease, cognitive disturbances develop 
although they are sometimes observed from the offset. Primarily loss of executive function, sleep 
disorders, loss of attentiveness and slowed cognitive speed, which can deteriorate into mood and 
behaviour changes, memory loss and dementia (Caballol, Martí and Tolosa, 2007).  
Diagnosis is by neurological examination, however such a test is only 75-90% accurate and a true 
diagnosis can only be confirmed by autopsy where cell death in the substantia nigra, specifically in 
the pars compacta, is observed. This region of the brain plays a significant role in motor control 
(Hodge and Butcher, 1980; Pioli et al., 2008), as well as additional roles in learned responses to 
stimuli (Ljungberg, Apicella and Schultz, 1992; Da Cunha et al., 2006) and temporal processing 
(Matell and Meck, 2000) and it has been suggested that it also has a role in the sleep-wake cycle 
(Lima et al., 2007), accounting for the observed symptoms. The surviving surrounding cells are also 
observed to have high numbers of inclusions enriched in phosphorylated α-synuclein (Lesage and 
Brice, 2009) known as Lewy Bodies. The presence of these Lewy Bodies combined with the cell death 
in the substantia nigra pars compacta is what clinically distinguishes PD from other 
neurodegenerative diseases such as Dementia with Lewy Bodies. 
Currently the only therapies that exist for PD are aimed at treating its symptoms as the underlying 
causes of the disease are currently unknown. The main treatment is with L-DOPA, a precursor to 
dopamine, or with dopamine agonists. However their ability to cross the blood-brain barrier is poor 
so they need to be administered in conjunction with other medications to supress the side-effects, 
however these may also have their own side-effects. Eventually all patients stop responding to such 
treatment as all of the dopaminergic neurones die off and there is nothing for them to act upon. 
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Several genes have been strongly implicated in PD, including α-synuclein (SNCA), microtubule-
associated tau protein (MAPT), and LRRK2 (PARK8) in autosomal dominant PD; and E2-ubiquitin 
ligase parkin (PARK2), PTEN-induced kinase 1 (PARK6), and protein deglycase DJ-1 (PARK7) in 
recessive forms of PD (Davie, 2008; Drolet, Sanders and Kern, 2011).  However Mendelian familial 
inheritance accounts for only a small percentage of PD cases (around 5-10%, Kang and Marto 
(2017)), and so it is the convention to refer to Parkinsonism with a genetic cause as “Familial PD”, in 
order to distinguish it from the truly idiopathic “Sporadic PD”.  
The role of LRRK2 in this disease is not well understood (Aliaga, Cai and Liu, 2012), despite its 
mutations accounting for 5% of Familial PD cases and 3% of Sporadic PD cases (Tan and Jankovic, 
2006), the highest single attributable cause of PD. Primarily this is because LRRK2 is a promiscuous 
kinase, modulating the activities of many different pathways, thereby acting as a hub and allowing 
crosstalk. LRRK2 is expressed throughout the brain (Biskup et al., 2006; West et al., 2014) as well as 
peripheral organs including the kidney, lung, spleen, and peripheral blood mononuclear cells (Su et 
al., 2004; Larsen and Madsen, 2009). This explains why LRRK2 knockout mice were observed 
developing deep pathological legions on the kidney and lungs (Herzig et al., 2011).  
LRRK2 is primarily a cytoplasmic protein but does associate with membrane organelles such as 
mitochondria, ER, Golgi apparatus, endosomes and synaptic vesicles (Cookson, 2010) and recent 
studies have also shown LRRK2 to play a significant role in synaptic transmission (Piccoli et al., 2014). 
LRRK2 is able to modulate both synaptic vesicle exocytosis, via its ability to phosphorylate Snapin 
(Piccoli et al., 2011; Yun et al., 2013), and clathrin-mediated endocytosis (Arranz et al., 2015). 
This suggestion is further supported by studies that demonstrate that LRRK2 is involved in the 
dynamic assembly of Filamentous actin (F-actin) and microtubule assembly (Parisiadou and Cai, 
2010). LRRK2 phosphorylates the ezrin, radixin and moesin (ERM) family proteins (Jaleel et al., 2007), 
targeting them to the growing tips of neurites where they tether the F-actin to the cytoplasmic 
membrane of the protruding filopodia, regulating neurone morphology (Parisiadou et al., 2009). The 
LRRK2 mutations which increase its phosphorylation rate, also enhances ERM phosphorylation, 
possibly perturbing the neurone morphology homeostasis (Winner et al., 2011). 
LRRK2 also interacts with microtubules through its GTPase domain where it has a stabilising effect 
(Gandhi et al., 2008; Gillardon, 2009). This has been demonstrated in mouse models, where it was 
observed that free tubulin was increased in the brain homogenates of LRRK2 knockout mice 
(Gillardon, 2009), and decreased in those over-expressing LRRK2 or LRRK2 variant with enhanced 
phosphorylation activity (Lin et al., 2009). Dynamic assembly and disassembly of microtubules is 
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important to the health of neurones, so it is thought that this excessive stabilisation may be 
detrimental. LRRK2 has also been shown to phosphorylate tau protein, a protein that also binds and 
stabilises microtubules (Drubin and Kirschner, 1986). However phosphorylated tau protein 
(phospho-tau) is less effective at stabilising microtubules (Johnson and Stoothoff, 2004) which has 
an opposite effect to LRRK2, suggesting LRRK2 plays a far more complicated role in microtubule 
regulation than previously understood. Phospho-tau is observed aggregated in neurofibrillary 
tangles in Alzheimer’s patients, which may be a cause of the dementia suffered in late-stage PD 
(Rizzo et al., 2008).  
α-Synuclein (α-syn) is a cytosolic protein whose normal function in neurones is not fully understood 
but is suggested to play roles in synaptic vesicle dynamics, intracellular trafficking and mitochondrial 
function as well as potentially being a chaperone (Vekrellis et al., 2011; Wales et al., 2013; Burré, 
2015). α-Syn gains its neurotoxicity through aggregation from soluble monomer to soluble 
oligomers, to small protofibrils and finally large insoluble fibrils. However there is some 
disagreement as to whether it is the small soluble oligomers (Conway et al., 2000) or the large 
Figure 1-12 – The PD-associated interactions of LRRK2. The proposed interactions of LRRK2 that might lead to neuronal 
cell dysfunction in Parkinson’s disease.  Reproduced from Kang and Marto (2017). 
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insoluble fibrils (Trojanowski and Lee, 1998) that are the neurotoxic species. Phosphorylation at 
serine-129 seems to be the trigger for this aggregation although the cause of this change in 
behaviour has not being satisfactorily explained (Iwatsubo, 2003; Sato, Kato and Arawaka, 2013). 
There is also increasing evidence that aggregated α-syn can propagate in a prion-like manner 
providing an explanation as to why Lewy Bodies are observed in neurones neighbouring the 
substantia nigra pars compacta (Brundin, Melki and Kopito, 2010; Brundin and Melki, 2017). 
One might speculate that as LRRK2 is a kinase, it is LRRK2 which is responsible for α-syn 
phosphorylation. However only a single study has been published showing that a fragment reputed 
to correspond to the catalytic domain of LRRK2 phosphorylates wild-type α-syn to a significant 
degree (Qing et al., 2009) whereas numerous other studies have failed to replicate these findings. 
However LRRK2 has been shown to phosphorylate the A53T mutational variant of α-syn at 
threonine-53, which also had the effect of promoting its rate of aggregation and the progression of 
the neurodegeneration in transgenic mouse models (Lin et al., 2009).  
LRRK2 and α-syn are also believed to mediate cytotoxicity via the 14-3-3 family of proteins (Xu et al., 
2002; Nichols et al., 2010). This family of proteins makes up 1% of total brain proteins and are 
capable of interacting with a variety of protein partners, allowing it to perform multiple cellular 
functions (Dougherty and Morrison, 2004), modulated by phosphorylation patterns. One important 
function is that the 14-3-3 proteins sequester proapoptotic proteins (Yuan and Yankner, 2000) and 
one theoretical cause of cell death is that α-syn binds to and sequesters the 14-3-3, preventing the 
apoptosis suppression (Recchia et al., 2004). LRRK2 has also been shown to interact with the 14-3-3 
family proteins, when the Ser910 and Ser935 are phosphorylated (Dzamko et al., 2010), where it has 
the potential to alter the phosphorylation state of the 14-3-3 proteins and hence theirs propensity to 
bind α-syn. 
There is increasing evidence that LRRK2 dysfunction might mediate neuron toxicity by disruption of 
mitochondrial homeostasis (Niu et al., 2012). Dynamin-related protein 1 (DRP1) promotes 
mitochondrial fission and is activated by phosphorylation at S616. Over-expression of wild-type 
LRRK2, as well as the PD-associated hyperactive G2019S variant has been shown to enhance DRP1 
mediated mitochondrial fragmentation (Wang et al., 2012; Su and Qi, 2013), and 
hyperphosphorylation of DRP1 at S616 has been observed in non-LRRK2 related sporadic PD (Santos 
et al., 2015). Similarly the regulators of mitochondrial fusion, optic atrophy 1 and mitofusion 1 and 2, 
have decreased expression in PD patients carrying the G2019S mutation (Stafa et al., 2014). 
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Neuroinflammation has also been strongly implicated in the degeneration of dopaminergic neurones 
in PD (Barnum and Tansey, 2012) for which LRRK2 may play a role (Russo, Bubacco and Greggio, 
2014). LRRK2 has been shown to act as a MAPKKK, phophorylating  MAPKKs (Gloeckner et al., 2009; 
Hsu et al., 2010) as well as MAPK scaffolding proteins (Hsu, Chan and Wolozin, 2010) promoting 
inflamation through activation of c-Jun N-terminal kinases and p38. Indeed MPTP, which is a prodrug 
to the neurotoxin MPP+ and is used to produce Parkinsonism in mouse models (Jackson-Lewis and 
Przedborski, 2007), has been shown to act through both disruption of mitochondrial complex 1 
(Kanazawa et al., 2017) and activation of the p38 MAPKs (Hwang et al., 2016). 
Figure 1-13 – The proposed role of LRRK2 as a canonical Wnt signalling scaffold: Reproduced from Berwick and Harvey 
(2012). Description taken from that paper: “(A1) In the basal state, LRRK2 is associated with the BDC. The distribution of 
BDCs between membrane and cytosol is in dynamic equilibrium dependent on interactions between Fz receptors (FzR) and 
DVL proteins, between DVL proteins and LRRK2 and between LRP5/LRP6 co-receptors and LRRK2. (A2) Following 
stimulation with Wnt ligand, DVL proteins are polymerized, thereby recruiting BDCs to the membrane via interaction with 
LRRK2 and additional BDC proteins. LRRK2 also interacts with the intracellular domain of LRP5/LRP6, thus bridging DVL 
proteins, the BDC and LRP5/LRP6, and facilitating LRP5/LRP6 phosphorylation by GSK3β, and the formation of LRP5/LRP6 
signalosomes. (A3) Signalosomes containing phosphorylated LRP5/LRP6 and GSK3β are internalized into the endosomal 
system and ultimately sequestered into multi-vesicular bodies. Sequestration of GSK3β prevents phosphorylation of newly 
synthesized b-catenin allowing the protein to accumulate in the cytoplasm and activate β-catenin-dependent transcription 
in the nucleus. Whether LRRK2 is sequestered into MVBs with LRP6 and GSK3β or recycled to the cytosol remains to be 
determined. Note that LRRK2 is involved in multiple steps and interacts with multiple Wnt components. By altering 
strength of interaction with these proteins, PARK8 mutations are expected to compromise canonical Wnt activity 
stimulated by Wnt ligands, and perhaps also to alter basal β-catenin activity. (B) The primary effect of loss of LRRK2 is 
disruption of the BDC, leading to β-catenin stabilization. (C) Overexpressed DVL protein polymerizes and is sufficient to 
recruit BDCs to the membrane via increased interactions with FzRs and LRRK2. Presumably, the overexpression of LRRK2 
further increases the strength of the LRRK2-DVL interaction. (D) Overexpressed LRP6 also increases the membrane 
recruitment of BDC via binding to LRRK2. (E) Membrane-targeting of LRRK2 ensures the DVL-LRRK2 interaction takes place 
at membranes, thereby maximizing the membrane recruitment of BDCs.” 
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1.4.3 LRRK2 in the Canonical Wnt Signalling Pathway 
A final way in which LRRK2 has been proposed to play a role in PD, is through modification of the 
transcription signals from the canonical Wnt signalling pathway (Berwick and Harvey, 2013). As has 
already been mentioned in Section 1.3, Wnt signalling plays an important role in cell fate 
determination and homeostasis, including in neurones (Inestrosa and Varela-Nallar, 2015). In 
particular, it has been shown that Wnt signalling is vital for the development of dopaminergic 
neurones (Castelo-Branco et al., 2003, 2009; Parish et al., 2008). Recently, Berwick and Harvey 
(2012) were able to show that LRRK2 is able to associate with key members of the canonical Wnt 
signalling pathway (Axin, Dvl, GSK3β and β-catenin itself) and that the presence of LRRK2 modulated 
canonical Wnt signalling activity. They suggest that LRRK2 plays a scaffolding role in the BDC in both 
its cytosolic and membrane-bound states (see Figure 1-13). While Berwick and Harvey have not 
mentioned it, I have noted previously in Sections 1.3 and 1.4.2 that LRP6 phosphorylation, an 
important step in BDC membrane association, has been shown to be mediated by MAPKs (Davidson 
et al., 2009) and LRRK2 contains a MAPKKK-like domain, suggesting another possible mechanism for 
LRRK2-based Wnt signal modulation. 
1.5 β-Catenin 
1.5.1 β-catenin as a Tandem Repeat Protein 
β-catenin is the human homologue of the Drosophila protein Armadillo, the protein that gives its 
name to the ARM repeat (Peifer, Berg and Reynolds, 1994), and as such, β-catenin is often used as 
the main example of an ARM repeat protein. The isolated ARM repeat domain (residues 134-671) of 
β-catenin was first crystallised in 1997 but it was not until 2008 that structure of the full-length 
protein was finally solved (Huber, Nelson and Weis, 1997; Xing et al., 2008). This was likely due to 
the N- and C-terminal regions (1-133 and 672-781 respectively) being mostly disordered, which, as 
mentioned in Section 1.2, is known to cause problems with crystal packing and formation. 
β-catenin itself contains twelve imperfect ARM repeats which stack linearly to form a right-handed 
superhelix of helices. The third helix (H3) of each ARM repeat lines the groove formed by the 
superhelix and is enriched in positively charged residues (Huber, Nelson and Weis, 1997), creating an 
extended docking site for β-catenin’s negatively charged binding partners; APC, E-cadherin and the 
TCF/LEF family of transcription factors (Graham et al., 2000; Eklof Spink, Fridman and Weis, 2001; 
Poy et al., 2001; Ha et al., 2004; Xing et al., 2004). 
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1.5.2 β-catenin: function and dysfunction 
β-catenin fulfils two important functions in vivo, the first of which is that it acts as the signal 
transducer in the canonical Wnt signalling pathway (see Section 1.3) (MacDonald, Tamai and He, 
2009). Upon Wnt stimulation, β-catenin translocates to the nucleus where it binds the TCF/LEF 
family of transcription factors (Arce, Yokoyama and Waterman, 2006), resulting in the transcription 
of a number of developmentally important genes including cyclin D1 and c-Myc (Daniels, Eklof Spink 
and Weis, 2001; Conacci-Sorrell, Zhurinsky and Ben-Ze’ev, 2002). The β-catenin-TCF/LEF complex 
binds to a DNA consensus sequence called the Wnt Responsive Element, 5’-A-(C/G)-(A/T)-T-C-A-A-A-
G-3’, causing localised DNA bending (Hatzis et al., 2008). From there, the complex recruits a range of 
coactivators, including BCL9, Pygo, Mediator, p300/CBP and TRRAP/TIP60 histone acetyltransferases, 
MLL1/2 histone methyl-transferases, the SWI/SNF family and the PAF1 complex, leading to 
transcription initiation and elongation and histone and chromatin modification (Willert and Jones, 
2006; Mosimann, Hausmann and Basler, 2009). 
The other role β-catenin plays in vivo is as an adaptor, mediating cell-cell adhesion at adherens 
junctions. At adherens junctions, β-catenin binds to the intracellular domain of the cadherin family 
of proteins via β-catenin’s positively charged superhelical groove (Huber and Weis, 2001). β-catenin 
then binds α-catenin via β-catenin’s C-terminal domain, and α-catenin binds to the filamentous actin 
(F-actin) of the cytoskeleton (Pokutta and Weis, 2007). Meanwhile the extracellular domain of the 
cadherins bind homophilically with cadherins from other cells, thereby bridging the cytoskeletons of 
neighbouring cells promoting tissue formation (Harris and Tepass, 2010). Adherens junctions 
effectively compete with the BDC for cytosolic β-catenin (Herzig et al., 2007) and between these two 
mechanisms, the basal level of cytosolic β-catenin is kept at a safe low level. 
From its dual roles in the cell, it can be easily seen that β-catenin is oncogenic and its dysfunction 
has been implicated in numerous types of cancer (Clevers and Nusse, 2012). In addition to the cell 
cycle promoters cyclin D1 and c-Myc, Wnt/β-catenin signalling also induces a number of other gene 
targets known to promote cancer progression, namely matrilysin (Crawford et al., 1999), a pro-
metastatic matrix metalloproteinase, and the multidrug resistance protein, Mdr1 (Yamada et al., 
2000), so tight control is key (Kim, Kim and Jho, 2013). Mutations in β-catenin, as well as other 
members of the BDC which help regulate it, are known to cause cancers, primarily in the gut 
(Korinek et al., 1997; Morin et al., 1997; Liu et al., 2000), with disruption of APC being the single 
most common event in colorectal cancers (>85%, Bienz and Clevers (2000)).  
Additionally, disruption of β-catenin binding at adherens junctions is also cancer promoting (Yoshida 
et al., 2001). Aside from being inherently pro-metastatic through the weakening of cell-cell adhesion 
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(Conacci-Sorrell, Zhurinsky and Ben-Ze’ev, 2002), adherens junction-associated β-catenin represents 
a significant cellular pool of β-catenin (Herzig et al., 2007), the release of which can result in nuclear 
accumulation and unregulated gene activation (Polakis, 2007). Studies have shown that loss of E-
cadherin in particular is implicated in the transformation of benign adenoma cells to malignant 
carcinoma cells and that its reintroduction reduced cancel cell metastasis (Conacci-Sorrell, Zhurinsky 
and Ben-Ze’ev, 2002; Gail, Frank and Wittinghofer, 2005). 
β-catenin would therefore seem like a prime target for intervention in cancer, however it has so far 
proven to be a difficult goal. The challenge lies in the binding interface of the ARM superhelical 
groove for which many of its binding partners compete (see Figure 1-14). Any drug aimed at 
modulating one of the functions of β-catenin needs to be carefully designed so as not to disrupt any 
of its other functions. 
Table 1-4: Binding affinities of β-catenin binding to its partners. 
Binding Partner Kd (nM)* 
ICAT1 12.0 ± 1.8 
APC repeat 31 3100 ± 300 
phosphorylated APC repeat 31 10 ± 1.3 
TCF7L22 16 ± 3 
E-cadherin cytoplasmic domain (Ecyto)1 46 ± 4.4 
phosphorylated Ecyto1 0.052 ± 0.005 
Axin1 1300 ± 200 
Lef-1 (1-65)1 49 ± 3.6 
* As determined by ITC. Exact conditions varied between studies 
1 Choi, Huber and Weis (2006), 2 Sun and Weis (2011) 
That being said, there have been a number of successful attempts at directly targeting β-catenin 
made in recent years. Mani et al. (2009) were able to reduce the expression levels of several Wnt-
induced cell cycle regulators in mouse xenograft models using short hairpin RNA (shRNA) to target 
and disrupt the interaction between β-catenin and its coactivator BCL9. Then later Takada et al. 
(2012) were able to replicate this same effect in mouse xenograft models using a hydrocarbon-
stapled α-helical peptide based on the structure of BCL9. However it should be noted that BCL9 
binds to a different region of β-catenin (the N-terminal-most ARM repeats) not to the superhelical 
groove (de la Roche et al., 2012).  
Grossmann et al. (2012) took a similar approach to Takada et al. (2012) in inhibiting Wnt signalling. 
They designed a hydrocarbon-stapled α-helical peptide based on the sequence and structure of the 
α-helix formed when Axin binds to β-catenin, which does bind in the superhelical groove. The 
intention was to compete directly with Tcf4 for the superhelical groove and thereby inhibit 
transcription, and they were able to inhibit cell proliferation in cell lines containing known mutations 
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of APC and β-catenin that prevent β-catenin ubiquitination and degradation. They also designed and 
tested peptides based on the Tcf4 sequence but found at an early stage that an equivalently sized 
























Figure 1-14 – β-catenin binding to its partners: A superposition of the crystal structures of β-catenin (cyan) in complex 
with its binding partners (purple through to dark green), visualised in UCSF Chimera: Xenopus TCF7L1 (PDB ID 1G3J, 
Graham et al. (2000)), human Tcf4 (2GL7, Sampietro et al. (2006)), Axin (1QZ7, Xing et al., (2003)), APC third repeat (1TH1, 
Xing et al. (2004)), ICAT (1LUJ, Graham et al. (2002)), the cytoplasmic domain of E-cadherin (3IFQ, Choi et al (2009)) and 
human Lef-1 (3OUW, Sun and Weis (2011)). Some of their individual affinities are listed in Table 1-4. α-helices are 
represented by cylinders and unstructured regions are denoted by a dashed line. All partners except axin, bind antiparallel 
to β-catenin and the consensus binding motif, DxΦΦxΩx2-7E is highlighted (dark blue) (where Φ indicates a hydrophobic 
residue and Ω indicates an aromatic residue).  
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1.6 TCF7L2 
Transcription factor 7-like 2 (TCF7L2), also known as Tcf4, is a member of the T-cell factor/lymphoid 
enhancer-binding factor (TCF/LEF) family of transcription factors. In mammals, there are four 
members of the TCF/LEF family: Transcription factor 7 (TCF7, also known as Tcf1), Lymphoid 
enhancer-binding factor 1 (LEF1), Transcription factor 7-like 1 (TCF7L1, also known as Tcf3) and 
TCF7L2, each of which contains a conserved N-terminal β-catenin binding domain (Behrens et al., 
1996), a DNA binding high mobility group (HMG) box domain, which recognises the Wnt responsive 
element (Hatzis et al., 2008) and a nuclear localisation signal. The crystal structures of the TCF/LEF 
family have yet to be solved but it is known that the N-terminal β-catenin binding domain is 
intrinsically disordered, gaining some structure on binding (Graham et al., 2000, 2001; Poy et al., 
2001; Sampietro et al., 2006). 
In the absence of the Wnt signal, the TCF/LEF family members bind to the Groucho/TLE family of 
corepressors to inhibit the transcription of the Wnt target genes (Brantjes et al., 2001). It is 
interesting to note that, mirroring β-catenin (see Section 1.5.2), Groucho actually acts through the 
recruitment of further corepressors, namely histone deacetylases 1 & 2 (HDAC1 & 2) (Chen et al., 
1999; Brantjes et al., 2001). Then on canonical Wnt activation, Groucho/TLE is displaced from the 
TCF/LEFs by β-catenin leading to transcription of those genes (MacDonald, Tamai and He, 2009). The 
TCF/LEF family members are not functionally redundant, with LEF1 behaving as a transcriptional 
activator, TCF7L1 as a transcriptional repressor, and TCF7 and TCF7L2 behaving in a context-
dependant manner (Cadigan and Waterman, 2012).  
Of the four TCF/LEF family members, TCF7L2 has been the most widely studied and is also the most 
ubiquitously expressed in adult tissues (Archbold et al., 2012; Hrckulak et al., 2016). TCF7L2 is most 
highly expressed in the small intestine and colon where it plays a vital role in proper development of 
the small intestine and in the homeostasis of the colonic epithelium in adult tissue (van Es et al., 
2012). As a result, TCF7L2 mutations are implicated in many types of cancers (Tang et al., 2008) and 
colorectal cancers in particular (Hazra et al., 2008; Slattery et al., 2008). Single nucleotide 
polymorphisms within the TCF7L2 gene are also a genetic biomarker for an increased risk for the 
development of both type 2 and gestational diabetes (Vaquero et al., 2012; Zhang et al., 2013). This 
is thought to be due to the aberrant activation of Wnt target genes, which repress proglucagon 
synthesis (Jin and Liu, 2008). 
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1.7 Project Aims 
Understanding the intricacies of the canonical Wnt signalling pathway is one of the biggest 
challenges in science today. The pathway is implicated in a range of human diseases which have so 
far proven to be resistant to treatment including Parkinson’s disease, diabetes mellitus, and a range 
of different cancer types. The aim of this project is to broaden our understanding of the interplay 
between some of the members of the canonical Wnt signalling pathway, namely the Parkinson’s 
disease-implicated, repeat protein LRRK2, and intrinsically disordered transcription factor TCF7L2. 
The biophysical data generated in this study are intended to further our understanding of the 
canonical Wnt signalling pathway and to support the rational design of novel therapeutics in the 
treatment of the diseases associated with this pathway. 
In Chapter 3, I discuss experiments to develop a protocol for the expression, purification and storage 
of the previously unmapped protein-protein interaction domains of the large, multi-domain protein 
leucine-rich repeat kinase 2 (LRRK2). These purported domains have recently, been predicted to be 
comprised of tandem repeats of the ANK, ARM, LRR and WD40 families (Mills et al., 2012). The 
intension was to biophysically characterise the isolated domains: determine their equilibrium 
stabilities to chemical and thermal denaturation using circular dichroism and intrinsic fluorescence 
as well as their kinetic folding and unfolding rates via stopped-flow fluorescence and circular 
dichroism, as well as attempting to obtain crystal structures to confirm their identities. 
Chapter 4 focuses on the development of a protocol for the expression and purification of the N-
terminal β-catenin-binding domain of wild-type TCF7L2. The equilibrium binding constant of the 
wild-type TCF7L2 for β-catenin will be determined using isothermal titration calorimetry (ITC) and 
the kinetic rate constants for association and dissociation determined by stopped-flow fluorescence 
spectroscopy. A fluorescent reporter system will need to be developed as the intrinsic fluorescence 
of β-catenin and fluorescently-labelled β-catenin have both historically been inadequate reporters of 
partner binding. 
The work described in Chapter 5 focuses on understanding the driving forces that allow intrinsically 
disordered TCF7L2 to display three distinct structures when bound to β-catenin. A series of variant 
constructs to alanine residues thought to be key to TCF7L2-β-catenin binding, but which vary 
between structures, will be created, and their effect on the association and dissociation kinetics 
determined using the methods described in Chapter 4. 
In Chapter 6, I map the kinetic pathway of complex formation through a series of TCF7L2 variants 
within the regions in TCF7L2 that are conserved between the three crystal structures. These variants 
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will be used investigate the potential for multiple association and dissociation pathways, analogous 
to the multiple folding and unfolding pathways observed for tandem repeat proteins. The effect of 
these mutations on the kinetic rate constants are determined by a combination of stopped-flow 
fluorescence spectroscopy and time-dependent fluorescence spectroscopy. 
Finally, the work in Chapter 7 covers other aspects of the TCF7L2-β-catenin interaction. The role of 
electrostatic interactions in TCF7L2-β-catenin binding is investigated in the wild-type protein and a 
variant with a lower net charge. The effect of increasing electrostatic shielding on the kinetic rate 
constants for both constructs is determined by the methods described in Chapter 6. To determine 
whether TCF7L2-β-catenin binding follows an induced folding or a conformational selection pathway 
stapled α-helical TCF7L2 constructs are made. And to determine whether TCF7L2-β-catenin binding 
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Chapter 2 - Materials and Methods 
2.1 Reagents and Solutions 
All chemical reagents were purchased from Sigma-Aldrich Chemical Company unless otherwise 
stated. 
2.1.1 E. coli bacterial strains 
All cell lines are divided into 50 µl aliquots, flash frozen with liquid nitrogen and stored at -80°C until 
use: 
 α-Select Gold Competent Cells, which are a DH5α derivative modified for increased 
transformation efficiency and recombinant plasmid production, were purchased from 
Bioline.  
 α-Select Bronze Competent Cells, which are the same derivative as α-Select Gold Competent 
Cells but lower colony forming efficiency, were also purchased and used to create a lab stock 
culture.  
 C41 Competent Cells (Miroux and Walker, 1996), which are a BL21(DE3) derivative modified 
for increased transformation efficiency, recombinant protein overexpression and toxic 
protein resistance, were from our lab stock culture.  
 B834(DE3) Competent Cells (Wood, 1966), which are the methionine auxotrophic parental 
strain of BL21(DE3) and allow for high specificity labelling of target proteins at methionine 
residues e.g. 35S-methionine or selenomethionine for crystallography (Leahy et al., 1992), 
were purchased from Novagen. 
2.1.2 Plasmids and DNA Primers 
Custom primers were ordered from either Integrated DNA Technologies or Sigma Aldrich and are 
listed in Appendix B. The plasmids used in this Thesis are detailed below: 
 pUC57 - pUC57 is at iterative derivative of pUC19 (Yanisch-Perron, Vieira and Messing, 1985) 
which contains the ampicillin (amp)  resistance gene, bla(ApR) and no tag. This vector was 
not used for expression and the genes supplied in this vector were subcloned into other 
plasmids used for expression. 
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 pGEX - contains amp resistance and a thrombin cleavable (Leu-Val-Pro-Arg-|-Gly-Ser) 
glutathione S-transferase (GST) fusion tag. Expression is under the T7 bacteriophage 
promoter and the lacI repressor which allows protein expression to be induced in the 
presence of isopropyl β-D-1 thiogalactopyranoside (IPTG). 
 pRSET-A - contains amp resistance and a thrombin cleavable N-terminal Hexa-His tag 
(originally purchased from Life Technologies). Expression is under the T7/lacI system. 
 pRSET-GST which contains amp resistance and a thrombin cleavable N-terminal GST-fusion 
tag. This is a custom plasmid used by our lab, it is a derivative of pRSET-A (described above) 
where the Hexa-His tag has been removed and replaced with a GST-fusion tag transferred 
from pGEX-2T (originally from Pharmacia). Expression is under the T7/lacI system. 
 pET-41a(+) - contains kanamycin (kan) resistance, a thrombin cleavable combined N-
terminal GST-fusion tag followed by a Hexa-His tag (thrombin cleaves both) followed by an 
enterokinase cleavable (Asp-Asp-Asp-Asp-Lys-|-X) N-terminal S-tag (enterokinase would 
cleave all three), and a C-terminal Octa-His tag (originally purchased from Merck Millipore). 
Expression is under the T7/lacI system. 
 pACYCDuet-1 - contains chloramphenicol resistance and two multiple cloning sites (MCSs). 
The first MCS contains an un-cleavable N-terminal Hexa-His tag, whilst the second MCS 
contains an un-cleavable C-terminal S-tag (originally purchased from Merck Millipore). 
Expression is under the T7/lacI system. 
2.1.3 Buffers for Molecular Biology 
 50x TAE Buffer (Stock) – 2 M Tris base, 1 M acetic acid, 50 mM EDTA. TAE buffer solubilises 
DNA by sequestering metal cations, exposing the negatively charged phosphate backbone. 
 10000x SYBR® Safe – purchased from ThermoFisher Scientific. SYBR Safe is a safer 
alternative to ethidium bromide, it also chelates with DNA allowing it to be visualised under 
UV-light but is much less cell penetrating. 
 Gel Solubilisation buffer – 20 mM Tris-HCl pH 6.6, 5.5 M guanidinium-SCN 
 Resuspension buffer – 50 mM Tris-HCl pH 8.0, 10 mM EDTA, 100 µg/ml RNaseA. RNaseA is 
not stable in Lysis buffer and so is present in the Resuspension buffer and is stored at 4°C 
 Lysis buffer – 200 mM NaOH , 1% (w/v) SDS 
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 Neutralisation buffer – 4.2 M Guanidinium-HCl, 0.9 M KOAc, pH 4.8 with AcOH 
 Wash buffer – 10 mM Tris-HCl pH 7.5, 80% (v/v) EtOH 
 Elution buffer – 10 mM Tris-HCl pH 7.5 
2.1.4 Growth Media and Buffers for Protein Expression 
 2xYT culture medium containing 1.6% (w/v) Tryptone, 1.0% (w/v) yeast extract, 0.5% (w/v) 
NaCl was purchased from Formedium. 
 SelenoMet™ Medium. M9 minimal media supplemented with glucose, vitamins and all 
amino acids except methionine, so as to allow proteins to be labelled with selenomethionine 
or 35S-methionine was purchased from Molecular Dimensions Ltd. 
 LB (amp+) agar plate containing: 1.5% (w/v) agar, 1.0% (w/v) Tryptone, 0.5% (w/v) yeast 
extract, 0.5% (w/v) NaCl, 50 µg ml-1 ampicillin; and LB (kan+) agar plate containing: 1.5% 
(w/v) agar, 1.0% (w/v) Tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl, 100 µg ml-1 
kanamycin were provided by the MRC Laboratory of Molecular Biology. 
 50 mg ml-1 ampicillin solution (amp). This is a 1000x concentrated stock, frozen and stored at 
-20°C. 
 50 mg ml-1 kanamycin solution (kan). This is a 1000x concentrated stock, frozen and stored 
at -20°C. 
 34 mg ml-1 chloramphenicol in 100% ethanol. This is a 1000x concentrated stock, stored at -
20°C. 
 LB (amp+, kan+) agar plates containing: 32 g l-1 Lennox L Agar (Invitrogen), 50 µg ml-1 
ampicillin, 50 µg ml-1 kanamycin; LB (amp+, chloramphenicol+) agar plates containing: 32 g l-1 
Lennox L Agar, 50 µg ml-1 ampicillin, 34 µg ml-1 chloramphenicol; LB (kan+, chloramphenicol+) 
agar plates containing: 32 g l-1 Lennox L Agar, 50 µg ml-1 kanamycin, 34 µg ml-1 
chloramphenicol; and LB (amp+, kan+, chloramphenicol+) agar plates containing: 32 g l-1 
Lennox L Agar, 50 µg ml-1 ampicillin, 50 µg ml-1 kanamycin, chloramphenicol 34 µg ml-1 
chloramphenicol. 
 1 M isopropyl β-D-1 thiogalactopyranoside solution (Stock) (IPTG). This stock is frozen and 
stored at -20°C. 
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2.1.5 Buffers for Protein Purification 
Buffers containing DTT or protease inhibitors were made fresh from stock solutions on the day of 
use. 
Stock solutions 
 10x PBS pH 7.4 solution – 80 g/l NaCl, 2 g/l KCl, 14.4 g/l Na2HPO4, 2.4 g/l KH2PO4 buffered to 
pH 7.4 with KOH. Sterile Filtered. 
 1 M Tris-HCl at pHs 7.5, 8.5 and 8.9 
 1 M dithiothreitol solution (DTT). This stock is frozen and stored at -20°C. 
 1 M imidazole-HCl pH 7.4. Imidazole is a weak base and will affect the pH of 1x PBS pH 7.4, 
so the 1M imidazole solution was acidified with HCl until pH 7.4. 
 5 M NaCl solution. 
His-tagged LRRK2 Constructs 
 Lysis buffer – 1x PBS pH 7.4, EDTA-free Protease Inhibitor Cocktail Tablets (Sigma) (1 
tablet/50 ml). 
 Wash buffer – 1x PBS pH 7.4, 2 mM DTT, 20 mM imidazole-HCl pH 7.4. 
 Elution buffer – 1x PBS pH 7.4, 2 mM DTT, 200 mM imidazole-HCl pH 7.4. 
 G75 buffer – 50 mM Tris-HCl pH 7.4, 150 mM NaCl. 
GST-tagged LRRK2 Constructs 
 Lysis buffer – 50 mM Tris-HCl pH 7.5, EDTA-free Protease Inhibitor Cocktail Tablets (Sigma) 
(1 tablet/50 ml). 
 High Salt Wash buffer – 50 mM Tris-HCl pH 7.5, 2 mM DTT, 1 M NaCl 
 Low Salt Wash buffer – 50 mM Tris-HCl pH 7.5, 2 mM DTT, 150 mM NaCl 
 G75 buffer – 50 mM Tris-HCl pH 7.4, 150 mM NaCl. 
His-tagged TCF7L2 Constructs and variants 
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 Lysis buffer – 1x PBS pH 7.4, EDTA-free Protease Inhibitor Cocktail Tablets (1 tablet/50 ml), 1 
mM DTT. 
 Wash buffer – 1x PBS pH 7.4, 1 mM DTT, 50 mM imidazole-HCl pH 7.4. 
 Elution buffer – 1x PBS pH 7.4, 1 mM DTT, 200 mM imidazole-HCL pH 7.4. 
 G75 buffer – 1x PBS pH 7.4, 1 mM DTT. 
GST-tagged TCF7L2 Constructs and variants 
 Lysis buffer – 50 mM Tris-HCl pH 7.5, EDTA-free Protease Inhibitor Cocktail Tablets (Sigma) 
(1 tablet/50 ml), 1 mM DTT, 1 M NaCl. 
 High Salt Wash buffer – 50 mM Tris-HCl pH 7.5, 1 mM DTT, 1 M NaCl. 
 Low Salt Wash buffer – 50 mM Tris-HCl pH 7.5, 1 mM DTT, 50 mM NaCl. 
 G75 buffer – 50 mM Tris-HCl pH 7.5, 1 mM DTT, 150 mM NaCl. 
GST-tagged β-catenin Weis Construct  
 Lysis buffer – 50 mM Tris-HCl pH 8.5, EDTA-free Protease Inhibitor Cocktail Tablets (Sigma) 
(1 tablet/50 ml), 1 mM DTT, 1 M NaCl. 
 High Salt Wash buffer – 50 mM Tris-HCl pH 8.5, 1 mM DTT, 1 M NaCl. 
 Low Salt Wash buffer – 50 mM Tris-HCl pH 8.9, 1 mM DTT, 50 mM NaCl. 
 G75 running buffer – 50 mM Tris-HCl pH 8.9, 1 mM DTT, 150 mM NaCl. 
 High Salt MonoQ buffer – 50 mM Tris-HCl pH 8.9, 1 mM DTT, 1 M NaCl. 
 Low Salt MonoQ buffer – As Low Salt Wash buffer. 
Buffers for SDS-PAGE 
 20x NuPAGE® MES-SDS Running Buffer (Novagen) 
 20x RunBlue® MES-SDS Running Buffer (Expedeon) 
 20x RunBlue® Teo-Tricine Running Buffer (Expedeon) 
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 Coomassie Blue Stain – 60-80 mg Coomassie Brilliant Blue G-250 in 1 l mQ water, acidified to 
approximately pH 2 with 3 ml concentrated HCl (Lawrence and Besir, 2009) 
2.2 Molecular Biology 
2.2.1 Gift Plasmids 
Plasmids encoding the armadillo (ARM) repeat domain of human β-catenin (residues 134-671) were 
given to us as a kind gift from Professor W.I. Weis. The human β-catenin (residues 134-671) 
construct (hereafter referred to as the Weis construct) is in a pGEX derived vector which contains 
ampicillin (amp) resistance and an N-terminal, thrombin cleavable (Leu-Val-Pro-Arg-|-Gly-Ser), 
glutathione S-transferase (GST) fusion tag. Expression is under the tac promoter, a synthetic 
promoter which is a hybrid of the trp and lac promoters, and the lacI repressor which allows protein 
expression to be induced in the presence of IPTG (de Boer, Comstock and Vasser, 1983). 
2.2.2 Subcloning using Restriction Endonucleases 
Synthetic genes for human LRRK2 subdomains ARM, ANK, LRR and WD40 were ordered from 
GenScript USA Inc.’s Gene Synthesis Service and were supplied in the pUC57 plasmid vector. pUC57 
is at iterative derivative of pUC19 (Yanisch-Perron, Vieira and Messing, 1985) which contains the 
amp resistance gene, bla(ApR) and no tag. This vector was not a useful vector for in vitro protein 
studies due to this lack of a purification tag so these constructs required subcloning into other 
plasmids more useful for expression. Human TCF7L2 (residues 1-54) was short enough to be ordered 
as a gene strings and similarly required subcloning into an expression plasmid. It and all other gene 
strings were ordered from ThermoFisher Scientific’s GeneArt Gene Synthesis Service. All of these 
constructs were designed to have an N-terminal BamHI restriction site (GGATCC) and C-terminal 
HindIII restriction site (AAGCTT), two restriction sites commonly found in MCSs, for this reason. 
A double digest was set up on ice as described in Table 2-1 below, and incubated at 37°C overnight. 
The reactions were then heated to 80°C for 10 min to inactivate both BamHI and HindIII and the 
results were analysed by agarose gel electrophoresis and the correct products were purified by gel 
extraction, as described in Section 2.2.3. Separate digestions were set up for each of my four LRRK2 
constructs and for TCF7L2 which was done 12 months later. 
Although the cut ends of the recipient plasmid are incompatible they can still associate through non-
covalent interactions, which can drastically reduce ligation efficiency. This can be reduced by 
dephosphorylating the 5’ ends of the cut plasmid; this also has the effect that the plasmid could not 
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religate even if it did have compatible ends. Digest B was taken neat and a reaction was set up with 
Antarctic Phosphatase (Rina et al., 2000) (NEB UK) on ice as described in Table 2-2 below. The 
reaction mixture was incubated at 37°C for 1 hr before being heat inactivated by heating to 70°C for 
5 min. The dephosphorylated plasmid DNA can be used immediately for ligation or stored at -20°C 
for future use. 
Table 2-1: Digestion conditions for subcloning the LRRK2 constructs  
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* 1 unit is defined as sufficient to cleave 1 μg of lambda DNA in 5 minutes at 37°C in 1X FastDigest 
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Table 2-2: Reaction conditions for dephosphorylating recipient vector 
Dephosphorylation of Plasmid DNA 
20 µl Digest B (neat*) 
2.5 µl 10x Antarctic Phosphatase reaction buffer 
2.5 µl Antarctic Phosphatase (12.5 units**) 
25 µl Total Volume  
*NEB state that their Antarctic phosphatase can be added to any restriction reaction under any 
conditions 
**1 unit is defined as being the amount of enzyme that will dephosphorylate 1 µg of pUC19 vector 
DNA cut with HindIII (5´ protruding ends), HincII (blunts ends) or PstI (5´ recessed ends) in 30 
minutes at 37°C. Dephosphorylation is defined as > 95% inhibition of recirculation in a self-ligation 
reaction and is measured by transformation into E. coli. 
The purified DNA fragments corresponding to my LRRK2 constructs from digests A and the cut and 
dephosphorylated recipient plasmid were ligated using T4 Ligase (Murray, Bruce and Murray, 1979) 
(NEB UK) as described in Table 2-3 below. The construct DNA and plasmid DNA were pre-mixed and 
heated to 50°C for 10 min to discourage self-association/recircularisation, and then cooled on ice to 
encourage the constructs and plasmid to associate before adding buffer and ligase. Although the 
“ideal” vector to insert molar ratio is 1:3, the concentration of construct DNA was undetermined so I 
elected to saturate the plasmid with excess construct DNA. The reaction mixture was incubated at 
16°C overnight and for most of the following day before being transformed into α-Select Gold cells 
as described in Section 2.2.4 and miniprepped as described in Section 2.2.5. 
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Table 2-3: Ligation conditions for subcloning the LRRK2 constructs using T4 ligase 
Ligation using T4 Ligase 
1 µl 10x T4 DNA Ligase buffer 
1 µl Recipient plasmid DNA 
7 µl Construct DNA 
1 µl 
 
T4 DNA Ligase (400 units*, double manufacture suggested 
concentration) 
10 µl  Total volume 
*One unit is defined as the amount of enzyme required to give 50% ligation of HindIII fragments of λ 
DNA (5´ DNA termini concentration of 0.12 µM, 300- µg/ml) in a total reaction volume of 20 μl in 30 
minutes at 16°C in 1X T4 DNA Ligase Reaction Buffer. 
Ligations of the LRRK2 extensions and the TCF7L2 gene string were performed using QuickStick 
Ligase (a derivative of T4 Ligase) (Bioline). The reaction condition are described in Table 2-4 below 
and the method is identical except the reaction mixture only needed to be incubated for 15 min at 
room temperature. 
Table 2-4: Ligation conditions for subcloning the TCF7L2 constructs using QS ligase 
Ligation using QuickStick Ligase 
5 µl  4x QS Buffer 
Up to 100 ng  Total DNA 
1 µl QuickStick Ligase (1 unit*) 
Up to 14 µl mQ water 
20 µl Total volume 
*1 unit is defined as sufficient to ligate 99% of λ/HindIII cohesive-ended fragments, or 80% of 
λ/EcoRV blunt-ended fragments, in 5 minutes at room temperature. 100% ligation of blunt-ended 
fragments can be achieved by increasing the ligation time to 15 minutes at room temperature. 
2.2.3 Agarose Gel Electrophoresis and Gel Extraction 
Different sized DNA molecules were separated by electrophoresis through an agarose-TAE gel. A gel 
consisting of 1xTAE buffer, 0.5-2% (w/v) agarose and 1x SYBR® Safe was cast in a mold and ran at 
100V for 30 min using 1xTAE buffer as a source of conductance. The percentage (w/v) of agarose 
was varied to optimise separation of the desired product from contaminants: for DNA molecules 
between 1 and 5 kilobases, 1% agarose was used; for molecules less than 1 kilobase, 2% agarose was 
used; and for molecules greater than 5 kilobases, 0.7% agarose was used. DNA was visualised by 
stimulation with UV-light, causing the SYBR® Safe to fluoresce in the presence of nucleobases, and 
photographed using an Alpha Imager (Alpha Innotech Corporation). 
Bands corresponding to DNA of the desired length were excised and extracted from the agarose gel 
by a method derived from Hamaguchi and Geiduschek (1962) and Vogelstein and Gillespie (1979). 
Premade kits are available for this (e.g. Qiagen Gel Extraction kit) but our lab prefers to use our own 
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buffer recipes, detailed in Section 2.1.3, and EZ-10 spin columns (purchased from Bio Basic Canada 
Inc.). The protocol is otherwise identical to that of the Qiagen Gel Extraction kit. 
2.2.4 Transformation of Competent Cells 
50 µl of cells were thawed on ice then 50-500 ng of plasmid (depending on purpose and cell line) 
was added and incubated on ice for 5-30 min. The cell line used depended on the purpose: C41 was 
used for the majority of protein expression, B834 cells were used for the expression of proteins 
incorporating unnatural amino acids, α-Select Bronze for miniprepping a known plasmid (for 
increasing stocks) and α-Select Gold for miniprepping a newly ligated plasmid where reliability is key. 
The tubes were then heat shocked by heating to 42°C for 45 s in a water bath and then returned to 
ice for a further 2 min. 200 µl of fresh 2xTY medium without antibiotics was added to the aliquot and 
the tube was incubated in a shaking incubator at 37°C at 550 rpm and allowed to grow out for 1 hr. 
The transformed cells were then plated out on an LB agar plate containing the appropriate antibiotic 
and incubated in a static incubator at 37°C overnight.   
2.2.5 Plasmid Amplification and Purification by Miniprep 
α-Select Gold or Bronze-efficiency competent cells are E. coli strains optimised for plasmid 
production used by our lab for creating new plasmids stocks or amplifying existing ones respectively. 
After transforming as described in Section 2.2.4, the plates were then refrigerated at 4°C until later 
that day when individual colonies (3 or 4 per plate) were picked and inoculated into 5 ml of 2xTY 
media containing the appropriate antibiotics and grown overnight at 37°C in a shaking incubator. 
The cells from the overnight culture were harvested by centrifugation at 1000 g for 10 min at 4°C, 
after which the supernatant was discarded. Plasmids were extracted and purified from the cell pellet 
using a method of plasmid purification derived from Birnboim and Doly (1979) and Vogelstein and 
Gillespie (1979). Premade kits are available for this (e.g. Qiagen Miniprep kit) but our lab prefers to 
use our own buffer recipes, detailed in Section 2.1.3, and EZ-10 spin columns (purchased from Bio 
Basic Canada Inc.). The protocol is otherwise identical to that of the Qiagen Miniprep kit. 
The purified plasmids concentration and purity was determined by spectrophotometry using a 
NanoDrop 2000 UV-Vis spectrophotometer (Thermo Scientific) and it sequence determined by 
Eurofins Genomics Sanger sequencing service.  
2.2.6 Site-Directed Mutagenesis (SDM) 
Matched ssDNA oligonucleotide primer pairs, each with the desired mutation encoded within them, 
were designed by visual inspection of the DNA sequence determined as described in Section 2.2.5. 
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Primers were designed to ideally have a melting temperature (Tm) 60- 72°C as determined by NEB’s 
Tm calculator. For the Phusion™ High-Fidelity DNA Polymerase (Phusion), Tm is calculated using  the 
formula described by Breslauer et al., (1986) corrected for different salt concentrations using the 
Schildkraut formulae detailed in Owczarzy et al., (2004). For Q5® High-Fidelity DNA Polymerase (Q5), 
Tm is instead calculated using the formulae described in (SantaLucia, 1998), similarly corrected for 
salt concentrations. The primers were also designed to ideally have a GC content 50-60% and an 
overlap of at least 10 bases. All the primers used are listed in Appendix A. 
Site-Directed Mutagenesis (SDM) was performed by Polymerase Chain Reaction (PCR) to incorporate 
and amplify mutations encoded by the primer pairs. Reactions were carried out using either Phusion 
or Q5 (both NEB) polymerases and a Techne TC-512 Thermocycler (Bibby Scientific Inc.) using the 
reaction mixture described in Table 2-5 and the reaction conditions described in Table 2-6. 
Table 2-5: Reaction mixtures for SDM by PCR 
Phusion™ Q5® 
10 µl 5x Phusion GC Buffer 10 µl 5x Q5 Reaction Buffer 
2.5 µl 10 µM Forward Primer 2.5 µl 10 µM Forward Primer 
2.5 µl 10 µM Reverse Primer 2.5 µl 10 µM Reverse Primer 
1 µl 10 mM dNTPs 1 µl 10 mM dNTPs 













50 µl  Final Volume 50 µl  Final Volume 
Table 2-6: Reaction conditions for SDM by PCR  
Step Phusion™ Q5® 
Initial Denaturation 98°C 2 min 98°C 2 min 














1 min per kb 
Final Extension 72°C 5-10 minutes 72°C 5-10 minutes 
Hold 4°C  4°C  
*The Tm of the primer pair, as determined by NEB’s Tm calculator was used for the Annealing 
temperature 
All SDMs were initially attempted using Phusion™. After the PCR is complete, 1 µl of HF-DpnI was 
added to the reaction mixture and was incubated at 37°C for at least 2 hrs to remove the methylated 
template DNA before being analysed by agarose gel electrophoresis. The desired product were 
purified by gel extraction, as described in Section 2.2.3, then transformed directly into α-Select 
Bronze cells, as described in Section 2.2.4, and miniprepped, as described in Section 2.2.5.  
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If the SDM fails first time the PCR was repeated with Phusion™ but lowering the annealing 
temperature by 5°C. If it fails a second time, the PCR is attempted with Q5®, and if it still fails, then 
the primers were redesigned or Round-the-horn PCR was attempted, as described in section 2.2.7. 
2.2.7 Round-the-horn (RTH) PCR 
For more difficult SDMs, and for the removal of larger sections of DNA, Round-the-horn (RTH) PCR 
(OpenWetWare, 2013) was employed. Primers are purposely designed not to overlap, but are 
instead back to back in the sequence, with the desired mutation encoded in a single primer in the 
most 5’ position, such that the end will not anneal to the wild-type sequence. Ideally Tms of 60-72°C 
and GC contents of 50-60% were chosen.  
This method of PCR results in blunt ended dsDNA (see Figure 2-1b) that requires ligating before 
transformation, so the primers need to be 5’-phosphorylated before the PCR. This was done using T4 
Polynucleotide Kinase (PNK) (NEB). The reaction was set up as described in Table 2-7 below, 
incubated at 37°C for 30-60 min, then heat inactivated by heating to 65°C for 20 min. 
Table 2-7: Reaction mixture for T4 Polynucleotide Kinase 
T4 Polynucleotide Kinase (PNK) 
1 µl 10x T4 DNA Ligase buffer* (1 µM final concentration ATP) 
1 µl 100 µM Forward Primer 
1 µl 100 µM Reverse Primer 
1 µl PNK (1 unit**) 
6 µl mQ water 
10 µl Total Volume 
*T4 PNK comes supplied with its own 10x buffer, which does not contain 10 µM ATP. NEB has stated 
that PNK functions to 100% efficiency in their T4 DNA Ligase buffer, which does contain ATP. 
**1 unit is defined as the amount of enzyme catalysing the incorporation of 1 nmol of acid-insoluble 
[32P] in a total reaction volume of 50 μl in 30 minutes at 37°C in 1X T4 Polynucleotide Kinase 
Reaction Buffer with 66 µM [γ-32P] ATP (5 x 106 cpm/µmol) and 0.26 mM 5´-hydroxyl-terminated 
salmon sperm DNA. 
PCR is then performed as described in Tables 2-5 and 2-6, except that 2.5 µl of the phosphorylated 
primer mixture, which contains 10 µM each of forward and reverse primer, and an additional 2.5 µl 
of mQ water were used in place of the normal 2.5 µl each of 10 µM forward and reverse primers. 
After the PCR is complete, the mixture was DpnI digested, analysed and gel extracted as described in 
Section 2.2.6, then the gel extracted DNA was ligated using QuickStick Ligase as described in Table 2-
4, before being transformed into α-Select Bronze cells, as described in Section 2.2.4, and 
miniprepped, as described in Section 2.2.5. 
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2.3 Protein Expression 
For almost all recombinant protein expression, E. coli strain C41 competent cells were used. 50 µl 
aliquots were transformed with the plasmid of choice as described in Section 2.2.4. Colonies were 
collected from the agar plate and inoculated into fresh, sterilised 2xYT culture medium containing 
the appropriate antibiotic at 1 ml of stock solution per 1 l of medium and grown at 37°C in a shaking 
incubator until OD600 = 0.6. At this point they were induced with 0.5 mM IPTG and grown overnight 
(18 hrs.) at 25°C. Protein was either expressed on a small scale as a test of expression levels, using 5 
ml of 2xYT in a 50 ml falcon tube, or on a large scale to create a stock for further experimentation, 
using 2 l or more of 2xYT in 0.5 l aliquots in a 2 l Erlenmeyer flask.  
For large scale expressions, the cells were harvested by centrifuging at 8000 g for 8 minutes. The 
supernatant was decanted and the cell pellet was either immediately resuspended in the 
appropriate lysis buffer as described in Section 2.5.1, or collected and stored at -20°C for lysis at a 
later date. 
Figure 2-1 – Site-directed Mutagenesis (SDM):  A comparison of the processes of “normal” SDM (A) and Round-the-horn 
(RTH) PCR (B). In normal SDM, the desired mutation (red) is incorporated into both PCR primers, whereas in RTH PCR, the 
mutation is present in only one primer and mutated region does not anneal to the template plasmid. (A) is better for small 
changes of one or a few base pairs, and (B) is better for larger mutations, deletions and insertions. 
A B 
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2.4 Testing Protein Expression (Small Scale Preparation) 
BugBuster® Master Mix (hence forth referred to simply as BugBuster) is a cell lysis agent that 
contains protein solubilising agents, including detergents, Benzoase® Nuclease and lysozyme 
designed to extract soluble proteins from cell pellets.  
2 ml of culture from a 5 ml preparation was pelleted by centrifuging at 14000 g for 10 min at room 
temperature, and the supernatant discarded. The cell pellet was resuspended in 600 µl of BugBuster 
and incubated at room temperature for 20 min on a rotator. 30 µl of the lysate was removed as a 
sample of total cell protein to be analysed by SDS-PAGE later, before the lysate was pelleted by 
centrifuging at 14000 g for 10 min. 30 µl of the supernatant was removed as a sample of total 
soluble protein to be analysed by SDS-PAGE. 
The insoluble fraction was then analysed by first discarding the supernatant and washing the 
pelleted debris twice by resuspending in 1 ml of 10% BugBuster in mQ water, repelleting by 
centrifuging at 14000 g for 10 min at room temperature, and discarding the supernatant. The 
remaining pellet was then resuspended in 300 µl of BugBuster and 30 µl was removed as a sample to 
be analysed. 
2.5 Protein Purification (Large Scale Preparation) 
2.5.1 Cell lysis 
Fresh or frozen cell pellets were resuspended with 10 ml per 1 l of cell culture of the appropriate 
lysis buffer. The cell suspension was then lysed at 12000 psi using an EmusliFlex-C5 cell cracker 
(Avesin). A 10 µl sample of total cell lysate was taken for later analysis by SDS-PAGE, as described in 
Section 2.5.4. The lysate was then centrifuged at 35000 g for 35 min at 4°C, and the supernatant 
containing the soluble proteins was collected. A 10 µl sample of total soluble protein was taken for 
SDS-PAGE analysis.  
2.5.2 Batch Purification 
For proteins containing a thrombin-cleavable His-tag, nickel-NTA-agarose beads (Generon) (1 ml + 1 
ml per litre of culture) were washed with 50 ml of the appropriate wash buffer, to remove storage 
solution. The washed beads and the supernatant from Section 2.5.1 were combined and incubated 
for 1-2 hrs at 4°C on a nutator, rotating at 8 rpm. The mixture was then pelleted by centrifugation at 
1000 g for 5 min at 4°C, the supernatant, containing the unbound proteins, was collected and 
retained for SDS-PAGE analysis. The Ni-NTA beads with protein bound were then washed three 
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times by resuspending in 45 ml of Wash buffer, and then pelleted by centrifugation at 1000 g for 5 
min at 4°C. Each time the supernatant was collected and retained for SDS-PAGE analysis.  
The Ni-NTA beads were then resuspended in 5 ml of wash buffer and a 30 µl sample of the matrix 
before thrombin cleavage was taken for SDS-PAGE analysis. 25 units per 1 l of culture of thrombin 
from bovine plasma were added and then incubated for overnight at 4°C, rotating at 8 rpm to 
facilitate thrombin cleavage of the protein from the His-tag.  
Afterwards 1 ml of 1 M imidazole-HCl pH 7.4 was added to raise the imidazole concentration to 
approximately 200 mM and the suspension was mixed for a further 1 min before being pelleted by 
centrifugation at 1000 g for 5 min at 4°C. The supernatant was collected as the first elution. Two 
more elutions were obtained by resuspending the beads in 5 ml of the appropriate Elution buffer, 
mixing for 1 min, then pelleting by centrifugation at 1000 g for 5 min at 4°C, and collecting the 
supernatant. 
For proteins containing a thrombin-cleavable GST-tag, a similar protocol was used with the following 
exceptions: glutathione sepharose beads (Generon) were used in place of Ni-NTA-agarose beads; the 
beads with proteins bound were washed three times with High Salt Wash buffer and three times 
with Low Salt Wash buffer for a total of six washes; and the elutions were done using just Low Salt 
Wash Buffer 
2.5.3 Further Purification using Column Chromatography 
Soluble protein aggregates and DNA were removed using column chromatography on an Äkta Pure 
or an Äkta Purifier (GE Healthcare). For TCF7L2 constructs this was done by size-exclusion 
chromatography (SEC). A HiLoad™ 26/60 Superdex™ 75 column (G75) (GE Healthcare) was pre 
equilibrated with G75 buffer. The three elutions were combined, filtered using a Millex Express PES 
0.22 µm filter (Merck) and loaded onto the G75, and eluted with 1.2 column volumes (CV) of G75 
buffer. The fractions corresponding to A215 peaks were analysed by SDS-PAGE and the fractions 
containing >95% of the protein of interest were combined, then divided into aliquots, flash frozen 
with liquid nitrogen and stored at -80°C until use. 
For the Weis β-catenin construct, additional purification was done by anion exchange. A Mono-Q HR 
10/10 anion exchange column (MonoQ) (GE Healthcare) was pre-equilibrated with 3 CV of Low Salt 
MonoQ buffer. The three elutions were combined, diluted up to 45 ml, 0.22 µm filtered as above, 
loaded onto the MonoQ, and eluted using a linear gradient of High Salt MonoQ buffer over 15 CV. 
The fractions corresponding to A280 peaks were analysed by SDS-PAGE and the fractions containing 
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>95% of the protein of interest were combined. Purified β-catenin was snap frozen with dry ice and 
lyophilised under vacuum before being stored at -80°C until use. 
2.5.4 Protein Analysis by SDS-PAGE 
Samples from the output fractions from the Äkta were analysed in order to determine which contain 
the protein of interest, along with those taken throughout the purification process, in order to 
troubleshoot any potential problems, such as low yield. The samples were prepared as described in 
Table 2-8 below, however some samples contain higher concentrations of protein than others and 
so smaller volumes of these samples were used (see Table 2-9). 
The SDS-PAGE samples were heated 80°C for 10 min then 18 µl loaded into the wells of the gel. 
NuPAGE® Novex 4-12% Bis-Tris gels (Novagen) were used for LRRK2 constructs, RunBlue Bis-Tris 4-
12% gels (Expedeon) were used for TCF7L2 constructs and RunBlue SDS 4-20% gels (Expedeon) were 
used for β-catenin. Bis-Tris gels were run using their respective 1x MES-SDS at 200 V and 120 mA per 
gel for 45 min, the 4-20% SDS gels were run using 1x Teo-Tricine at 180 V and 110 mA per gel for 60 
min. Proteins were visualised with Coomassie Brilliant Blue G-250 as described Lawrence and Besir 
(2009) and the gels photographed under white light using an Alpha Imager.  
Table 2-8: SDS-PAGE sample preparation 
SDS-PAGE Samples 
5 µl 4x SDS Loading Buffer 
1-10 µl Sample 
1 µl 1 M DTT 
Up to 13 µl mQ water 
20 µl Total Volume 
Table 2-9: Amount of sample used in SDS-PAGE 
Sample Amount used 
Total cell lysate, total soluble protein, unbound protein 1 µl 
Wash 1/high salt wash 1, matrix before and after thrombin 5 µl 
All other washes, all elutions, all Äkta fractions, all BugBuster fractions 10 µl 
2.5.5 Estimation of Protein Concentration 
An estimation of protein concentration was obtained by measuring the absorbance at 280 nm (A280) 
using a NanoDrop 2000 UV-Vis spectrophotometer. The concentration of a substance can be 




                                                                            [2-1] 
Where C is the concentration in M, Ax is the absorbance value at x nm, εx is the extinction coefficient 
of that substance at x nm in M-1 cm-1, and l is the pathlength in cm. 
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The residues of tyrosine and tryptophan, and to a lesser extent phenylalanine and Cystine, the 
diamino acid formed by the formation of a disulfide bridge between two cysteine residues, absorb 
strongly at 280 nm. An estimation of ε280 for each of my constructs was obtained using ProtParam 
(Gasteiger et al., 2005) which uses the Edelhoch Method (Edelhoch, 1967): 
𝜀280(𝑃𝑟𝑜𝑡𝑒𝑖𝑛) = 𝑁𝑢𝑚𝑏(𝑇𝑦𝑟) × 𝜀280(𝑇𝑦𝑟) +  𝑁𝑢𝑚𝑏(𝑇𝑟𝑝) × 𝜀280(𝑇𝑟𝑝) +  𝑁𝑢𝑚𝑏(𝐶𝑦𝑠𝑡𝑖𝑛𝑒) × 𝜀280(𝐶𝑦𝑠𝑡𝑖𝑛𝑒) [2-2] 
Where ε280(Tyr) = 1490, ε280(Trp) = 5500, and ε280(Cystine) = 125. (Pace et al., 1995) 
Absorbance values for the NanoDrop are correct for a pathlength of 1 cm and the estimations of the 
ε280s of my constructs are listed in Table 2-10 below. 
Table 2-10: Extinction coefficients of protein constructs used in this Thesis 
Protein ε280 / M-1 cm-1 
LRRK2 ARM Construct 43400 
LRRK2 ANK Construct 14480 
LRRK2 LRR Construct 26065 
LRRK2 WD40 Construct 44055 
Weis β-catenin 32025 
TCF7L2 - 
The TCF7L2 constructs only contains a single phenylalanine which does not produces a strong 
enough absorbance signal to allow concentration to be determined by this method. The 
concentration of TCF7L2 stocks were estimated by Bicinchoninic Acid (BCA) assay, using a Pierce™ 
BCA protein Assay Kit (ThermoFisher) and determined more accurately by ion-exchange-ninhydrin 
analysis performed by Dr. Peter Sharratt at the University of Cambridge PNAC Facility. 
2.5.6 Confirmation of Protein Identity 
Purified proteins were analysed by ion-exchange-ninhydrin analysis as described in Section 2.5.5 to 
determine amino acid composition and protein concentration and by matrix-assisted laser 
desorption/ionisation time of flight (MALDI TOF) mass spectroscopy, performed by Dr. Len Packman 
also at the PNAC Facility. Corroboration between these two analytical techniques was taken as 
evidence that the isolated protein was the protein of interest. 
2.6 Fluorescent Labelling 
2.6.1 Labelling Lysine Residues with Fluorescein Isothiocyanate (FITC) 
The isothiocyanate moiety reacts with amines and also sulfhydryl groups by a simple addition 
reaction, reacting faster at the less crowded ε-amines of lysine residues than the N-terminal amine 
group.  
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A 500 µl aliquot of TCF7L2 (1-54) in 1x PBS was buffer exchanged using a Centri Pure P5 desalting 
column (Generon) into a buffer containing 10 mM phosphate between pH 9 and 10, and 1 M NaCl. 
This is to ensure that the amine moieties were deprotonated. 10 mM FITC in 100% DMSO was added 
to a 5 times molar excess and incubated at 37°C in an opaque, black microfuge tube in the dark for 
at least 3 hrs.  
Excess unreacted FITC was removed by buffer exchange into 1xPBS using a PD MidiTrap G-10 column 
(GE Healthcare). The collected fractions with analysed by SDS-PAGE, visualised and photographed 
under UV light before Coomassie staining, then visualised and photographed again under visible light 
after Coomassie staining (see Figure 2-2). Fractions that contained protein of the correct molecular 
weight, which also fluoresced under UV light were collected and pooled. Excess FITC ran at the same 
molecular weight as the dye front. Final concentration of protein was determined by BCA assay and 
final label concentration was determined by Nanodrop, using the extinction coefficient ε519 = 68000. 
Labelling efficiency was determined by comparison of label and protein concentrations.  
 
2.6.2 Labelling Cysteine Residues with Fluorescein Maleimide 
The maleimide functional group reacts with sulfhydryl groups via nucleophilic conjugation addition 
and so can be used to label proteins at cysteine residues. A 500 µl aliquot of TCF7L2 (1-54) construct 
containing a cysteine residue in 1x PBS buffer with 1 mM DTT was buffer exchanged into fresh 1x 
PBS without DTT, as described in Section 2.6.1. Fluorescein maleimide also reacts with the sulfhydryl 
groups present in DTT, which is in vast excess of the protein and so needs to be removed before 
labelling. 20 mM fluorescein maleimide in 100% DMSO was added to a 5 times molar excess and 
incubated at 37°C in an opaque, black microfuge tube in the dark for at least 1 hr.  
Figure 2-2 – SDS-PAGE analysis of FITC labelled TCF7L2 (1-54). Visualised with UV-light before Coomassie Blue staining 
(left) and white light after Coomassie Blue staining (right). Lane 1 – ladder; 2 – labelling reaction mixture; 3-10 – fractions 
1-8. 
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Excess fluorescein maleimide was removed using a method developed by Vivès and Lebleu (2003). 
10x volume of acetone, pre-chilled to -20°C, is added to the labelling reaction mixture, mixed by 
vortex, and incubated at -20°C for 30 min. Fluorescein, and its derivatives, are very soluble in 
acetone, whereas peptides and proteins are insoluble in acetone. The addition of acetone to 90+% 
causes the protein to precipitate out of solution, while the unreacted fluorescein maleimide remains 
in solution. The reaction mixture was centrifuged at 15000 g at 4°C for 10 min to collect the 
precipitated, labelled, protein and the supernatant removed and the pellet was resuspended in 1x 
PBS. This acetone wash process is repeated twice more but the precipitated protein pellet was not 
resuspended on the final wash. The pellet is left at room temperature, in the dark, and open to the 
air for 16 hrs to ensure that any residual acetone has evaporated away, after which the desiccated 
labelled-TCF7L2 can be stored at 4 °C for up to 5 days.  
 
2.7 Isothermal Titration Calorimetry (ITC) 
ITC measurements were performed using VP-ITC Calorimeter (Malvern, formally Microcal). Both β-
catenin and TCF7L2 construct after labelling are stored as lyophilised powders. To ensure matched 
buffers, lyophilised β-catenin was resuspended in mQ water and the buffer exchanged into fresh 50 
mM Tris pH 8.9, 100 mM NaCl 2 mM DTT using Centri Pure P5 desalting column and the TCF7L2 was 
resuspended in the same buffer. Unlabelled TCF7L2 was washed with acetone three times, as 
described in Section 2.6.2 to produce the lyophilised pellet. β-catenin was used at a concentration of 
2-4 µM and TCF7L2 was used at 6-10x higher concentration (18-40 µM). Blank titrations of TCF7L2 
into water and water into β-catenin were performed to demonstrate that the reaction observed was 
a binding interaction. All experiments were performed at 30°C. 
Figure 2-3 – SDS-PAGE analysis of fluorescein maleimide labelled TCF7L2 S31C (1-54). Visualised with UV-light before 
Coomassie Blue staining (left) and white light after Coomassie Blue staining (right). Lane 1 – Ladder; 2 – Unlabelled 
TCF7L2 S31C stock; 3 – labelling reaction mixture; 4-6 – supernatant from acetone washes 1-3; 7 – resuspended TCF7L2 
after 3 washes; 8-12 – empty lanes. 
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Data was fitted using Origin software package (Malvern, formally Microcal) using the one site 
binding equation to calculate the equilibrium association constant, Ka, enthalpy change, ∆H, entropy 
change, ΔS, and stoichiometry, n, of binding. 
2.8 Kinetic Studies by Stopped-Flow Spectroscopy 
Stopped-flow spectroscopy was performed using a SX-19 Stopped flow fluorimeter (Applied 
Photophysics) in fluorescence mode. Excitation and emission wavelengths were set to 495 nm and 
519 nm respectively and a 515 nm long-pass filter was used to improve the signal to noise ratio. All 
proteins were prepared in fresh 1x PBS buffer with 1 mM DTT and the experiments performed at 
15°C, except when otherwise stated. 
For association experiments, a fixed concentration of labelled TCF7L2 construct was rapidly mixed, in 
a 1:1 ratio, with varying concentrations unlabelled β-catenin and the change in fluorescence 
intensity was recorded. The β-catenin concentrations were chosen to be at least ten times higher 
than that of the TCF7L2 to ensure a pseudo-first order association reaction. A final concentration 10 
nM TCF7L2 was used and the final concentration of β-catenin was varied between 100 nM and 1000 
nM. 
For dissociation experiments, a complex of labelled TCF7L2 and β-catenin was pre-formed by mixing 
to two proteins in a 1:1 molar ratio and incubating them at 15°C for 1 hr in the dark to reach 
equilibrium. The pre-formed complex was then mixed in a 1:1 ratio with 50 times molar excess 
unlabelled WT TCF7L2 and the change in fluorescence intensity was measured. The final 
concentration of complex used was 200 nM with a final competitor concentration was 10 µM. 
A total of five traces for each concentration of β-catenin were collected, and a minimum of three 
traces, usually all five, were averaged. The average curve was plotted using GraphPad Prism 6 
(GraphPad Software, Ltd), and fitted with either a one- or two-phase exponential equation: 
𝑦(𝑡) = 𝐴𝑒−𝑘𝑡 + 𝑏𝑡 + 𝑐                                                            [2-3] 
𝑦(𝑡) =  𝐴1𝑒
−𝑘1𝑡 + 𝐴2𝑒
−𝑘2𝑡 + 𝑏𝑡 + 𝑐                                                [2-4] 
Where y(t) is the fluorescence intensity at time, t; An and kn are the amplitude and rate constant of 
phase n, respectively; b is correction factor for linear drift as a result of photo-bleaching (only 
relevant for very long recordings) and c is the fluorescence intensity when the trace has reached a 
plateau. In all cases the first 2 ms of each trace was excluded from the fit to reduce error brought 
about by incomplete mixing of the two binding partners. 
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For association experiments, the observed rate constant, kobs, was then plotted against the 
concentration of β-catenin and kon calculated from the linear fit: 
𝑘𝑜𝑏𝑠 = 𝑘𝑜𝑛[βcatenin] + 𝑐                                                          [2-5] 
2.9 Kinetic Studies by Fluorescence Spectroscopy 
After it was found that the stopped-flow was unsuitable for recording over sufficiently long time 
scales to measure complex dissociation, time-dependent fluorescence spectroscopy was performed 
using a LS55 Luminescence Spectrometer (Perkin-Elmer) using a cell of pathlength 10 mm. Excitation 
and emission wavelengths were set to 495 nm and 519 nm respectively, shutter width was 5 nm and 
excitation voltage was 650 V. All proteins were prepared in fresh 1x PBS buffer with 1 mM DTT and 
the experiments performed at 15°C, except when otherwise stated. 
For dissociation experiments, a complex of labelled TCF7L2 and β-catenin was pre-formed by mixing 
to two proteins in a 1:1 molar ratio and incubating them at 15°C for 1 hr in the dark to reach 
equilibrium. The pre-formed complex was then mixed in a 1:1 ratio with 50 times molar excess 
unlabelled WT TCF7L2 and the change in fluorescence intensity was measured. Individual traces 
were fitted with Equations [2-3] and [2-4]. 
2.10 Equilibrium Studies by Fluorescence Anisotropy 
Fluorescence spectroscopy was performed using a LS55 Luminescence Spectrometer (Perkin-Elmer) 
using a cell of pathlength 10 mm. Excitation and emission wavelengths were set to 495 nm and 519 
nm respectively, shutter width was 10 nm and excitation voltage was 750 V. All proteins were 
prepared in fresh 1x PBS buffer with 1 mM DTT and the experiments performed at 15°C, except 
when otherwise stated. 
Titrations of β-catenin in 42 steps were performed using a Microlab 500C series dispenser (Hamilton 
Company). These titrations were divided into 20 steps of 1 µl, followed by 10 steps of 2 µl, followed 
by 12 steps of 5 µl, for a total of 100 µl added to 1 ml of TCF7L2 construct in a cuvette. The solution 
in the cuvette was stirred for 30 s then incubated for a further 60 s before the fluorescence intensity 
and polarisations were recorded.  
Anisotropy is measured as: 
𝑟 =  
(𝐼𝑉𝑉−𝐺𝐼𝑉𝐻)
(𝐼𝑉𝑉−2𝐺𝐼𝑉𝐻)
                                                                   [2-6] 
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Where IVV is the fluorescence intensity with both polarisers aligned vertically, IVH is the fluorescence 
intensity with the excitation polariser aligned vertically and the emission polariser aligned 




                                                                          [2-7] 
Where IHV is the fluorescence intensity with the excitation polariser aligned horizontally and the 
emission polariser aligned vertically and IHH is the fluorescence intensity with both polarisers aligned 
horizontally. The grating factor is a correction factor to allow for differences in instrument 
polarisation. For these experiments, 1.09 ≤ G ≤ 1.12, and titrations did not commence until G 
measurements were stable to 2 d.p.s. 
Fluorescence measurements need to be corrected for dilution. All data was plotted in GraphPad 
Prism 6 and was fitted to the following equations: 
Polarisation, accounting for ligand depletion –  
𝑟 = 𝑟𝑚𝑖𝑛 +
(𝑟𝑚𝑎𝑥− 𝑟𝑚𝑖𝑛)×(𝑏−√𝑏2−4𝑐)
2𝑎
                                                  [2-8] 
Where r is the anisotropy reading, 𝑎 = [𝑇𝐶𝐹7𝐿2], 𝑏 = [𝑇𝐶𝐹7𝐿2] + [βcatenin] + 𝐾𝑑, 𝑐 =
[𝑇𝐶𝐹7𝐿2] × [βcatenin], rmin is the free ligand polarisation, and rmax is the saturation polarisation, for 
constant [TCF7L2]. 
Hills Equation -  





                                                [2-9] 
Where r is the anisotropy reading, rmin is the free ligand polarisation and rmax is the saturation 
polarisation, and H is the Hill’s coefficient. 
Mono-Wyman-Changeux (MWC) model - 




The MWC model (Monod, Wyman and Changeux, 1965; Stefan, Edelstein and Le Novère, 2009) is 
another model which accounts for cooperativity in multiple ligand binding. The MWC model 
assumes that there are n identical ligand-binding sites, where each undergo concerted allosteric 
transitions. These binding sites are assumed to adopt two conformations, a “tense”, low ligand-
affinity conformation, “T”, and a “relaxed”, high ligand-affinity conformation, “R”. L in Equation 2-10 
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is a constant defined as the ratio of binding sites in the “tense” conformation to those in the 
“relaxed” conformation in the absence of ligand: 𝐿 =  [𝑇0] [𝑅0]⁄ . K
R is the association constant for 
the “relaxed” state and the constant c in Equation 2-10 is the ratio of association constants for 
“tense” and “relaxed” states 𝑐 =  𝐾𝑇 𝐾𝑅⁄ . 
2.11 Errors 
The error in the sum a + b = c, γ 
𝛾 = √α2 + β2                                                                 [2-11] 








2                                                        [2-12] 
The error in the exponential exp(a) = c, γ 
𝛾 = 𝑎 × 𝛼                                                                      [2-13] 
The error in the logarithm ln(a) = c, γ 
𝛾 = 𝛼 𝑎⁄                                                                         [2-14] 







⁄                                                   [2-15] 
And the error in the weighted mean, <a>, <α> 
< 𝛼 >= √
∑ ((𝑎𝑖−< 𝑎 >) α𝑖)2⁄
𝑛
𝑖=1
(𝑛 − 1) ∑ α𝑖−2
𝑛
𝑖=1
⁄                               [2-16] 
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Chapter 3 – LRRK2: From Model to Molecule 
The original intended subject of my studies was the protein Leucine-Rich Repeat Kinase 2, hereafter 
referred to as LRRK2. This very large, 2527 residue protein has been strongly linked to familial 
Parkinson’s disease. It is believed to be comprised of seven domains: A MAPKKK-like, 
serine/threonine kinase domain; a Roc (Ras of complex proteins) domain encoding a GTPase; a COR 
(C-terminal of Roc) domain forming a catalytic core; and four protein-protein interaction domains 
predicted to be ARM repeat, ANK repeat, LRR and WD40 repeat domains (Mills et al., 2012). At the 
time of writing, the structure of this protein is largely unsolved, with only the isolated COR-domain 
being solved (PDB ID 2ZEJ) (Deng et al., 2008). 
This project originated from the paper, Analysis of LRRK2 Accessory Repeat Domains: Prediction of 
Repeat Length, Number and Sites of Parkinson's Disease Mutations by Mills et al. (2012). In this 
paper Mills et al. used homology modelling to predict the structure of the four repeat domains. The 
purpose of this project was to biophysically and structurally characterise these domains, both in 
isolation and in the context of the whole protein.  
LRRK2 has been shown to interact with a large number of different protein partners (Kang and 
Marto, 2017). So after these domains have been characterised the goal was then to determine 
where and how a number of these partner interact. This can then serve as basis for the design of 
small molecule inhibitors for those interactions. 
In this Chapter I describe my efforts to design, express and purify proteins constructs corresponding 
to the four tandem repeat domains described in Mills et al. (2012), first in isolation, then by co-
expressing the individual constructs. 
3.1 Designing LRRK2 Constructs 
The full-length protein sequence was taken from UniProt’s Protein Knowledgebase, ID Q5S007, and 
compared to the proposed repeat-containing regions described in Mills et al., (2012) (See Appendix 
A, Section A.1). The main consideration, when designing the initial constructs, was that the predicted 
locations of the repeats may be inaccurate and that repeat proteins tend to have accessory loops N- 
and C-terminal of the repeating region to aid overall stability, so as many as was reasonable amino 
acids were included either side of the repeating region. The other main consideration during the 
initial design was that I wanted to study the domains in isolation from each other, so the constructs 
were designed such that their sequences did not overlap. The nucleotide base sequence used was 
taken from NCBI’s Gene Bank, file 120892. 
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The ARM repeat domain is the largest and most N-terminal of the predicted domains, with fourteen 
proposed repeats of 42 aa (residues 49-657 aa). The construct designed to represent this domain 
comprises residues 1-661 aa. The ANK repeat domain is the next domain predicted in the sequence 
and is also the smallest with seven repeats of 33 aa (residues 676-902 aa). The construct designed to 
represent this domain comprises residues 668-928 aa. The LRR repeat domain is the last of the 
predicted N-terminal domains with fourteen repeats of 24 aa (residues 984-1320 aa). The construct 
designed to represent this domain comprises residues 979-1328 aa. Finally the WD40 repeat domain 
is predicted to be at the C-terminus, after the catalytic domains, and is comprised of 7 repeats of 40 
aa (residues 2164-2515 aa). The construct designed to represent this domain comprises residues 
2159-2527 (see Appendix A, Sections A.1.1-4).  
All four constructs were given a 5’ (N-terminal) methionine codon and a 3’ (C-terminal) stop codon 
where appropriate. They were also given BamHI and HindIII cloning sites as the 5’ and 3’ end 
respectively. 
An estimate of the biophysical properties of the four artificial constructs was obtained using ExPASy 
ProtParam (Gasteiger et al., 2005). The key properties of interest are: the molecular weight, so the 
construct proteins could be identified by SDS-PAGE; the extinction coefficient at 280 nm (ε280), so the 
concentration of protein could be obtained by spectrophotometry; and the theoretical isoelectronic 
point (pI) as this represents the pH at which there is no net charge on the protein and therefore 
buffers should have a pH at least 1 unit above or below this value. The pIs of my four constructs 
were 5.48, 4.99, 6.50 and 8.93 for ARM, ANK, LRR and WD40 respectively, so a pH of 7.4 was chosen 
for buffers. While not ideal for the LRR construct it did at least serve as a starting point.  
It also so happened that all of my constructs naturally contain at least one tryptophan residue, so it 
may be possible to measure biophysical properties through intrinsic fluorescence (see Table 2-10 in 
Section 2.5.5), providing they are in a solvent-responsive microenvironment. They also all contain 
cysteine and lysine residues for labelling with dyes if intrinsic fluorescence is not suitable. The codon 
usage was optimised for E. coli expression whilst conserving BamHI and HindIII cloning sites using 
GeneArt (Life Technologies). 
3.2 Initial Expression Tests Showed Proteins were Present but Insoluble 
Once all of my constructs had been subcloned into expression vectors, a small-scale expression was 
performed as described in Section 2.3, and the proteins extracted with BugBuster according to 
Section 2.4 except that a sample of total cell protein was also taken from the pre induced cells. Each 
of the individual constructs expressed but none of them showed a significant degree of soluble 
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expression (see Figure 3-1). Three of the constructs, His-tagged WD40, GST-tagged ANK and GST-
tagged LRR, showed a significant amount of insoluble expression (lane 1 of (B), (C) and (E) 
respectively). 
Figure 3-1 – Initial expression test of four LRRK2 constructs in different expression vectors. Visualised by Coomassie blue 
staining (A) WD40 construct in pRSET-GST vector (Mw ≈ 67.5 kDa); (B) WD40 construct in pRSET vector (Mw ≈ 41.5 kDa); (C) 
ANK construct in pRSET-GST vector (Mw ≈ 52.7 kDa); (D) ANK construct in pRSET vector (Mw ≈ 26.7 kDa, but runs higher); 
(E) LRR construct in pRSET-GST vector (Mw ≈ 66.1 kDa); (F) ARM construct in pRSET-GST vector (Mw ≈ 100.5 kDa). The 
expected position is denoted by . Lanes marked 1 are the insoluble protein fraction; 2 are the soluble protein fraction; 3 
are the total cell protein after induction with IPTG; and 4 are the total cell protein before induction. The protein ladder was 
the same for all gels. 
(A) (B) 
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Hexa-His tagged WD40 ((B) in Figure 3-1) appeared to show the highest expression but it was 
difficult to tell the relative level of soluble expression due to the ubiquitous band at ≈ 40 kDa, and so 
a larger-scale expression was attempted, performed as described in Section 2.3. Two different 
methods were used in an attempt to isolate and purify the soluble fraction. First an attempt was 
made using SEC as described in Section 2.5.3 using a HiLoad™ 26/60 Superdex™ 75 column, and the 
second was made using a Mono S 5/50 GL (GE Life Sciences) cation exchange column in the place of 
the MonoQ. Neither attempt was successful, as there was too little soluble protein to be isolated 
(see Figure 3-2). Whilst washing the Mono S column with 20% ethanol afterward, a large peak was 
observed within one column volume that could have corresponded to protein. 
A third large scale purification attempt was made, this time using the GST-fused ANK construct ((C) 
in Figure 3-1) as described in Sections 2.3 and 2.5.2. The samples, including the insoluble fraction 
were analysed by SDS-PAGE before Äkta purification was attempted. The gel revealed that there was 
no ANK construct protein present in any of the elutions and only a very small amount was present 
on the glutathione sepharose matrix after thrombin cleavage. Almost all of the protein was in the 
insoluble fraction (see Figure 3-3, lane 3).  
Figure 3-2 – Analysis of larger scale expressions. The top trace is the elution profile from the first attempt to purify WD40 
in pRSET. The graph shows how the absorption at 215 nm (purple - peptide bond), 260 nm (red - nucleic acids) and 280 nm 
(blue - protein fluorescent residues) changed with elution volume. The second trace is the elution profile from the attempt 
to purify WD40 in pRSET by Mono S.  
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3.3 Screening Lysis Additives 
A recent paper by Leibly et al. (2012) has shown that many recombinant proteins only become 
insoluble during the lysis stage of recombinant protein purification, as chaperones and other cellular 
stabilising agents are removed or destroyed, and that a number of compounds could be added to 
the lysis buffer to successfully obtain soluble protein from previously insoluble expression. A list of 
144 additives was compiled, from which they obtained a short list of sixteen that were successful in 
rescuing multiple recombinant proteins (see Table 3-1).  
These sixteen additives were added to BugBuster, to the concentration described in Table 3-1 and a 
1 l expression of ANK in pRSET was prepared as described in Section 2.3. The cell pellet was then 
washed with 500 ml 1x PBS, repelleted, and then resuspended in 500 ml of 1x PBS. 2 ml aliquots 
were removed and the protein extracted as described in Section 2.4 using the BugBuster containing 
the various additives and the fractions were analysed by SDS-PAGE. None of the additives had the 
desired effect of solubilising the ANK construct, although it is interesting to note that sodium 
selenite resulted in the band predicted to be the ANK construct running lower than it had for the 
other additives (see Figure 3-4). Nothing in the literature make a reference to this observed effect. 
 
 
Figure 3-3 – SDS-PAGE analysis of the attempted purification of GST-fused ANK. Lane 1 - Total cell protein; 2 - Total 
soluble protein; 3 - Total insoluble protein; 4 - Unbound protein; 5-7 - Matrix washes 1-3; 8 - Matrix after thrombin 
incubation; 9-11 - Elutions 1-3. The top  indicates the expected position of the GST-ANK fusion protein and the bottom 
indicates that of just the ANK protein. 
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Table 3-1: Short list of additives used by Leibly et al..   
Compound Concentration Compound Classification 
Trehalose 0.75 M 
Naturally occurring sugars Mannitol 0.5 M 
Xylitol 1 M 
Glycine betaine 1 M 
Zwitterionic osmolytes 
TMAO 1 M 
L-proline 0.5 M 
L-arginine 0.375 M 
NDSB 195 1 M Non-naturally occurring 
zwitterions NDSB 201 1 M 
Trisodium citrate 0.1 M 
Naturally occurring salts 
Dipotassium hydrogen phosphate 0.1 M 
Sodium selenite 0.01 M Inorganic salt 
Copper (II) chloride 0.01 M Metal ion 
CTAB 0.5% (w/v) 
Detergents SDS 0.1% (v/v) 
Triton X-100 0.5% (v/v) 
3.4 Troubleshooting the Lack of Solubility 
There are a number of reasons that could explain why the designed constructs are insoluble whereas 
the parent protein is soluble. The first, in this case, is the fact that repeat proteins tend to very 
dependent on the stability of the terminal repeats. The internal repeats tend to be enriched with 
hydrophobic residues as large regions of the repeats’ surfaces tend to be packed against 
neighbouring repeats, and are reliant on these interactions with their neighbours for stability. 
Whereas the terminal repeats tend to be slightly more stable as they have only have one neighbour 
which can contribute to stability. So when the terminal repeat is destabilised to the point where it 
can no longer fold, it leads to a cascade of unfolding as the internal repeats lose stability provided by 
their neighbour as they successively unfold. Generally repeat proteins have extended terminal loops 
that fold across the first/last repeat giving increased stability. For my constructs, this could be 
rectified with additional subcloning to extend the loops and was the first solution attempted, 
however for some of the constructs it was not possible to provide an extended loop at both termini 
without extending into neighbouring domains.  
Another probable cause of the insolubility could be that the different domains interact with each 
other, lending stability to each other in an analogous way to the repeats within a repeating region, 
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and separating them as I have done has led to them being insoluble. This could be solved by either 
co-expressing the constructs or by fusing my constructs back together by subcloning. 
One final way to stabilise the insoluble constructs would be to express them in either a mammalian 
or insect system as these systems contain different protein chaperones which would be more similar 
to those found in human. The problem with this approach is that it is very difficult to scale up 
protein expression to the amounts obtainable in E. coli, and the sequence has already been codon-
optimised for E. coli expression, likely leading to slower expression and lower overall yields in these 
systems. A possible solution to this would be to attempt expression in the Pichia pastoris yeast 
system, which can have comparable expression levels to recombinant expression in E. coli. However 
our research group does not have the facilities for culturing P. pastoris and the set up would have 
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Figure 3-4 – Screening the effect of lysis additives on the solubility of my ANK construct. Visualised with white light after 
Coomassie blue staining. The top two gel photos show the total cell protein fractions and the bottom two show the total 
soluble protein fraction. The expected position is denoted by . Lanes C – Control; 1 – 0.75 M Trehalose; 2 – 1 M glycine 
betaine; 3 – 0.5 M mannitol; 4 – 0.1 M trisodium citrate; 5 – 1 M TMAO; 6 – 0.5 M L-proline; 7 – 1 M NDSB 195; 8 – 0.375 
M L-arginine; 9 – 1 M xylitol; 10 – 0.01 M sodium selenite; 11 – 1 M NDSB 201; 12 – 0.1 M dipotassium hydrogen 
phosphate; 13 – 0.01 M copper (II) chloride; 14 – 0.5% (w/v) CTAB; 15 – 0.1% (v/v) SDS; 16 – (v/v) Triton X-100. The 
protein ladder was the same for all gels. 
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3.5 Further Bioinformatics Studies of the Constructs 
Before designing the extensions the protein sequences were analysed for their propensity to form 
repeat structure from the sequence alone and there are a number of online resources that are able 
to do this. Historically it has been difficult to predict repeating structure, due to the amount of 
variation that can exist around the consensus sequence, especially the detection of the terminal 
repeats which tend to be significantly different in composition but not tertiary structure.  
A number of online repeat prediction programmes were first tested with proteins of known 
repeating structure. These test proteins were: β-catenin (UniProt ID P35222, PDB ID 2Z6H (Xing et 
al., 2008)), an ARM repeat protein; gankyrin (UniProt ID O75832, PDB ID 1UOH (Krzywda et al., 
2004)), an ANK repeat protein; internalin B (UniProt ID P25147, PDB ID 2Y5Q (Ebbes et al., 2011)), a 
Figure 3-5 – Crystal structures of known tandem 
repeat proteins. (A) β-catenin – 12 ARM repeats, (B) 
gankyrin – 7 ANK repeats, (C) internalin B – 7 LRRs, 
and (D) C-terminal domain of Tup1 – 7 WD40 
repeats. Structures were visualised in UCSF Chimera 
using the PDB IDs 2Z6H (Xing et al., 2008), 1UOH 
(Krzywda et al., 2004), 2Y5Q (Ebbes et al., 2011) and 
3DW8 (Sprague, 2000) respectively. Individual 
tandem repeats are coloured red to magenta from 
the N- to the C-terminus. 
A B C 
D 
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LRR repeat protein; and the C-terminal domain of Tup1 (UniProt ID P16649, PDB ID 1ERJ (Sprague, 
2000)), a WD40 repeat protein (see Figure 3-5). 
Three programmes were found to be fairly accurate: RADAR, which uses the RADAR algorithm 
(Heger and Holm, 2000; Goujon et al., 2010); Motif Scan (Pagni et al., 2007), which matches motifs 
against the ‘motif’ databases, Prosite (Sigrist et al., 2013), Pfam (Finn et al., 2014) and HAMAP 
(Pedruzzi et al., 2013); and InterProScan, which uses multiples algorithms including BLAST and 
HMMER to match protein sequence to data from multiple public databases (see paper for complete 
list (Jones et al., 2014)).  
For these four test proteins, RADAR was able to identify all ARM and LRR repeats including the 
terminal ones, all ANK repeats except the terminal ones, but none of the WD40 repeats. It also 
shifted the frame of the repeat motif in each case. Motif Scan was able to find all ARM repeats, all 
ANK and LRR repeats except for the terminal repeats and some WD40 but tended to underestimate 
the actual length of the repeat motifs. InterPro identified all ARM and WD40 repeats, all but one of 
the LRR repeats and all but two of the ANK repeats. However it was not especially accurate as to the 
location or length of the repeats but made up for the lack of accuracy by identifying “repeat-like 
domains” extending beyond the actual repeats.  
When my ARM construct was analysed, RADAR identified ten repeats in sets of four, three and 
three, compared to the thirteen predicted by Mills et al., which were not aligned as predicted by 
Mills et al.. InterPro was unable to identify any repeats but did identify an area of ARM-like fold that 
encompassed the predicted repeat region. Motif Scan, on the other hand, only identified a single 
potential ARM repeat with low certainty (see Figure 3-6a).  
Analysis of the predicted ANK domain was less conclusive. RADAR identified no repeating structure, 
Motif Scan identified a single potential ANK repeat with low certainty, and InterPro identified only 
the N-terminal half as being an ANK-like fold domain (see Figure 3-6b). 
When the predicted LRR domain was analysed, RADAR identified twelve of the fourteen predicted 
which were aligned as predicted by Mills et al., although again the frame was shifted.  Motif Scan 
identified only six repeats but with high confidence and InterPro predicted eleven repeats, with the 
three spaces between the predicted repeats, being the size of repeats (see Figure 3-6c). 
Analysis of the WD40 construct was also not particularly reassuring. RADAR identified some 
repeating structure but not anything resembling WD40 repeats and Motif Scan identified a single 
potential WD40 repeat with low certainty. However InterPro did identify that there was a WD40-like 
fold domain, encompassing most of the predicted repeat domain (see Figure 3-6d). 
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Figure 3-6 – Predicted repeat locations in the LRRK2 constructs. (A), (B), (C) and (D) are the ARM, ANK, LRR and WD40 
constructs respectively. The positions of the repeats, as predicted by Mills et al. are denoted in blue. Predictions by 
RADAR, Motif Scan and InterProScan are marked in green, yellow and purple respectively. 
A B 
C D 
Taken together these predictions suggest there is likely to be some inaccuracy in the predicted 
positions of the individual repeats and the repeat domains by Mills et al., which led me to believe 
that extending the constructs may improve their solubility. Although tandem repeating structure has 
historically been difficult to predict, consensus sequences for these four motifs have been known for 
a while (Andrade et al., 2001; Li and Roberts, 2001; Mosavi, Minor and Peng, 2002; Bella et al., 
2008). The three prediction tools I have used all try to predict structural elements from proteins 
sequence whereas the predictions of Mills et al. come from homology modelling. Both techniques 
have different strengths and pitfalls and so corroboration between these two predictive methods 
gave me some confidence in the existence of the proposed repeats for the ARM and LRR constructs, 
less so for the ANK and WD40 constructs. 
3.6 Designing the Construct Extensions 
The ARM construct already extends all the way to the N-terminus of LRRK2 so it could only be 
extended from the C-terminus. However I then encountered the problem that the loop between 
ARM and ANK is quite short. In my original construct design, I had chosen not to have any sequence 
overlap between the four constructs in order to study the domains in isolation. However in order to 
extend the ARM construct in the hope of increasing expression level and solubility I had to overlap 
with the ANK construct. When I designed the original constructs, a hydrophobicity plot of each 
construct and the connecting loops was produced in order to help determine the optimum construct 
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length. During this process it was noticed that the N-terminal region of the ANK construct is 
particularly hydrophilic and so would help aid in solubilising the ARM construct. 
This overlap of the ARM and ANK construct, although not what I had originally intended, did allow 
me to plan ahead to future experiments. Silent mutation analysis (Palmer, 2014) was performed on 
the region where the two constructs would overlap and a potential unique BbsI restriction site was 
found. This restriction site would allow me to make a contiguous ARM-ANK domain fusion protein at 
a future point. The C-terminal ARM construct extension (see Appendix B, Section B.1.1) was 
designed to include this BbsI site as well as HindIII sites restriction sites at the 5’ and 3’ ends with 
which to subclone the extension. The stop codon at the end of the original ARM construct would 
need to be removed by RTH PCR afterwards, and the BbsI restriction site would need to be mutated 
into the ANK construct by SDM. 
Extending the ANK N-terminally did not seem to be a good idea as the ARM-ANK loops is short and 
the aforementioned hydrophobicity plots had shown the C-terminal region of the ARM construct is 
not particularly hydrophilic. The ANK-LRR loop, however, is long and quite hydrophilic and so a C-
terminal extension was designed for the ANK construct. It was not practical to design this extension 
to overlap directly with the LRR construct but as I intended to extend the LRR construct N-terminally, 
the C-terminal ANK extension was designed to overlap with the N-terminal LRR extension. Silent 
mutation analysis of the ANK construct revealed a potential AfeI restriction site in C-terminal region 
that would need to be introduced by SDM, so AfeI-HindIII was chosen for subcloning. Similar analysis 
of the ANK-LRR loop revealed a potential BbvCI restriction site which was chosen to facilitate 
crosslinking the ANK and LRR constructs (see Appendix B, Section B.1.3). 
The LRR construct was extended N-terminally rather than C-terminally to avoid extending into the 
COR domain and because the ANK-LRR loop was more hydrophilic and would allow the ANK and LRR 
domains to be fused. A potential SpeI restriction site was found in the N-terminal region of the LRR 
construct and so BamHI-SpeI was chosen for subcloning, and BbvCI was already chosen for 
crosslinking (see Appendix B, Section B.1.4). 
3.7 Subcloning the Extensions  
The extension for the ARM construct was ordered as a double-stranded DNA string from Life 
Technologies’ GeneArt. The C-terminal ARM extension, ARM construct in both pRSET and pRSET-
GST, was digested with HindIII, then digested ARM construct in it vectors was then treated with 
Antarctic phosphatase before being combined with the digested gene string and ligated as described 
in Section 2.2.2. The ligated plasmids were then amplified as described in Section 2.2.5 then sent for 
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sequencing (Source Bioscience). The results from sequencing revealed that all of plasmids were re-
ligated, original ARM construct.  
This process was repeated twice more with no positive results, at which point it was realised that the 
strings as designed did not include excess bases on either side of the cut sites, and HindIII is a 
restriction enzyme that requires a minimum of three excess bases for effective cleavage (NEB, no 
date). So primers had to be designed and ordered to extend the extension to the point where they 
could be digested with HindIII (see Appendix B, Section B.1.2). Fortunately I had not yet ordered the 
extensions for the ANK and LRR constructs and so their design could be rectified before I made the 
same mistake. 
The C-terminal ARM extension was extend using PCR, as described in Section 2.2.2, digested with 
HindIII, and ligated into the ARM constructs in each vector, as above. Again sequencing revealed no 
successful subcloning had occurred. 
3.8 Co-expression of the ARM, ANK and LRR Constructs 
In order to facilitate co-expression of my repeat domain constructs, an attempt was made to clone 
the ARM, ANK and LRR into the pET-41a(+) and pACYCDuet-1 plasmid vectors, which contain a 
kanamycin and a chloramphenicol resistance gene respectively. Each of the three constructs, along 
with the pET-41(+) and pACYCDuet-1 vectors, were digested with BamHI and HindIII then gel 
extracted, as described in Sections 2.2.2. The two vectors were both treated with Antarctic 
phosphatase, and each of three constructs were ligated into each vector, amplified by miniprep and 
sequenced. In this first attempt the ANK and LRR constructs were successfully cloned into the pET-
41a(+) vector and the LRR construct was successfully cloned into the pACYCDuet-1 vector’s first MCS.  
However it was at this point that it was realised that in the pACYCDuet-1 vector’s first MCS, the 
BamHI and HindIII restriction sites resulted in the LRR construct being in a different reading frame, as 
would also have been the case for my other constructs. This meant that I was unable to attempt the 
triple co-expression straight away but could later be rectified by RTH SDM to remove sufficient bases 
to bring the construct back into frame. 
Trial co-expressions were attempted by transforming separate aliquots of C41 cells simultaneously 
with equal molar amounts of ARM in pGST and ANK in pET-41a(+), ARM in pGST and  LRR in pET-
41a(+), and ANK in pGST and LRR in pET-41a(+), and grown overnight on agar plates containing both 
ampicillin and kanamycin. Each of these four plasmids were also individually transformed into 
separate aliquots of C41 cells alongside these co-expressions. The single transformants were each 
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grown on agar containing ampicillin only, kanamycin only or both antibiotics under the same 
conditions to act as controls demonstrating the requirement of two plasmids for survival. 
The only successful co-transformation from this test was ARM and LRR co-expression, which is the 
pair I had predicted to be the least likely to successfully co-express, as the two domains do not 
neighbour each other in the sequence and the ANK domain between them would likely physically 
separate the two in the full-length protein. There are two plausible explanations for this low success 
rate. Either during the resting period (1 hr at 37 °C) one of the two plasmids was ejected by the 
bacterium to reduce energy expenditure or the double transformation had not succeeded in the first 
place, resulting in 0 colonies formed.  
Colonies from the ARM + LRR co-transformation were picked and inoculated into 5 ml of fresh 2xYT 
media containing both kanamycin and ampicillin for a protein expression test as described in Section 
2.3. The cells were harvested and lysed with BugBuster, as described in Section 2.4, then the results 
were analysed by SDS-PAGE (see Figure 3-7).  
From the pattern of bands, the ARM and the LRR constructs did not appear to co-express, with the 
expression pattern resembling that of the ARM only expression (see Figures 3-1 (F) and 3-8). I could 
be sure that both plasmids must still be present within the cells as they would have been unable to 
grow in the presence of both antibiotics otherwise. The likely explanation for this is a difference in 
plasmid copy numbers, pET-41a(+) is a low copy number plasmid (≈40) whereas pRSET derivatives 
are high copy number (>200). This would have resulted in different relative expression levels or even 
Figure 3-7 – SDS-PAGE analysis of the co-expression of ARM and LRR. Lanes 1-3 – Total cell protein for ARM only, LRR only 
and ARM +LRR; 4-6 – Total soluble protein for ARM only, LRR only and ARM +LRR; 7-9 – Total insoluble protein for ARM 
only, LRR only and ARM +LRR. The top  indicates the expected position of the GST-ARM fusion protein (Mw ≈ 100.5 kDa) 
and the bottom indicates that of the GST-His-S-tag-LRR fusion protein (Mw ≈ 72.5 kDa). 
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preferential expression of one over the other. Ideally what I should have done is used a single 
plasmid with more than one MCS, such as the pACYCDuet-1 vector, as this would have resolved the 
issues I had with both the double transformation and the relative expression levels. 
3.9 Mammalian expression system 
The expression of each of my LRRK2 constructs in a mammalian cell system was also tested using a 
TNT® Quick Coupled Transcription/Translation kit (Promega). This kit uses rabbit reticulocyte lysate 
combined with additional recombinant proteins which allow in vitro translation of proteins under 
the control of either the T7 or SP6 promotors in a eukaryotic cell system. This kit was combined with 
FluoroTect™ GreenLys (Promega), an in vitro translation labelling system which uses lysine-charged 
tRNA that was already labelled with BODIPY-FL fluorescent dye at the ε amine group. Proteins 
expressed will incorporate fluorescently labelled lysines during in vitro translation. The TNT® T7 
Quick Master Mix also contains a plasmid encoding for luciferase under the T7 promoter which acts 
as a positive control for transcription/translation. In this system, the luciferase will also be 
fluorescently labelled by the FluoroTect™ GreenLys. These two kits were used according to their 
manufacturer’s instructions and the reaction mixture was as described in Table 3-2. 
Table 3-2: Reaction mixture for eukaryotic expression using TNT Quick Coupled Transcription/Translation kit 
TnT Mammalian Transcription/Translation 
8 µl TNT® T7 Quick Master Mix 
0.2 µl 1 mM L-Methionine 
1 µl Plasmid DNA at ≈ 100 ng µl-1* 
0.4 µl FluoroTect™ GreenLys 
0.4 µl mQ water 
10 µl Total Volume 
*Actual plasmid concentrations used were 105.4 ng µl-1, 81.5 ng µl-1, 114.3 ng µl-1, and 97.5 ng µl-1 
for the ARM, ANK, LRR and WD40 constructs respectively. 
A reaction was set up for each of my four GST-tagged LRRK2 constructs as well as a plasmid-free 
control (1 µl of mQ water was used instead of plasmid), incubated for 90 min at 37°C and then 
analysed by SDS-PAGE. BenchMark™ Fluorescent Protein Standard (ThermoFisher Scientific) was 
used in place of the usual protein ladder and the gel was fixed using 25% (v/v) isopropanol, 10% (v/v) 
acetic acid in mQ water prior to being visualised under UV-light (see Figure 3-8). From the SDS-PAGE 
analysis it appeared that none of the constructs expressed in the mammalian system. This result is 
likely due to the plasmid DNA sequence being codon optimised for recombinant expression in E. coli. 
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3.10 Refolding from Inclusion Bodies 
Lastly, an attempt was made to produce soluble protein by refolding insoluble protein from inclusion 
bodies (Singh and Panda, 2005). This was a far from ideal solution and very much a last ditch 
attempt to express my LRRK2 constructs solubly. Partially folded and aggregated proteins 
sequestered in inclusion bodies are denatured and solubilised using chaotropic agents, e.g. urea or 
GnHCl, then the chaotropic agent is removed to allow the re-solubilised proteins to refold. Refolding 
from inclusion bodies was avoided previously, as it is necessary to demonstrate that protein purified 
by this method refolds back into the native structure. However, at the time these experiments were 
performed, the crystal structures for this region of LRRK2 was (and at the time of writing still is) 
unsolved and therefore demonstrating that the protein has refolded back to the native state would 
not be possible. Nevertheless I did attempt to produce soluble protein by inclusion body refolding, 
as described below.  
A 6 l prep of GST-ANK was made as described in Section 2.3 and lysed as described in Section 2.5.1. 
After removing the supernatant containing the soluble proteins, the cell pellet was resuspended in 
100 ml of a buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 mM DTT and 8 M urea, 
vortexed until homogenous and incubated at 4°C on a nutator for 1 hr. The cell debris was then re-
pelleted by centrifuging at 35000 g at 4°C for 35 min, and the supernatant containing the solubilised 
inclusion body proteins was decanted. 
Figure 3-8 – SDS-PAGE analysis of the mammalian expression of my LRRK2 constructs. Visualised with UV light. Lane 1 – 
No plasmid control; 2 – ARM; 3 – ANK; 4 – LRR; 5 – WD40. A ubiquitous band can be seen at MW ≈ 63 kDa around the 



















    1             2            3             4            5             
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Chapter 3 – LRRK2: From Model to Molecule 79 
 
In order to refold the extracted inclusion body proteins, the urea needs to be removed or diluted to 
a concentration where the folded state is favoured, usually below 50 mM urea (160-fold dilution). 
There are three main methods to do this, the first two of which involve diluting out the urea, either 
by dialysis, or by rapid dilution, each of which has problems associated with them. With rapid 
dilution the danger is that there is a kinetic trap along the folding pathway causing the protein to 
misfold upon renaturing. For dialysis kinetic traps are avoided although other time-dependent 
mechanisms of aggregation are more like to occur. The third method is by affinity purification, the 
target protein is extracted from solution via its existing purification tag. However this is not possible 
in this case as the GST-fusion purification tag is also denatured in the presence of 8 M urea and 
unable to bind to glutathione resin. Had I chosen a His-tagged construct, then nickel-affinity 
purification would have been possible. 
18 ml of decanted supernatant and sealed in 10 kDa MWCO dialysis tubing and dialysed into 3 l of 
pre-cooled 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 mM DTT at 4°C for 16 hrs (>165-fold dilution). 
Meanwhile another 12 ml of decanted supernatant was mixed rapidly into 2 l of the same buffer, 
also precooled and at 4°C. Upon doing so a white precipitate of protein immediately formed. 
Similarly upon returning to the dialysis it was found that the dialysis tubing was filled with a white 
precipitant. I took this as evidence that the GST-ANK construct was simply not soluble.  
3.11 Concluding the LRRK2 Project 
In this chapter I attempted to study the four tandem repeat domains of LRRK2, as previously 
proposed by Mills et al. (2012). However despite the application of many common biochemical 
methods to increase protein solubility I was unable to obtain soluble protein constructs comprising 
the proposed domains.  
Although it must be admitted that not every method was attempted with each construct, and the 
techniques were not used in combination with each other, the fact that no single technique resulted 
in a significant increase in soluble expression of any domain, strongly suggests that there are other 
factors significantly affecting the protein stability. It is likely that the neighbouring domains provide 
extensive stabilising interactions and it is their absence that resulted in this significant loss of 
stability. Although these experiments are not sufficient to either prove or disprove the predictions of 
Mills et al., I believe they are sufficient to demonstrate that recombinant expression of the isolated 
domains in E. coli is not the optimal way to study this protein. 
It may still be possible to study these domains in isolation if their codons were optimised for 
expression in other systems e.g. baculovirus/insect cells (Kost, Condreay and Jarvis, 2005), which 
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utilise different chaperone proteins to aid soluble expression. However, I expect that others may 
find more success in studying these proposed domains using larger constructs comprising multiple 
domains.  
Although crystallisation of multi-domain proteins with intrinsically disordered linkers for x-ray 
diffraction is often difficult to optimise if not sometimes impossible, there are now many other 
techniques for determining protein structure such as cryo-electron microscopy (cryoEM) and atomic 
force microscopy (AFM) (lower resolution) (Ozkan et al., 2016; Cuniasse et al., 2017; Ott et al., 2017; 
Perilla et al., 2017). 
Regarding AFM, our collaborator Dr. Pia Jeggle (Edwardson group, Department of Pharmacology, 
University of Cambridge) expressed full-length, myc-tagged, human LRRK2 in a human cell line and 
was able to obtain AFM images of the protein. However this is not an area of research that the 
Itzhaki group has much expertise in, and so I did not pursue this avenue of investigation any further 
and instead refocused my studies on a new topic: β-catenin and TCF7L2. 
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Figure 4-1 – The crystal structures of the β-catenin/TCF7L2 complex. (A), (B) and (C) are the crystal structures of TCF7L2 
(red) in complex with β-catenin (cyan) obtained by Poy et al., Graham et al. and Sampietro et al. respectively. In structure 
(C), BCL9 (purple) is also shown in complex with β-catenin. (D), (E) and (F) are cartoon diagrams of (A), (B) and (C) 
respectively, demonstrating the differences between the three structures and highlighting the relative positions of 
significant residues. Structure images (A) (B) and (C) were created using UCSF Chimera (Pettersen et al., 2004) from PDB 
IDs 1JPW (Poy et al., 2001), 1JDH (Graham et al., 2001) and 2GL7 (Sampietro et al., 2006) respectively. 


























































Chapter 4 – β-Catenin and TCF7L2: Method 
Development 
As detailed in Chapter 1, β-catenin is a cancer-associated ARM repeat protein of interest to the 
Itzhaki group. It interacts with a large number of partner proteins many of which are intrinsically 
disordered or have intrinsically disordered regions which form the binding interaction. One of these 
partners, which will be the subject of the remainder of this thesis, is the transcription factor, 
Transcription Factor 7-Like 2 (TCF7L2). TCF7L2 is often referred to as Tcf4, being the fourth identified 
member of the Tcf/LEF family of transcription factors, but I will be using TCF7L2 so as to avoid 
confusion with TCF4 (Transcription Factor 4). 
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The origin of this project is a curiosity in the crystal structures of human TCF7L2 binding to β-catenin. 
There exist three unique crystal structures of TCF7L2 bound to β-catenin in the PDB and they show 
significant differences between them (see Figure 4-1). I noted in Section 1.2.1, that the IDR of the 
tumour suppressor protein p53 is capable of adopting different structural conformations when 
binding to different partner, allowing a diversity of function. Similarly I discussed in Sections 1.5.2 
and 1.6, the TCF7L2-β-catenin complex recruits a number other proteins in order to perform its 
functions. This then raises the question: are the alternative conformations seen in the crystal 
structure biologically relevant? 
For the remainder of this thesis I will be investigating the biophysical origins of this difference and 
the potential consequences of forming different structures in complex including the mechanisms of 
binding and unbinding. In this chapter I will discuss the development of a protocol for the expression 
and purification of the N-terminal β-catenin-binding domain of wild-type TCF7L2. Additionally I 
describe the development of a fluorescence reporter system for the TCF7L2-β-catenin interaction 
which was required for the work described in later chapters. 
4.1 β-Catenin and TCF7L2 Purification 
The β-catenin construct used in this thesis was provided by Professor W. Weis, hereafter referred to 
as Weis β-catenin. It comprises residues 134-671, which corresponds to the ARM repeat domain as 
described by Choi, Huber and Weis (2006) (see Appendix A, Section A.2). The majority of the 
methods and techniques for the purification, storage and handling of Weis β-catenin, as described in 
Chapter 2, were devised and optimised by Dr. S.D. Dunbar and Dr. P.J.E. Rowling, who were working 
with Weis β-catenin before I began this project and for which I am very grateful.  
In the three different crystal structures of TCF7L2 bound to β-catenin, each paper uses a slightly 
different TCF7L2 construct: Poy et al. uses residues 8-54, Graham et al. uses 1-54 and Sampietro et 
al. uses 1-53. I opted to use the 1-54 construct as it included all residues used in these structures 
(see Appendix A, Section A.3.1). This sequence for this was taken from UniProt’s Protein 
Knowledgebase, ID Q9NQB0, codon optimised for expression in E. coli, ordered as a gene string from 
ThermoFisher Scientific and cloned into the expression plasmid vectors: pRSET and pGST (see 
Section 2.2.2). 
Initial test expressions of TCF7L2 showed that the majority of TCF7L2 expressed in the soluble 
fraction when expression was induced with 500 µM IPTG and incubated at 25°C overnight. TCF7L2 
was then grown and expressed on a large scale, as described in Section 2.3, and purified using a 
buffer system based on 50 mM potassium phosphate at pH 6.0, 150 mM NaCl and 1 mM DTT. This 
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buffer was chosen as the TCF7L2 had a pI of 3.88 as determined by ProtParam (Gasteiger et al., 
2005). This was later replaced by buffers based on 1x PBS pH 7.4 and 1 mM DTT when it was decided 
that experiments were to be done in that buffer, thereby avoiding extra buffer exchange steps. 
In my first attempt to purify TCF7L2, I used a method that Dr. P.J.E. Rowling had developed to purify 
other small intrinsically disordered proteins (IDPs) which she was working on. After the batch affinity 
purification step (Section 2.5.2), the few remaining protein contaminants were found to be 
sufficiently different in molecular weight from that of my TCF7L2 construct that they would 
theoretically be separable using a Vivaspin centrifugal concentrator (GE Healthcare) of a suitable 
molecular weight cut off (MWCO). For my wild-type TCF7L2 (1-54) construct, which has a molecular 
weight of 5.9 kDa after thrombin cleavage, a 10 kDa MWCO Vivaspin followed by a 3 kDa MWCO 
Vivaspin should remove all protein contaminants, and have the added benefit of concentrating the 
protein as required.  
However upon testing this hypothesis, it was found that this construct not only did not pass through 
a 10 kDa MWCO filter it also would not pass through a 30 kDa MWCO filter, and therefore not 
separate the TCF7L2 from other larger contaminants. It is common for IDPs to behave as though 
they had a higher molecular weight (Gontero and Maberly, 2012). This is due IDPs having a higher 
hydrodynamic radius for their mass than globular proteins as a result of their lack of tertiary 
structure (English et al., 2016; Tomasso et al., 2016). Many common lab techniques such as SDS-
PAGE actually separate proteins by hydrodynamic radii, which for globular proteins are proportional 
to molecular mass, so it is likely that the MWCOs stated by the manufacturer are calibrated for 
globular proteins. 
In further trial purifications it was found that the wild-type TCF7L2 (1-54) construct does not bind to 
a MonoQ column in either 50 mM KPhos pH 6.0/150 mM NaCl/1 mM DTT or 1x PBS pH 7.4/1 mM 
DTT. However it was possible to isolate TCF7L2 using a G75 SEC column and so this was used in all 
future preparations of TCF7L2 and mutation variants. TCF7L2 was obtained in sufficient quantity that 
I felt that no further optimisation was required. 
4.2 Labelling with FITC 
The wild-type TCF7L2 construct contains no tryptophan or tyrosine residues, and therefore shows no 
intrinsic fluorescence. This presents a problem, as the majority of biophysical techniques employed 
in this Thesis use fluorescence as a way of monitoring the progress of a reaction, and ideally I would 
have liked to have used the intrinsic fluorescence of my proteins. The Weis β-catenin does contain 
three tryptophan and ten tyrosine residues; however Dr. P.J.E. Rowling and Dr. S.D. Dunbar had 
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Chapter 4 – β-Catenin and TCF7L2: Method Development 84 
 
found previously that there is not a sufficiently large change in fluorescence on β-catenin binding to 
other protein partners to be of use, likely due to their buried nature.  
The main technique available for monitoring the binding equilibrium of proteins, without using 
fluorescence, is isothermal titration calorimetry (ITC), which monitors the changes in heat, either 
released or absorbed in a reaction. However the VP-ITC requires large quantities of both binding 
partners and, despite a significant amount of work by Drs. Rowling and Dunbar, β-catenin expression 
was not high enough for the technique to be used throughout this project. Consequently I opted to 
label my TCF7L2 (1-54) constructs with commercial fluorescent dyes, although some ITC was done to 
ensure the labelling process did not significantly affect binding.  
Initially I chose to label the wild-type TCF7L2 (1-54) with fluorescein isothiocyanate (FITC) as this 
construct contains no cysteine residues but it does contain three lysine residues: K22, K30 and K45. 
However after several labelling reactions it was found that labelling wild-type TCF7L2 (1-54) with 
FITC was not consistent, achieving between 1.8 and 2.5 fluorescein moieties per TCF7L2 on average. 
Also on further inspection of the crystal structures it was noted that two of the three lysine residues, 
K22 and K45, are located at the binding interface between β-catenin and TCF7L2, and was therefore 
likely to affect binding. 
This lack of consistency was undesirable so I tried an alternative labelling method. The wild-type 
construct contains no natural cysteine residues so I decided to engineer one in by SDM. Doing so 
would mean that the construct would be less native-like and my results would be less representative 
of the β-catenin-TCF7L2 in vivo interaction, however it would give me more precise control over the 
labelling reaction. 
4.3 Labelling with Fluorescein Maleimide and the Choice of Labelling 
Position 
To minimise the effect of the SDM on TCF7L2, I chose to make a conservative serine to cysteine 
mutation in the wild-type TCF7L2 (1-54). I also considered introducing a tryptophan residue into the 
construct, and to use its intrinsic fluorescence to monitor the binding reaction. However one 
tryptophan residue would likely not produce a strong signal change to be observed over the 
background signal from β-catenin and was likely to have a significant impact on the expression and 
solubility of the construct. 
The wild-type TCF7L2 (1-54) construct contains eight serine residues, excluding the one left behind 
as a result of removing the purification tag with thrombin. The crystal structures were inspected to 
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Figure 4-2 – Structure maps of the three β-catenin/TCF7L2 crystal structures. (A) is a map of how major structural 
elements differ between the three crystal structures, by residue. (B) is a map of the number of contacts each residue 
makes with β-catenin as determined by contact map analysis (Sobolev et al., 2005) with the default range and no 
minimum threshold for contact area. 
A 
B 
find a position where the addition of a bulky, hydrophobic dye molecule would not have a significant 
steric effect on binding but would be able to report on the different observed crystal structures. To 
aid in this a contact map analysis was performed on each of the crystal structures (Sobolev et al., 
2005). 
The contact map analysis revealed that only one serine residue; S31, formed no contacts to β-catenin 
in any of the crystal structures, indicating that it is in a sterically unhindered position. This position 
also has the additional benefit of being in different environments between the E24-bound structures 
(Poy et al. and Sampietro et al.) and the E29-bound structure (Graham et al.). In the E24-bound 
structures, S31 is in a disordered unresolved loop, whereas, in the E29-bound structure, it is in the first 
α-helix, pointing away from the surface of β-catenin. Consequently S31 was chosen for use as a 
controlled labelling position. The TCF7L2 (1-54) S31C construct is hereafter referred to as the “WT” 
S31C, as it is used as a pseudo wild-type with which all other TCF7L2 constructs will be compared 
(see Appendix A, Section A.3.2). 
4.4 Testing effect of label using ITC  
In order to determine whether the S31C mutation, and its subsequent labelling with fluorescein 
maleimide, had had a significant effect on TCF7L2 binding to β-catenin, equilibrium binding 
experiments were performed using ITC. These ITC experiments were performed as described in 
Section 2.7. Previous studies of TCF7L2-β-catenin binding have used ELISA (Omer et al., 1999) and 
ITC (Sun and Weis, 2011) to determine the Kd of the interaction using similar constructs. The values 
they obtained were 15 ± 6 nM and 16 ± 3 nM for TCF7L2 (1-53) and TCF7L2 (1-57), respectively.  
The results of these ITC experiments are shown in Figure 4-3 and are summarised in Table 4-1. As 
there was no significant difference between my wild-type TCF7L2 (1-54), “WT” S31C, fluorescein-
labelled “WT” S31C (”WT” flS31C), and the literature values, I felt I could proceed in using the “WT” 
flS31C construct as a substitute for true wild-type, TCF7L2 (1-54). These experiments were only 
performed once as they were intended to be a “proof of concept” that the addition of a fluorescent 
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label at position 31 did not significantly affect binding. Going forward with the project I opted not to 
use ITC any further in this study, as it was too consuming of resources, i.e. β-catenin, which, as 
already mentioned, was proving difficult to optimise further for increased protein yield. 
Figure 4-3 – ITC measurements for TCF7L2 constructs binding to β-catenin. The top panels show the heat signal obtained 
from a series of injections of different TCF7L2 into the ITC cell containing β-catenin, and the bottom panels show the 
binding curves calculated using the One-Site fitting model using the Origin software package. (A), (B) and (C) are the 
TCF7L2 (1-54), “WT” S31C and the fluorescein-labelling “WT” S31C construct binding to my Weis β-catenin construct 
respectively and (D) is data taken from (Sun and Weis, 2011) of TCF7L2 (1-57) binding to full length β-catenin. (A), (B) and 
(C) were performed in 25 mM Tris-HCl pH 8.9, 100 mM NaCl, 2 mM DTT at 30°C, whereas (D) was performed in 25 mM Tris 
pH 8.8, 100 mM NaCl, 2 mM DTT at 30°C. 
A B 
C D 
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Table 4-1: The Kd for different TCF7L2 constructs binding to β-catenin using ITC 
Construct Method Kd (nM) n† 
TCF7L2 (1-53) (Omer et. al.) ELISA 15 ± 6 3-20 not specified 
TCF7L2 (1-57) (Sun & Weis) ITC 16 ± 3 2 
TCF7L2 (1-54) ITC 13 ± 7 1 
“WT” S31C ITC 15 ± 4 1 
“WT” flS31C ITC 28 ± 12 1 
† n is the number of repeats  
4.5 Kinetic and Equilibrium Studies of “WT” flS31C 
Having shown that the “WT” flS31C construct had suitably similar Kd to wild-type TCF7L2 (1-54) with 
ITC, I then wanted to switch to using other techniques to study the TCF7L2-β-catenin binding 
reaction. It was also at this time that I decided to switch to using the 1xPBS + 1 mM DTT buffer in 
order to be able to compare my results with those Drs. Rowling and Dunbar obtained for other β-
catenin binding partners. 
Fluorescence stopped-flow spectroscopy was used to determine the association rate constant of the 
“WT” flS31C construct in both the PBS buffer and the SunWeis Buffer (25 mM Tris pH 8.9, 100 mM 
NaCl, 2 mM DTT), as described in Section 2.8. For both buffers this produced a time-dependent 
decay in fluorescence intensity that was well described by the one-phase exponential function, 
equation [2-3]. In both cases, the two-phase exponential function, equation [2-3], sometimes 
seemed to produce a better fit, however GraphPad Prism 6 was not always able to fit two rate 
constants for a given concentration of β-catenin, and even when it could, there was a large error on 
the values obtained and there seemed to be no pattern to the second rate constant as the 
concentration of β-catenin was varied (see Figure 4-4).  
Similarly, an attempt was made to determine the dissociation rate constant using stopped-flow 
spectroscopy, as described in Section 2.8. While a time-dependent increase in fluorescence intensity 
was observed the rate of change was too slow to be accurately measured, and on the longest 
practical recording time the trace never reached a plateau. I was able to determine the dissociation 
rate constant of “WT” flS31C in both PBS and SunWeis buffer, by using time-dependent fluorescence 
spectroscopy, as described in Section 2.9. Again the time-dependent increase in fluorescence 
intensity was observed but I was then able to record until a stable plateau had been reached. This 
time there were clearly two phases in the dissociation traces in both buffers, a major slow phase and 
a minor fast phase, as opposed to the single phase seen for association (see Figure 4-5).  
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The weighted averages of the association and dissociation rate constants for “WT” flS31C in both 
PBS and SunWeis buffer are summarised in Table 4-2. The errors given in the table are the weighted 
errors of the standard errors of the individual fits, and the true error is likely to be higher than those 
given. As all the kinetic rate constants for the two buffers are within error of each other I felt 
confident in continuing, using the PBS buffer. However it is worth noting the difference between the 
calculated kinetic Kd, Kd,kin, and the values found in the literature and from my own ITC experiments. 
Figure 4-4 – Stopped-flow spectroscopy measurement of “WT” flS31C associating to β-catenin. (A) shows the time-
dependent change in fluorescence when 10 nM “WT” flS31C and 900 nM β-catenin are mixed, taken from the same data 
set as (B), (C) and (D). These data were fitted with a one-phase (red) and a two-phase (green) exponential function and 
their associated residual traces are shown below. (B) is the plot of the observed one-phase rate constant against the 
concentration of β-catenin from which the association rate constant, kon, is calculated. (C) and (D) are plots of the 
observed major and minor rate constants (respectively) against the concentration of β-catenin, when the same data used 
to plot (B) was instead fit with a two-phase exponential function. The errors in (B), (C) and (D) are the standard deviations 
of their respective fits. In the case of (D) a number of points had an error too large to be plot on the axes shown. In this 
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Table 4-2: Association and dissociation rate constants and Kd,kin for “WT” flS31C in different buffers. 
Buffer 
Association Dissociation Kd,kin 
(pM)* kon (x107 M-1 s-1) n† koff,major (x10-4 s-1) koff,minor (x10-3 s-1) % fast n† 
SunWeis 6.11 ± 0.41  1 5.07 ± 0.12  1.19 ± 0.11  34 ± 5 4 8.3 ± 0.6 
PBS 7.33 ± 0.14 16 5.73 ± 0.40 1.52 ± 0.28 23 ± 3 8 7.8 ± 0.6 
* The kinetic Kd defined here as 𝐾𝑑,𝑘𝑖𝑛 =  𝑘𝑜𝑓𝑓,𝑚𝑎𝑗𝑜𝑟 𝑘𝑜𝑛⁄  
† n is the number of repeats 
The Kd of an protein-protein or protein-ligand interaction can be calculated from its kinetic 
parameters using the simple relationship, 𝐾𝑑 =  𝑘𝑜𝑓𝑓 𝑘𝑜𝑛⁄ . In the case of association and/or 
dissociation being multi-phasic, it is conventional to use the major phase to calculate the kinetic Kd, 
Kd,kin, providing the major phase contributes significantly more to binding than any other phase. 
When this approach is applied to the kinetic data I obtained, the calculated Kd,kins were three orders 
of magnitude stronger binding than obtained from ITC measurements, both my own and from the 
literature.  
In order to investigate this difference, I used fluorescence anisotropy titration to study the system at 
equilibrium. Concentrated β-catenin was injected into a known concentration of “WT” flS31C and 
Figure 4-5 – Stopped-flow and time-dependent fluorescence spectroscopy measurements of the “WT” flS31C-β-catenin 
complex dissociating. 200 nM “WT” flS31C-β-catenin complex dissociating in the presence of 50 times molar excess of 
unlabelled WT TCF7L2 (1-54) as monitored by (A) stopped-flow spectroscopy and (B) time-dependent fluorescence 
spectroscopy. Both traces were fit with both a one-phase and a two-phase exponential function and the corresponding 
residuals are plotted below. Both experiments were performed in 1x PBS, 1 mM DTT at 15°C. 
A B 
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the change in fluorescence anisotropy measured, as described in Section 2.10. Fluorescence 
anisotropy is typically chosen over fluorescence intensity as it is concentration-independent. The 
fluorescence anisotropy was observed to increase with increasing β-catenin concentration until 
saturation of ligand. These traces were fit with three fairly common models of protein-ligand 
binding, to try to find the best approximate model: polarisation, accounting for ligand depletion 
(Equation [2-8]); the Hills equation (Equation [2-9]): and the MWC model (Equation [2-10]). However 
there was a general inconsistency in the traces, both in traces collected on the same day and 
between sets of traces collected on different days (see Figure 4-6). For these traces, the polarisation 
equation produced Kds ranging from 3 pM to 700 pM, the Hills equation gave Kds ranging from 2 nM 
to 7.5 nM, and the MWC gave Kds ranging from 5 pM to 1000 pM. 
4.6 Alternative Labelling Positions 
When deciding where to introduce a cysteine in order to label with fluorescein maleimide two other 
serine residues were considered for SDM, S20 and S46. Both of these residues form a single contact 
with β-catenin in all structures and so are less optimal than the S31 position, in terms of minimising 
steric hindrance from labelling, and also appear to be in near identical environments between the 
E24-bound and E29-bound structures. However, the main aim of this study is to elucidate a mode of 
binding for TCF7L2 and β-catenin, and for that it would be useful to have probes in different 
positions to report on local changes. The “WT” S46C and “WT” S20C constructs were made by SDM 
and their kinetic rate constants were determined in the same manner as the “WT” S31C construct 
(see Appendix A, Section A.3.2).  
On testing, it was found that the “WT” flS46C had a slightly slower association rate, but also a slightly 
slower koff,major resulting in similar Kd,kin values (summarised in Table 4-3, also see Figure 4-7a & b). 
For all three constructs the association traces were best described by a one-phase exponential 
Figure 4-6 – Fluorescence anisotropy titration measurements for “WT” flS31C binding to β-catenin. Eight independent 
traces of “WT” flS31C binding to β-catenin collected over three days. (B) shows the same data as (A) with the transitional 
part of the curves highlighted. All experiments were performed in 1x PBS, 1 mM DTT at 15°C. 
A B 
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A B 
Figure 4-7 – The kinetic parameters of the “WT” flS46C and “WT” flS20C construct. (A) shows the association rate of 
“WT” flS46C binding to β-catenin compared to “WT” flS31C. (B) shows the dissociation rate of 200 nM “WT” flS46C-β-
catenin complex in the presence of 50 times molar excess of unlabelled competitor. (C) and (D) show the “WT” flS31C and 
“WT” flS20C constructs binding to β-catenin respectively at the same [β-catenin]. (E) shows a typical plot of kobs against the 
concentration of β-catenin for the “WT” flS20C construct, demonstrating no clear concentration dependence for the 
observed reaction. (F) shows a typical trace for the dissociation of the “WT”flS20C-β-catenin complex. All experiments 
were performed in 1x PBS, 1 mM DTT at 15°C. 
C D 
E F 
function and the dissociation traces by a two-phase exponential function. However for the “WT” 
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flS20C construct, the change in fluorescence intensity on association or dissociation was significantly 
lower than for either the S31C or the S46C construct, requiring that the PMT voltage be increased in 
order to see any signal, worsening the signal to noise ratio. Whereas the dissociation of the “WT” 
flS20C-β-catenin complex could be plotted and fit in the same manner as for the other two, this was 
not true for the association traces. When the kobs for the association traces was plotted against the 
concentration of β-catenin to calculate the kon in the usual manner, there appeared to be no 
concentration dependence to the observed rate constant meaning a kon, and thus a Kd,kin, could not 
be calculated (see Figure 4-7c-f). 
Table 4-3: Association and dissociation rate constants and Kd,kin for “WT” flS46C and “WT” flS20C. 
Construct 
Association Dissociation Kd,kin 
(pM)* kon (x107 M-1 s-1) n† koff,major (x10-4 s-1) koff,minor (x10-3 s-1) % fast n† 
“WT” S31C 7.33 ± 0.14  16 5.73 ± 0.40  1.52 ± 0.28  23 ± 3 8 7.8 ± 0.6 
“WT” S46C 5.46 ± 0.12 4 3.17 ± 0.08 2.10 ± 0.05 26 ± 2 3 5.8 ± 0.4 
“WT” S20C n/a 4 4.74 ± 0.92 1.58 ± 0.48 37 ± 4 2 n/a 
* 𝐾𝑑,𝑘𝑖𝑛 =  𝑘𝑜𝑓𝑓,𝑚𝑎𝑗𝑜𝑟 𝑘𝑜𝑛⁄  
† n is the number of repeats 
4.7 Long-Term Storage of Labelled TCF7L2 
After several labelling reactions it became apparent that the amount of labelled TCF7L2 construct 
produced was more than required for most experiments. So excess labelled protein was flash frozen 
with liquid nitrogen and stored at -80°C for later use. However when the frozen labelled TCF7L2 
constructs were thawed and used in experiments, it produced considerable variability in the results 
obtained (see Figure 4-8 and Table 4-4). We were unable to explain this occurance as later testing 
showed no obvious aggregation of the labelled protein, or change in excitation/emission or 
fluorescence intensity of the fluorescein mioety. Consequently for the rest of this project it was 
required that all TCF7L2 be freshly labelled before use.  
4.8 Discussion 
After this rigorous testing I felt confident in using the “WT” S31C construct as a pseudo wild-type 
baseline with which to compare other TCF7L2 constructs. In the ITC experiments I have shown that 
the introduction of the S31C mutation had had a negligible effect on the TCF7L2-β-catenin 
interaction, giving a Kd of 15 ± 4 nM compared with the 15 ± 6 nM and 16 ± 3 nM from the literature 
(Omer et al., 1999; Sun and Weis, 2011). When this construct is labelled with fluorescein maleimide 
the Kd increases slightly to 28 nM, which is to be expected. The “WT” S31C construct is a small 
protein (5.9 kDa) with a high charge density (19 charged residues out of 56 total), and so conjugating 
this to a large (428 Da), hydrophobic fluorophore is likely to affect its dynamic properties. 
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Table 4-4: Association constants for fresh and frozen, “WT”S31C and “WT” S46C constructs in PBS buffer. 
“WT” S31C “WT” S46C 
A kon (x107 M-1 s-1) B kon (x107 M-1 s-1) 
Fresh 3.69 ± 0.21  Fresh 4.19 ± 0.17 
50 days frozen 5.49 ± 0.17 5 days frozen 5.12 ± 0.24 
84 days frozen 6.39 ± 0.46 9 days frozen 1.70 ± 0.04 
111 days frozen 7.24 ± 0.18 13 days frozen 3.06 ± 0.15 
C kon (x107 M-1 s-1) D kon (x107 M-1 s-1) 
2015-12-09 6.76 ± 0.40 2015-12-09 5.69 ± 0.21 
2015-12-15 8.23 ± 0.31 2015-12-15 6.06 ± 0.17 
2015-12-22 7.29 ± 0.19 2015-12-22 5.76 ± 0.33 
Weighted Average 7.33 ± 0.14 Weighted Average 5.46 ± 0.12 
When considering which fluorophore to use, a number were considered but ultimately fluorescein 
seemed optimal. With the added inefficiency of having to freshly label TCF7L2 before every 
experiment, price was a major factor in this decision. While there are certainly fluorophore which 
Figure 4.8 – The effect of freezing on labelled TCF7L2 constructs binding to β-catenin. (A) and (B) show how the 
association rate (kon) of the same batch of fluorescein maleimide labelled TCF7L2 binding to β-catenin is affected by 
freezing for different lengths of time for the “WT” S31C construct and the “WT” S46C construct respectively. (C) and (D) 
compare how association rate varies different batches of freshly labelled TCF7L2 constructs binding to the same batch of 
β-catenin for the “WT” S31C construct and the “WT” S46C construct respectively. All experiments were performed in 1x 
PBS, 1 mM DTT at 15°C. 
A B 
C D 
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are smaller, and so are less likely to have an effect on binding dynamics (e.g. coumarin-derived 
fluors), or which are less hydrophobic, and so are less likely to affect solubility (e.g. Alexa fluors), 
these factors did not seem to have a significant effect on monitoring the TCF7L2-β-catenin 
interaction. Fluorescein maleimide was cheap, had convenient excitation and emission wavelengths 
and the protocols for labelling and the removal of excess dye are quick and simple. 
What is more concerning is the difference between the Kd measured at equilibrium using the ITC and 
the kinetic Kd, Kd,kin, obtained from the association and dissociation kinetics. For the “WT” flS31C in 
SunWeis buffer, the Kd,kin was 8.3 ± 0.6 pM. While in this case the Kd,kin will be less certain, due to the 
dissociation being multi-phasic, this value is still three orders of magnitude tighter binding than that 
obtained by ITC. Even when the kinetic Kd is calculated from the faster minor phase, this gives a Kd of 
19.5 ± 2.3 pM, still three orders of magnitude different for the ITC Kd.  
Although unusual, there have been previous reports of naturally occurring binding interactions as 
strong as this for both globular proteins (streptavidin-biotin, Kd ≈ 1 fM (Weber et al., 1989), zinc-
hook proteins, Kd ≈ 1 fM (Kochańczyk, Jakimowicz and Krężel, 2013)) and intrinsically disordered 
proteins (S-peptide-S-protein, Kd ≈ 6 pM (Goldberg and Baldwin, 1998), PUMA BH3-Mcl1 , Kd ≈ 100 
pM (Rogers, Steward and Clarke, 2013)). Similarly, IDPs/IDRs with association rate constants similar 
to that of TCF7L2 (ACTR-NCBD, kon ≈ 5.9 x107 M-1 s-1 (Dogan et al., 2012)) and even 1-2 orders of 
magnitude higher (HIF-TAZ1, kon ≈ 1.3 x109 M-1 s-1 (Sugase et al., 2007), AD2 1-TAZ2, kon ≈ 1.7 x1010 M-
1 s-1 (Arai, Ferreon and Wright, 2012)) have been reported as well as interactions with similar 
dissociation rate constants (S-peptide-S-protein, koff ≈ 1 x10-4 s-1 (Goldberg and Baldwin, 1998), 
PUMA BH3-Mcl1 , koff ≈ 1.6 x10-3 s-1 (Rogers, Steward and Clarke, 2013)) 
I believe the source of this discrepancy lies in the exceptionally long dissociation times. The major 
and minor dissociation rate constants for “WT”S31C in SunWeis buffer were 5.73 ± 0.12 and 11.9 ± 
0.11 x10-4 s-1 respectively, which correspond to half-lives of 1370 ± 30 s (22.8 min) and 582 ± 56 s 
(9.7 min) respectively. These may seem excessively long for a biological system but can be 
rationalised in context. Transcription factors typically form large multi-component complexes, which 
logically would require a stable, long-lived core around which to assemble correctly for proper 
function. The TCF7L2-β-catenin interaction is the first step in the formation of a transcription factor 
complex and so it makes sense that it is stable (Kd ≈ 8 pM) and long-lived (dissociation half-life ≈ 23 
min). 
It was unfortunate that the fluorescence anisotropy titration experiments proved to be unreliable 
and failed to corroborate either the ITC or kinetic experiments. However on reflection, I think this 
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may have been due to problems with experimental design. When designing an anisotropy 
experiment, the concentration of one of the reactants should be kept constant at a concentration 
just below the Kd (Rossi and Taylor, 2011). In my experiment labelled TCF7L2 construct was kept at a 
constant concentration of 10 nM, which would have been acceptable had the Kd turned out to be in 
the region of 28 nM as suggested by ITC. On the contrary, had the Kd been in the region of 8 pM as 
suggested by kinetics this would have been inappropriate, but also the concentration of TCF7L2 that 
would have been suitable (e.g. 2 pM) would likely not produce a large enough signal to be 
measurable. 
It is also generally advised when designing equilibrium experiments like ITC to allow the reaction 
mixture to incubate for five times the longest kinetic half-life to allow the system to actually reach 
equilibrium, which for this system means approximately 2 hr. For a plate-based assay this is easy to 
do, but for titration experiments like ITC and fluorescence anisotropy titration it is impractical. I 
allowed 500 s between injections in my ITC experiments and only 90 s in my fluorescence anisotropy 
titrations which by this criterion is not long enough. I had considered a plate-based approach to 
measure the fluorescence anisotropy, but decided against it for the same reason I rejected ITC. 
The similarity between the results obtained for different buffers was reassuring. Any differences can 
be explained by the difference in salt concentration (100 mM NaCl for SunWeis, 140 mM NaCl for 
PBS), which is known to affect protein-protein interactions by disrupting electrostatic interactions 
(Sheinerman, Norel and Honig, 2000). PBS is a more universal buffer system than that used by Sun 
and Weis (25 mM Tris pH 8.8, 100 mM NaCl, 2 mM DTT) or Omer et al. (50 mM HEPES pH 7.5) which 
allows me to compare my findings not only to those of Drs. Rowling and Dunbar, but also to other 
protein-protein interactions detailed in the literature. 
Going forwards I decided to continue using the S31C labelling position over S46C position as I 
believed it would be better at reporting the difference between the E24-bound and E29-bound 
TCF7L2-β-catenin complexes, although it was never ruled out for further experiments. For many of 
the TCF7L2 variants detailed in later chapters, both to S31C and S46C variants were made but only 
the S31C variants were transformed, expressed and purified.  
The S20C variant is still interesting. The concentration independence of the association rate indicates 
that it is not the same TCF7L2-β-catenin binding event that is being detected by the label at this site, 
but rather a structural rearrangement after association. However it is also possible that the much 
poorer signal-to-noise ratio means that the kinetic traces cannot be accurately plotted. Indeed, 
when the data for all four repeats of the “WT” flS20C association experiments are plotted on the 
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same graph then there is a hint that there is a [β-catenin] dependence on the observed association 
rates (see Figure 4-9e). The best fit for these amalgamated data gives a kon of 0.94 ± 0.34 x107 M-1 s-1 
compared to 7.33 ± 0.14 x107 M-1 s-1 for the S31C construct. However the R2-value for this fit is only 
0.165, and when compared to the individual traces (see Figures 4-9a-d), it is apparent that there is 
no [β-catenin] dependence.  
Figure 4-9 – All association data for the “WT” flS20C construct. (A), (B), (C) and (D) are the four separate association 
experiments for “WT” S20C construct associating to β-catenin. When all four are plotted on the same axes (E) there 
appears to be a weak [β-catenin] dependence, but when compared to the individual traces that this is not the case. All 
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Figure 5-1 – The differences in crystal structures of TCF7L2 binding to β-catenin. (A), (B) and (C) are the crystal structures 
of TCF7L2 (red) in complex with β-catenin (cyan) obtained by Poy et al., Graham et al. and Sampietro et al. respectively. β-
catenin K312 and its interaction with the glutamates of TCF7L2 are highlighted. In structure (B), residues which are 
unstructured and unseen in (A) are coloured grey. Structure images (A) (B) and (C) were created using UCSF Chimera 
(Pettersen et al., 2004) from PDB IDs 1JPW (Poy et al., 2001), 1JDH (Graham et al., 2001) and 2GL7 (Sampietro et al., 2006) 
respectively. (D) is a map of how major structural elements differ between the three crystal structures, by residue. 
A B C 
D 
Chapter 5 – Three Crystal Structures and 
Ensemble Binding 
In the PDB there exist three unique crystal structures of TCF7L2 bound to β-catenin which have 
noteworthy differences between them. Two of these structures, those obtained by Poy et al. (PDB ID 
1JPW) and Graham et al. (PDB ID 1JDH), are the most dissimilar and curiously were simultaneously 
reported in the same issue of Nature Structural Biology (Graham et al., 2001; Poy et al., 2001). A 
later crystal structure of a ternary complex comprising TCF7L2, β-catenin and the co-activator BCL9 
(PDB ID 2GL7, see Section 1.5.2) was obtained by Sampietro et al. (Sampietro et al., 2006).  
Sampietro et al.’s structure is most similar to that obtained by Poy et al.’s, both of which show the 
glutamate at position 24 of TCF7L2 interacting with the lysine at position 312 of β-catenin. However 
in Graham et al.’s structure it is the glutamate at position 29 of TCF7L2 that interacts with lysine-
312. This is due to residues 21-32 forming an α-helix in Graham’s crystal structure, instead of 
extended structure, forcing glutamate-24 to point away from the surface of β-catenin and 
positioning glutamate-29 in the equivalent position where it can interact with lysine-312 (see Figure 
5-1). Previous studies of β-catenin in complex with its binding partners have identified lysine-312 
and lysine-435 as important (sometimes referred to as the “lysine buttons” or “charged buttons”) so 
it seems unusual that there should be such variation around this residue (Graham et al., 2000; Dyson 
and Wright, 2002; Gail, Frank and Wittinghofer, 2005; Xu and Kimelman, 2007; Sun and Weis, 2011). 
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In Graham’s structure we can see the position of every TCF7L2 residue between 12 and 49, whereas 
in the other two structures a significant number of residues in this region are disordered and not 
seen in the crystal structure (residues 27 to 39 in Poy’s structure and residues 29 to 37 in 
Sampietro’s structure). Again this is due to the formation of a second α-helix. Additionally the 
conserved C-terminal α-helix (residues 41-49) has an extra turn (residues 37-40), taken together 
these create the effect of TCF7L2 being pulled taut like a string across the surface of β-catenin. 
As was mentioned in Section 1.2.1 and in Chapter 4 alternative conformations of IDPs have the 
potential to affect IDP binding, e.g. p53, and the TCF7L2-β-catenin complex is known to recruit a 
range of other proteins. We speculate that these alternative structures present a mechanism for 
distinguishing between binding partners. 
In this Chapter, I investigate the differences between the E24-interacting and E29-interacting 
structures by measuring the effect of a series of mutational variants on the binding kinetics of the 
TCF7L2-β-catenin interaction using the methods developed in Chapter 4. I then investigate the 
impact of osmolality on the binding kinetics of the pseudo wild-type construct and mutational 
variant with a lower net charge. 
5.1 E24A S31C and E29A S31C 
In order to study the differences between the two crystal structures I decided to try to force the 
TCF7L2 constructs to preferentially adopt one structure over the other. To that end, I used SDM to 
create the E24A S31C and E29A S31C variants (see Appendix A, Section A.3.3). Without the 
glutamate at position 24, it was hoped that the E24A S31C construct would be more strongly biased 
towards adopting the E29-bound structure, and vice versa for the E29A S31C construct. These 
constructs were labelled as described in Section 2.6.2, and their association and dissociation rate 
constants were determined as for the “WT” flS31C construct. For each it was found that the 
association traces could be fit to a single exponential function, and the dissociation traces were best 
fitted to a two-phase exponential function with a faster minor phase and a slower major phase, as 
was the case for the “WT” flS31C construct (see Figure 5-2, summarised in Table 5-1). 
The E24A flS31C construct had very slightly slower association and dissociation rates compared with 
the “WT” S31C construct, resulting in a very similar Kd,kin (see Table 5-1). The E29A flS31C construct 
had a similar association rate to the E24A flS31C construct but faster dissociation rates, resulting in a 
Kd,kin roughly double that of the wild-type (see Table 5-1). This suggested that the E24-bound and the 
E29-bound structures are very similar in energies with the E24-bound structure being slightly higher in 
energy and that TCF7L2 can easily switch between the two structures. 
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Table 5-1: Association and dissociation rate constants and Kd,kin for E24A, E29A, and E24A E29A flS31C 
constructs. 
Construct 
Association Dissociation Kd,kin 
(pM)* kon (x107
 
M-1 s-1) n† koff,major (x10-4 s-1) koff,minor (x10-3 s-1) % fast n† 
“WT” 7.33 ± 0.14  16 5.73 ± 0.40  1.52 ± 0.28 23 ± 3 8 7.8 ± 0.6 
E24A 6.05 ± 0.12 6 5.03 ± 0.40 1.53 ± 0.21 26 ± 1 4 8.3 ± 0.7 
E29A 5.73 ± 0.43 2 8.97 ± 0.44 2.45 ± 0.21 18 ± 2 5 15.6 ± 1.4 
E24A E29A 6.13 ± 0.34 3 4.25 ± 0.29 1.73 ± 0.14 18 ± 4 3 6.9 ± 0.6 
* 𝐾𝑑,𝑘𝑖𝑛 =  𝑘𝑜𝑓𝑓,𝑚𝑎𝑗𝑜𝑟 𝑘𝑜𝑛⁄   
† n is the number of repeats 
5.2 E24A E29A S31C Double Mutational Variant 
Assuming that the E24-bound and the E29-bound are the only structures that TCF7L2 can adopt when 
binding to β-catenin, then a E24A E29A S31C variant construct should not be able to form either 
structure and therefore should have a significant effect on the binding affinity. To test this 
hypothesis I made this E24A E29A S31C construct with SDM and tested it as I had done for the 
previous constructs. Once again it was found that association was one-phase and dissociation was 
two-phase.  
Figure 5-2 – The kinetic parameters of the E24A. E29A and E24A E29A constructs. (A) is a comparison of the association 
rate constants of three mutant constructs to the pseudo wild-type construct. (B), (C) and (D) are representative 
dissociation traces for the E24A, the E29A and the E24A E29A constructs respectively. All experiments were performed in 
1x PBS, 1 mM DTT at 15°C. 
A B 
C D 
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Surprisingly the data showed that the E24A E29A double mutation had very similar kinetic rate 
constants to that of the E24A variant i.e. not significantly slower than those of the “WT” S31C 
construct, resulting in a similar Kd,kin to the pseudo wild-type (see Figure 5-2, summarised in Table 5-
1). This result is significant as it implies that TCF7L2 can adopt more structures when binding to β-
catenin than the two captured in crystal structures. 
5.3 Alternative Association Pathways 
With the idea that other, undetected (in crystallo) structures could exist, I examined the sequence of 
TCF7L2 in greater detail and noticed that in the same region of glutamate-24 and glutamate-29 there 
are three other negatively charged residues that could theoretically interact with lysine-312 of β-
catenin: aspartate-23, glutamate-26 and glutamate-28. E26 and E28 interacting with lysine-312 could 
easily be achieved through alternative positioning and length of the α-helix seen in Graham’s 
structure alternatively presenting either one or the other of the two residues to the “lysine button”. 
The D23-bound structure would be more difficult to achieve as it would require further stretching out 
of the region N-terminal to it, which may weaken the affinity. 
5.4 D23A S31C, E26A S31C, E28A S31C and XXXXX S31C 
To investigate these potential alternative structures I produced and tested four more mutational 
variant constructs: D23A S31C, E26A S31C, E28A S31C and the quintuple mutational variant: D23A 
E24A E26A E28A E29A S31C, hereafter referred to as XXXXX S31C (see Appendix A, Section A.3.3). 
When tested all of these variants produced one-phase association traces and two-phase dissociation 
traces (see Figure 5-3, summarised in Table 5-2). 
Table 5-2: Association and dissociation rate constants and Kd,kin for the ensemble binding constructs. 
Construct 
Association Dissociation Kd,kin 
(pM)* kon (x107
 
M-1 s-1) n† koff,major (x10-4 s-1) koff,minor (x10-3
 
s-1) % fast n† 
“WT” 7.33 ± 0.14  16 5.73 ± 0.40  1.52 ± 0.28  23 ± 3 8 7.8 ± 0.6 
E24A 6.05 ± 0.12 6 5.03 ± 0.40 1.53 ± 0.21 26 ± 1 4 8.3 ± 0.7 
E29A 5.73 ± 0.43 2 8.97 ± 0.44 2.45 ± 0.21 18 ± 2 5 15.6 ± 1.4 
E24A E29A 6.13 ± 0.34 3 4.25 ± 0.29 1.73 ± 0.14 18 ± 4 3 6.9 ± 0.6 
D23A 5.31 ± 0.25 3 3.00 ± 0.16 2.39 ± 0.70 15 ± 1 3 5.7 ± 0.4 
E26A 5.59 ± 0.22 3 4.74 ± 0.30 1.66 ± 0.16 24 ± 4 3 8.5 ± 0.6 
E28A 5.84 ± 0.35 4 4.96 ± 0.35 1.16 ± 0.28 23 ± 5 3 8.5 ± 0.8 
XXXXX 4.26 ± 0.17 4 2.95 ± 0.23 2.34 ± 0.33 15 ± 2 4 6.9 ± 0.6 
* 𝐾𝑑,𝑘𝑖𝑛 =  𝑘𝑜𝑓𝑓,𝑚𝑎𝑗𝑜𝑟 𝑘𝑜𝑛⁄  
† n is the number of repeats 
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Unexpectedly, I found that none of these constructs, even the XXXXX S31C construct, had 
significantly different rate constants from that of the pseudo wild-type construct. All of these 
ensemble binding constructs had slightly slower association rate constants than the pseudo wild-
type, with the XXXXX S31C construct being the slowest at approximately half that of the pseudo 
wild-type. All of these constructs, with the exception of the E29A S31C construct, also had slightly 
slower koff,major than the pseudo wild-type, again with the XXXXX S31C construct being the slowest at 
approximately half that of the pseudo wild-type. 
5.5 The Effect of Charge on the TCF7L2-β-Catenin Interaction 
It seems very unusual that the XXXXX S31C variant, in which five negative charges have been 
removed, should have such a negligible effect on the binding interaction given that electrostatic 
interactions are one of the major contributors to protein-protein binding energy. Electrostatic forces 
tend to have a greater influence on protein-ligand interactions (including protein-protein) than they 
do in protein folding (Sheinerman, Norel and Honig, 2000) because when folded, cytosolic proteins 
bury the majority of their hydrophobic residues and present mostly hydrophilic and charged residues 
Figure 5-3 – The kinetic parameters of the ensemble binding constructs. (A), (B), (C) and (D) are comparisons of the 
association rate constants, major and minor dissociation rate constants and kinetic Kd respectively for all the ensemble 
binding mutant constructs. All experiments were performed in 1x PBS + 1 mM DTT. 
A B 
C D 
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on their surface, in order to remain soluble. IDRs/IDPs are not folded by nature and tend to be 
enriched in charged residues, as they are typically disorder-promoting as well as increasing solubility 
(Dunker et al., 2001) and so one would expect IDP-partner interactions to have a significant 
electrostatic component to them. 
A way of determining the extent to which electrostatic interactions influence protein-protein binding 
is to vary the ionic strength of the buffer, usually by changing [NaCl], and measuring the changes in 
the Kd, and the association and dissociation rate constants. The magnitude of these variations can be 
determined by the slopes of –log(Kd) (or log(Ka)), log(kon) and log(koff) verses log([NaCl]), the 
gradients for which are referred to as ΓEqNaCl, ΓonNaCl, and ΓoffNaCl respectively (Vindigni et al., 1997; 
Grucza et al., 2000; Chemes, Sánchez and de Prat-Gay, 2011). A negative value of ΓEqNaCl and ΓonNaCl, 
and a positive value for ΓoffNaCl indicate that the complex is destabilised by increasing [NaCl]. 
𝛤𝑁𝑎𝐶𝑙






                                                 [5-1] 
𝛤𝑁𝑎𝐶𝑙
𝑜𝑛 =  
𝜕 log(𝑘𝑜𝑛)
𝜕 log([𝑁𝑎𝐶𝑙])
                                                                [5-2] 
𝛤𝑁𝑎𝐶𝑙
𝑜𝑓𝑓 =  
𝜕 log(𝑘𝑜𝑓𝑓)
𝜕 log([𝑁𝑎𝐶𝑙])
                                                                [5-3] 
As ΓonNaCl is a measure of how much the transition state is affected by variations in [NaCl], and ΓEqNaCl 
is a measure of how the complex stability is affected by [NaCl], we can use these values to do an 
analogous analysis to Φ-value analysis (discussed in much greater detail in Section 6.3), to measure 
what proportion of the energy in the rate-limiting transition state comes from electrostatic 
interactions, αNaCl (Chemes, Sánchez and de Prat-Gay, 2011). 
𝛼𝑁𝑎𝐶𝑙 =  
𝜕 log(𝑘𝑜𝑛) 𝜕 log([𝑁𝑎𝐶𝑙])⁄





𝐸𝑞                                                  [5-4] 
I used this method to test both my “WT” S31C construct and my XXXXX S31C construct, as I believed 
that the removal of five negatively charged residues would produce a significant change in these 
values from the pseudo wild-type. However, as with the Φ-value analysis (see Section 6.3), the 
values obtained for αNaCl are qualitative given I was unable to determine the equilibrium Kd for my 
TCF7L2 constructs binding to β-catenin. 
Buffers of the required salinity were prepared by mixing 10x PBS stock, 5 M NaCl stock and 1 M DTT 
to give final concentrations 1x PBS pH 7.4, 1 mM DTT + additional NaCl. These calculations were 
made under the assumption that 1x PBS already is 140 mM NaCl, so for example to make a solution 
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that had a final [NaCl] of 1 M, I added and amount of 5 M NaCl stock that would provide and 
addition 860 mM NaCl. 
For the association traces, lyophilised β-catenin and labelled TCF7L2 construct were both 
resuspended in the buffer with the desired final concentration of NaCl as described in Section 2.7, 
diluted to the required concentrations with the same buffer and then mixed in 1:1 ratios as 
described in Section 2.8. Association reactions were performed as described in Section 2.8, and the 
association traces for both constructs fit best to a one-phase exponential function at all 
combinations of [β-catenin] and [NaCl]. 
For dissociation traces this mixing method was not possible, as the concentrated, unlabelled wild-
type TCF7L2 (1-54) that I used as a competitor was stored in 1x PBS, 1 mM DTT and trying to buffer 
exchange it into high salt PBS would result in an unknown final concentration of competitor. So 
instead β-catenin and labelled TCF7L2 construct were prepared in a buffer with a higher [NaCl] such 
that, when diluted 1:1 with the competitor in 1x PBS, 1 mM DTT (final concentration ≈ 140 mM 
NaCl), would have the desired final [NaCl]. The TCF7L2 and β-catenin were pre-complexed in the 
higher salt buffer before being mixed 1:1 with the competitor as described in Sections 2.8 and 2.9. 
Dissociations reactions were performed as described in Sections 2.8 and 2.9, as it was found that for 
both constructs at the highest [NaCl] tested (800 mM final [NaCl]), the stopped flow was required to 
measure the dissociation rate. 
From these salt dependence experiments we can see that association rate decreased with increasing 
[NaCl] for both constructs and that the dissociation rate increased with increasing [NaCl], causing a 
rapid decrease in Kd,kin, i.e. complex stability, with increasing [NaCl] (see Figure 7-1). Also the 
magnitude of the minor fast phase decreases with increasing [NaCl]. However for each of the Γ-
values, the pseudo wild-type construct was affected to a greater degree than the XXXXX variant, and 
that the XXXXX mutation had a much larger impact on the salt dependence of dissociation than on 
the salt dependence of association.  
Table 5-3: [NaCl] dependence of “WT” S31C and XXXXX S31C constructs. 
Construct 
[NaCl] Dependence 
ΓonNaCl Γoff,majorNaCl Γoff,minorNaCl ΓKd,kinNaCl* αNaCl† 
“WT” -1.72 ± 0.08 1.50 ± 0.13 1.89 ± 0.20 -3.22 ± 0.16 0.53 ± 0.04 
XXXXX -1.33 ± 0.07 0.61 ± 0.06 0.70 ± 0.12 -1.95 ± 0.14 0.68 ± 0.06 
*𝛤𝑁𝑎𝐶𝑙
𝐾𝑑,𝑘𝑖𝑛 =  −𝜕 log(𝐾𝑑,𝑘𝑖𝑛) 𝜕 log([𝑁𝑎𝐶𝑙])⁄  
†𝛼𝑁𝑎𝐶𝑙 =  𝛤𝑁𝑎𝐶𝑙
𝑜𝑛 𝛤𝑁𝑎𝐶𝑙
𝐾𝑑,𝑘𝑖𝑛⁄  
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From the literature, the general trend for IDP-protein interactions is that increasing ionic strength 
decreases kon whilst having minimal effect on koff (Hemsath et al., 2005; Chemes, Sánchez and de 
Prat-Gay, 2011; Japrung et al., 2013; Rogers, Steward and Clarke, 2013; Dogan, Gianni and Jemth, 
2014), with the S-peptide-S-protein interaction being a notable exception (Bachmann et al., 2011, 
however Bachmann et al. speculate that this is an artefact caused by labelling with fluorescein, 
which results in a change in the net charge of the S-peptide from +1 to -1).  
From my experiments, the XXXXX S31C construct fits this trend much more closely than my pseudo 
wild-type construct, for which increasing ionic strength does have a significant effect on both 
dissociation rate constants (see Table 5-3 and Figure 5-4b). This result suggests that that cluster of 
negatively charged residues from 23 to 29 can strongly influcence the kinetics of TCF72-β-catenin 
binding, but at physiologically relevant ionic strengths they have little to no net effect on the 
interaction. 
Figure 5-4 – The effect of [NaCl] on TCF7L2-β-catenin complex formation for “WT” S31C and XXXXX S31C constructs. (A), 
(B), (C) and (D) show the effects of increasing NaCl concentration on the association rate constant, the dissociation rate 
constants, the relative proportions of the major and minor dissociation rate constants and Kd,kin respectively.  
A B 
C D 
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5.6 Discussion 
Ensemble binding, or fuzzy complexes, is commonly observed mode of binding for IDPs and IDRs 
binding to a structured partner (Sharma et al., 2015). IDPs have a lot of conformational flexibility and 
therefore forming a rigid structure upon binding to a partner incurs a very high entropic cost. By 
forming a more dynamic complex this cost is lessened whilst still providing a favourable enthalpic 
contribution to the binding interaction. However the simplest explanation of my observations is that 
this is not a case of ensemble binding. 
Taken together, these data suggest that this region of TCF7L2 does not actually contribute towards 
the TCF7L2 binding interaction as none of the measured rate constants differ significantly from those 
of the pseudo wild-type construct. Moreover the fact that the association traces for these variants 
were single phase and the dissociations biphasic, like the pseudo wild-type, suggests that I was 
observing the same association and dissociation events.  
These results lead me to conclude that the differences observed in the previously reported crystal 
structures (Graham et al., 2001; Poy et al., 2001; Sampietro et al., 2006) are simply a result of the 
different conditions in which the protein was crystallised. While it may be true that these are real 
structures that TCF7L2 is capable of adopting when binding to β-catenin in solution, they appear to 
be transient and do not contribute to binding, and it is simply by chance that these are the three 
structures obtained crystallographically for this region of TCF7L2. 
There are a range of methods that can be used to study the ensemble of structures adopted by IDPs, 
either as isolated proteins or in complexes, which could be applied to the TCF7L2- β-catenin complex 
(Peti et al., 2018). Multiple techniques are frequently used in combination with each other, in order 
to obtain a more accurate picture of the possible structures. These include solution NMR and SAXS 
which are able to produce probability distributions for the positions of individual atoms, which can 
then be resolved into ensembles of statistically likely structures using computational techniques like 
EROS (ensemble refinement of SAXS). Other techniques like hydrogen-deuterium exchange mass 
spectroscopy (HDX-MS) are more useful for studying IDPs/IDRs in complex. HDX-MS uses MS to 
measure the rate at which backbone amide N–H groups exchange to N–D in a deuterated solvent 
(often D2O). Areas where exchange is slow are areas that are less frequently solvent exposed so this 
technique can be used to measure what percentage of the time fuzzy binding regions are in contact. 
It is interesting to note that my findings are in contrast to those of Graham et al.. In addition to 
determining the E29-bound crystal structure (PDB ID 1JDH, Graham et al. (2001)), Graham et al. drew 
comparisons between their structure of human TCF7L2 in complex with human β-catenin and a 
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structure they had previously published, of Xenopus TCF7L1 in complex with Xenopus β-catenin 
(Graham et al., 2000). As part of their comparative study, they performed mutagenesis and 
measured the effect on TCF7L2-β-catenin binding by immunoprecipitation. They found that the E24A 
variant reduced binding by 18-53%, the E29A variant reduced binding by 35-70%, the E24A E29A 
double variant by 85-90%, and a E24A E26A E28A E29A quadruple mutational variant (comparable to 
my XXXXX mutational variant though not equivalent) eliminated binding. However it should be said 
that immunoprecipitation is a qualitative method that relies on antibody binding to a specific 
epitope, and if that epitope becomes disrupted, in this instance if the epitope falls in the residues 
23-29 region, then binding of the antibody will be lost. 
It is also important note there was a flaw in my initial reasoning for this investigation. In order to 
determine the properties of any given structure you need to ensure that it adopts that structure and 
no other. In this case, where more than two possible structures can exist, the single alanine 
mutations do not force a specific structure they force “specifically not this structure”. In hindsight, a 
better approach to examining the D23-bound, E24-bound, etc. structures specifically would have been 
to mutate to alanine the four other charged residues. Then I could be sure that the construct was 
indeed only capable of adopting the desired structure. Indeed I was in the process of creating the 
constructs by SDM (which I referred to as 1XXXX, X2XXX, XX3XX, XXX4X and XXXX5 respectively, 
1XXXX being equivalent to the constructed used by Graham et al.) but decided to make and test the 
XXXXX construct in order to determine whether this avenue was worth pursuing. But as I observed 
no effect on binding for the XXXXX construct this line of investigation was discontinued. 
Peptide stapling is another method I had considered as a way of forcing TCF7L2 to adopt the E29-
bound structure. By macrocyclising the TCF7L2 construct across the α-helix that is only present in 
the E29-bound structure, then the conformational selection would be heavily biased towards the E29-
bound structure, effectively forcing it to adopt that structure. Experiments on peptide stapling are 
described in more detail in Section 7.1 of this Thesis. 
The effect of charge on the TCF7L2-β-catenin interaction yielded some interesting results. A ΓKd,kinNaCl 
≈ -3 for the pseudo wild-type construct means that the TCF7L2-β-catenin complex is destabilised by 
three orders of magnitude for every order of magnitude increase in ionic strength. This sensitivity is 
relatively high compared to other IDP-protein interactions (ΓKd,kinNaCl ≈ -1 for the ACTR-NCBD 
interaction (Japrung et al., 2013), -1.4 > ΓKd,kinNaCl > -2.4 for various HPV E7 constructs binding to Rb 
(Chemes, Sánchez and de Prat-Gay, 2011)). In contrast it is only two orders of magnitude for the 
XXXXX S31C construct (ΓKd,kinNaCl ≈ -2) which this implies that the five negatively charged residues that 
have been removed in this construct are entirely responsible for this extra destabilising effect. This 
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change comes almost entirely from the unusual acceleration of disassociation (Γoff,majorNaCl ≈ 1.5 for 
pseudo-WT and Γoff,majorNaCl ≈ 0.6 for XXXXX S31C). 
A possible insight into what might be happening here comes from studies on the ACTR-NCBD 
interaction. When ionic strength was increased, a charge reversal occurred in going from 0.02 M to 
0.2 M (close to physiological) ionic strength, changing the overall charge of NCBD from positive to 
negative (Japrung et al., 2013). The explanation given for this phenomenon was that the highly 
positively charged NCBD attracts a shell of negatively charge chloride ions. At higher ionic strengths 
sufficient chloride ions are attracted to this shell to completely screen and eventually overwhelm the 
positive charge. I believe an analogous behaviour occurs with TCF7L2-β-catenin, except instead we 
have a shell of positively charged sodium ions forming around a negatively charged region.  
The decrease in ΓonNaCl upon mutation of the five charged residues is easy to explain as reducing the 
number of electrostatic interactions means that effects disrupting electrostatic interactions will have 
less of an impact. However the idea of an ionic shell/screen helps us explain the unusually high 
ΓoffNaCls for the pseudo wild-type construct, as well as the magnitude of the effect the XXXXX S31C 
mutation has on the ΓoffNaCls. As the variable region changes transiently between structures it would 
periodically part from the surface of β-catenin. While apart from β-catenin, the negatively charged 
residues can recruit a shell of positively charged sodium ions, which then inhibit re-association, 
promoting complete dissociation. This effect increases in magnitude with increasing ionic strength 
and is lost entirely when these residues are mutated to alanine in the XXXXX S31C construct. 
The change in αNaCl values between constructs can also be explained by the ionic shell model. Upon 
removing five charged residues (XXXXX S31C), αNaCl increased, implying that the energetic 
contribution to binding from electrostatic interactions increases. As this cannot be reasoned as being 
an increase in stabilising interactions, it must be due to a decrease in disruptive interactions, a 
phenomenon which is seen again in Chapter 6. As we have already established that β-catenin is 
primarily positively charged and the removed TCF7L2 residues are negative, this should result in a 
decrease of stabilising interactions, unless, of course, they recruit this positively charged shell. It 
could also be the case that it is the other way around, and it is β-catenin that recruits a shell of 
negatively charge chloride ions instead, but this is less likely simply due to the difference in charge 
density, the 23-29 region of TCF7L2 being much more charge dense than the surface of β-catenin.  
While the concept of a hydration/solvation shell is not new in protein science (Burling et al., 1996), 
Japrung et al.’s idea of an ion shell affecting protein kinetics is somewhat unusual but I believe fits 
what is being observed here. In their paper describing the ACTR-NCBD interaction, Japrung et al. 
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performed single molecule studies on the system by attracting single NCBD molecules into 
nanopores using and electric current then adding ACTR (Japrung et al., 2013). However they 
observed that at higher KCl concentrations, the NCBD would not be drawn into the pore with the 
current they had been using and they needed to reverse the current in order achieve the same 
effect. Potentially a similar experiment could be performed on a fragment of TCF7L2 containing the 
highly charged region to see if significant electrostatic shielding can be observed. 
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Chapter 6 – Alanine Scan and Φ-value Analysis 
In Chapter 5 I had shown that, somewhat surprisingly, the highly negatively charged region of 
TCF7L2 (residues 23-29) has no significant effect on the TCF7L2-β-catenin binding interaction. This is 
rather unexpected as studies of β-catenin binding to its other intrinsically disordered partners show 
that binding to the β-catenin “lysine button”, lysine-312, is important to their respective interactions 
(Graham et al., 2000; Dyson and Wright, 2002; Gail, Frank and Wittinghofer, 2005; Xu and Kimelman, 
2007; Sun and Weis, 2011). Yet TCF7L2 still forms a very tight interaction with β-catenin, the binding 
energy for which must therefore be provided by other residues of TCF7L2. Consequently, I chose to 
investigate the role of the other residues play in this binding interaction.  
The TCF7L2-β-catenin binding interface is very long, with many different TCF7L2 residues forming 
contacts with a large number of different β-catenin residues, which I divided into three distinct 
binding regions; the N-terminal region (residues 12-21), the variable region (residues 22-37), and the 
C-terminal region (residues 38-50). While each residue will likely provide a contribution to the 
binding, it is likely that the majority of the binding energy comes from a few “hot-spot” residues 
(Clackson and Wells, 1995; Bogan and Thorn, 1998).  
Indeed, Sun and Weis determined a consensus “lysine button” binding motif for β-catenin’s 
disordered partners (Sun and Weis, 2011; Reichen, Hansen and Plückthun, 2014). That sequence is 
DxΦΦxΩx2-7E, where the initial aspartate residue interacts with “lysine button” lysine-435, Φ is a 
hydrophobic residue, Ω is an aromatic residue, and the terminating glutamate residue interacts with 
“lysine button” lysine-312. For TCF7L2, the initial aspartate residue corresponds to D16, ΦΦ are L18 
and I19 respectively, Φ is F21, and the terminating glutamate is E24 or E29 depending on which crystal 
structure you’re looking at. 
In this chapter, I investigate the contribution of other regions of TCF7L2 to the TCF7L2-β-catenin 
binding interaction using a number of mutational variants as previously described in Chapter 5. 
These variants are then used to map the kinetic pathway of complex formation as well as investigate 
the potential for multiple association and dissociation pathways, analogous to the multiple folding 
and unfolding pathways observed for tandem repeat proteins.  
6.1 Choice of Positions to Mutate to Alanine 
In order to decide which residues to choose for an alanine scan I returned to the previously 
generated contact maps for the three crystal structures (see Figure 4-2). I looked for a mix of 
residues that formed the same or very similar contacts in each structure and some that were 
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different between structures. I also favoured residues that formed more contacts and had a larger 
contact areas as well as aiming to pick a mixture of charged, polar and hydrophobic residues. 
Another important consideration is that in order to perform Φ-value analysis, a mutation needs to 
significantly disrupt binding without eliminating it completely. For that reason I was hesitant about 
mutating residues within the consensus binding sequence described by Sun and Weis. In the end I 
decided on five residues from each of the N- and C-terminal binding regions: L12A, N15A, E17A, I19A 
and F21A, and E38A, L41A, V44A, K45A and L48A. 
L12 and E38 were chosen as they both form multiple contacts in Graham’s and Sampietro’s structures 
but none in Poy’s (see Figure 6-1), and seem to be delineating the beginning of their respective 
binding regions. This could be suggesting that these residues have more transient interactions and 
therefore provide a lesser contribution to overall binding, or it could be the effect of the different 
crystallisation conditions, as was likely the case for residues in the 23-29 region. The difference in 
Figure 6-1 – TCF7L2 leucine-12 and glutamate-38 in crystal structures. (A) and (B) are zoomed in pictures of TCF7L2 (red) 
in complex with β-catenin (cyan) taken from Poy et al. and Sampietro et al. respectively. TCF7L2 residue L12 is not visible in 
Poy’s structure but has been highlighted, along with its side chain interactions with β-catenin residues in Sampietro’s 
structure. (C) and (D) are zoomed in pictures of TCF7L2 (red) in complex with β-catenin (cyan) taken from Poy et al. and 
Graham et al. respectively. Similarly, TCF7L2 residue E38 is not visible in Poy’s structure but has been highlighted in 
Graham’s. Structure images were created using UCSF Chimera from PDB IDs 1JPW, 1JDH and 2GL7 respectively. 
A B 
C D 
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the number of contacts in the contact maps for these residues for Sampietro’s and Graham’s 
structure are due to variations in weaker contacts (>7 Å). 
Residues L41, V44, K45 and L48 form the face of TCF7L2s C-terminal α-helix which contacts the surface 
of β-catenin and thus seemed the logical choices for an alanine scan. In all three crystal structures 
these four residues form contacts with same β-catenin residues suggesting that these interactions 
are important to TCF7L2-β-catenin complex formation (see Figure 6-2). 
I purposely avoided the E16A mutation, as this residue contacts lysine-435 of β-catenin i.e. the other 
“lysine button”. Previous studies of β-catenin binding to its other intrinsically disordered partners 
(Graham et al., 2000; Dyson and Wright, 2002; Gail, Frank and Wittinghofer, 2005; Xu and Kimelman, 
Figure 6-2 – TCF7L2 leucine-41, valine-44, lysine-45 and leucine-48 in crystal structure. A diagram highlighting the relative 
positions of residues L41, V44, K45 and L48 when TCF7L2 (red) binds to β-catenin (cyan). Structure images were created using 
UCSF Chimera from PDB IDs 1JPW (Poy et al., 2001).  
Figure 6-3 – TCF7L2 asparagine-15, apartate-16 and glutamate-17 in crystal structures. A zoomed in picture of TCF7L2 
(red) in complex with β-catenin (cyan) taken from Poy et al.. The interactions of TCF7L2 residues N15, D16 and E17 with β-
catenin residues have been highlighted. Structure images were created using UCSF Chimera from PDB IDs 1JPW 
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2007; Sun and Weis, 2011) as well as Omer et al.’s original paper describing TCF7L2-β-catenin 
binding (Omer et al., 1999), have identified this lysine button interaction as a hot spot. Mutating this 
residue may disrupt binding so much that it is no longer detectable, so I instead opted to mutate the 
adjacent residues N15 and E17. From the crystal structures (see Figure 6-3) it can be seen that these 
two residues form well-defined interactions that should contribute significantly to binding.  
I19 and F21, in contrast, were chosen for their high contact area, hydrophobicity and their consistency 
between crystal structures (see Figure 6-4). F21 appears at first glance to be in different 
environments in the different crystal structures, being at the N-terminus of the transient α-helix in 
Graham’s structure as opposed to the elongated structure seen in the other two. However, closer 
inspection shows that it is the aforementioned weaker contacts as well as some backbone 
interaction that vary between the structures. 
These ten mutations were introduced into the “WT” S31C construct by SDM (see Appendix A, 
Section A.3.4). 
6.2 Alanine Scan 
The association rate constants for each of the ten alanine variants were determined as previously 
described, and once again it was found that the association traces were one-phase. Nine out of the 
ten mutations selected for this alanine scan showed decreases in association rate constants which 
were generally smaller in magnitude than the decreases observed for the variants used to test 
ensemble binding (Chapter 5), except those observed for the F21A S31C and V44A S31C constructs 
which were of comparable magnitude (see Figures 6-5a & 6-6a, summarised in Table 6-2). Worthy of 
Figure 6-4 – TCF7L2 isoleucine-19 and phenylalanine-21 in crystal structures. (A) and (B) are zoomed in pictures of TCF7L2 
(red) in complex with β-catenin (cyan) taken from Poy et al. and Graham et al. respectively, highlighting TCF7L2 I19 and F21 
and their interactions with β-catenin residues. It can be seen that despite a difference in back bone conformation, the side 
chain of F21 occupies a similar position, maintaining the same side chain contacts. Structure images were created using 
UCSF Chimera from PDB IDs 1JPW and 1JDH respectively. 
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Figure 6-5 – The association and dissociation traces of the alanine scan constructs. (A) is a comparison of the association 
rate constants of alanine scan mutants to the pseudo wild-type construct. The individual data points have been omitted 
for clarity. (B) through (L) are representative dissociation traces for L12A, N15A, E17A, I19A (by fluorimeter), I19A (by 
stopped flow), F21A, E38A, L41A, V44A, K45A and L48A S31C constructs respectively. The dissociation traces obtain using 
a fluorimeter ((B) through (E), (H), (K) and (L)) and those obtained by stopped flow ((F), (G), (I) and (J)) have been on 
identical axes for ease of visual comparison. All experiments were performed in 1x PBS, 1 mM DTT at 15°C. 
A B C 
D E F 
G H I 
J K L 
note is that the K45A variant, the only positively charged residue tested this way, actually resulted in 
an increase in the association rate. 
Dissociation traces were more interesting (see Figures 6-5b-l, 6-6b&c, summarised in Table 6-1), as 
for four of the variants (I19A, F21A, L41A and V44A) it was found that dissociation was sufficiently 
rapid as to be measureable on the stopped flow. Indeed for the most rapidly dissociating variants 
(F21A, L41A and V44A) the fluorimeter proved to be entirely unsuitable as it was only capable of 
taking a reading every 3 s, which would not have been sufficiently frequent to accurately capture the 
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faster phase. In all cases except the I19A S31C construct the dissociation was found to have a major 
slow phase of 70-90% and a minor fast phase of 10-30%, similar to those found for the pseudo wild-
type and ensemble binding constructs (Chapter 5).  
Table 6-1: Dissociation rate constants for the alanine scan constructs. 
Construct 
Dissociation 
koff,major (x10-4 s-1) Ratio koff,minor (x10-3 s-1) Ratio % fast n† Instrument 
“WT” 5.73 ± 0.40  1 1.52 ± 0.28  1 23 ± 3 8 Fluorimeter 
L12A 9.77 ± 0.75 1.7 2.64 ± 0.20 1.7 19 ± 12 2 Fluorimeter 
N15A 4.42 ± 0.15 0.77 3.65 ± 0.83 2.4 18 ± 2 3 Fluorimeter 
E17A 89.1 ± 2.9 15.5 28.3 ± 1.9 18.7 28 ± 4 3 Fluorimeter 
I19A 
165 ± 7 28.8 2.92 ± 0.05 1.9 82 ± 3 2 Fluorimeter 
110 ± 0.5 19.2 207 ± 10 136 15 ± 0.1 5 SF 
F21A 258 ± 2 45.0 423 ± 15 279 20 ± 0.1 8 SF 
E38A 5.39 ± 0.50 0.94 2.61 ± 0.28 1.7 30 ± 1 3 Fluorimeter 
L41A 993 ± 17 173 616 ± 111 406 11 ± 0.4 11 SF 
V44A 742 ± 8 129 498 ± 70 328 11 ± 0.4 8 SF 
K45A 21.9 ± 0.4 3.8 15.0 ± 1.3 9.9 19 ± 1 4 Fluorimeter 
L48A 13.2 ± 0.1 2.3 4.24 ± 0.13 2.8 17 ± 0.6 3 Fluorimeter 
† n is the number of repeats 





WT kon (x107 M-1 s-1) n† Ratio to WT 
“WT” 7.33 ± 0.14 16 1 7.8 ± 0.6 1 
L12A 7.19 ± 0.13 3 0.98 13.6 ± 1.1 1.7 
N15A 6.25 ± 0.23 3 0.85 7.1 ± 0.4 0.91 
E17A 6.30 ± 0.42 2 0.86 141.3 ± 10.5 18.1 
I19A 7.04 ± 0.52 2 0.96 
234.7 ± 20.0~ 30.0~ 
156.7 ± 11.6‡ 20.0‡ 
F21A 4.82 ± 0.17 2 0.66 535.0 ± 19.1 68.4 
E38A 6.20 ± 0.19 2 0.85 8.7 ± 0.8 1.1 
L41A 5.95 ± 0.24 2 0.81 1668.7 ± 72.9 213.4 
V44A 5.05 ± 0.46 2 0.69 1469.6 ± 135.6 187.9 
K45A 10.31 ± 0.19 2 1.41 21.3 ± 0.5 2.7 
L48A 5.67 ± 0.60 2 0.77 23.2 ± 2.5 3.0 
* 𝐾𝑑,𝑘𝑖𝑛 =  𝑘𝑜𝑓𝑓,𝑚𝑎𝑗𝑜𝑟 𝑘𝑜𝑛⁄  
† n is the number of repeats 
~ calculated from koff,major using fluorimeter 
‡ calculated from koff,major using stopped flow 
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Figure 6-6 – The kinetic parameters of the alanine scan constructs. A graphical representation of the data presented in 
Tables 6-1 and 6-2. (A), (B), (C) and (D) are comparisons of the association rate constants, major and minor dissociation 
rate constants and kinetic Kd respectively for each of the alanine scan constructs. Hydrophobic residues are coloured 
yellow, negatively charged residue are blue, positively charge residues are orange, and polar, uncharged residues are 
green. All experiments were performed in 1x PBS, 1 mM DTT at 15°C. 
A B 
C D 
The I19A variant proved to be the most interesting in terms of its dissociation kinetics. The 
dissociation rate for this variant was such that it could be measured on both the fluorimeter and the 
stopped flow. When the dissociation rate constant was measured on the stopped flow the 
dissociation was found to be two-phase, with a major slow phase of 85% of the total amplitude and 
a minor fast phase of 15%, in line with the other variants. However when the dissociation rate was 
measured using the fluorimeter it was found to be two phase, but this time there was a major fast 
phase of 82% and a minor slow phase of 18%. However, the major slow phase obtained from 
stopped flow and the major fast phase from the fluorimeter have similar rates (1.10 x10-2 s-1 and 
1.65 x10-2 s-1 respectively) and similar relative amplitudes, suggesting that association is actually 
three phase.  
𝑦(𝑡) =  𝐴1𝑒
−𝑘1𝑡 + 𝐴2𝑒
−𝑘2𝑡 + 𝐴3𝑒
−𝑘3𝑡 + 𝑏𝑡 + 𝑐                                      [6-1] 
When the individual dissociation traces for I19A S31C in both the stopped-flow and fluorimeter were 
fit to a three phase exponential function (Equation 6-1, see Figure 6-7), it was found that there were 
differences between the rate constants produced by each method (see Table 6-3).  
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Figure 6-7 – Dissociation trace of the I19A S31C construct. (A) and (B) are representative dissociation traces for the I19A 
S31C construct when measured using a fluorimeter and the stopped flow respectively. These data have been plotted with  
one-, two- and three-phase exponential functions and their residual traces have been plotted below (red, green and blue 
respectively). All experiments were performed in 1x PBS, 1 mM DTT at 15°C. 
A B 
Table 6-3: Three-phase dissociation of I19A flS31C 
Instrument 
Dissociation* 
k1 %1 k2 %2 k3 %3 k4 %4 n† 
Fluorimeter - - 87.6 ± 18.8 10 ± 0.5 15.0 ± 0.8 75 ± 4.5 2.66 ± 0.06 15 ± 4 2 
Stopped 
Flow 
535 ± 70‡ 6 ± 0.5 65.2 ± 7.3 15 ± 0.8 9.1 ± 0.2 79 ± 0.3 - - 5 
* Where kx is the xth association rate constant in x10-3 s1 and %x is the corresponding amplitude of that phase 
† n is the number of repeats 
‡ This value is close to upper limit of what the stopped flow can measure given the dead time is ≈ 1-2 ms 
For the dissociation traces produced using the fluorimeter, the major phase (75%) was the middle 
phase, with a rate constant of 15.0 ± 0.8 x10-3 s-1, similar to the major phases found for a two-phase 
exponential fit. A minor (15%) slow phase of 2.7 ± 0.1 x10-3 s-1, similar to the minor slow phase when 
from the fluorimeter, and a minor (10%) fast phase of 88 ± 19 x10-3 s-1, which is slower than the 
minor fast phase from the stopped flow two-phase exponential fit, were also found. 
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For the dissociation traces produced using the stopped flow, the major phase (79%) was actually the 
slow phase but the rate constant was 9.1 ± 0.2 x10-3 s-1, again similar to the previously major phases 
from all other fits. The minor fast(er) phase (6%) had a rate constant of 535 ± 70 x10-3 s-1, 2.5 times 
that of the minor fast phase from the stopped flow, and the minor middle phase (15%) had a rate 
constant of 65.2 ± 7.3 x10-3. This middle phase lies between the slower and faster phases of the two-
phase exponential fit and is similar to the fast phase obtained for the three phase fit of the 
fluorimeter dissociation. Taken together these results suggest that there are a total of four phases of 
dissociation.  
An attempt was made to fit the I19A dissociation data to a four-phase exponential function 
(Equation 6-2), using 0.5, 0.07, 0.01 and 0.003 s-1 as initial values for the rate constants and 5, 10, 75 
and 10 % as initial values for the relative amplitudes. None of the seven traces could be fit 
unambiguously to this equation.  




−𝑘4𝑡 + 𝑐                                [6-2] 
The alanine scan variants can be grouped into four broad categories: those with no effect on binding 
(N15A and E38A and also the seven ensemble binding variants from Chapter 5), those with a mildly 
destabilizing effect on binding (L12A, K45A and L48A), those with a moderately destabilising effect 
on binding (E17A, I19A and F21A), and those with a strongly destabilising effect on binding (L41A 
and V44A).  
In general, we can see that a significant proportion of the binding strength is provided by the 
interactions of hydrophobic residues (I19A, F21A, L41A and V44A). It can also be seen that there are 
other key salt bridges (e.g. E17 binding to lysine-508) in addition to the previously reported “lysine 
button” interactions make noticeable contributions to TCF7L2-β-catenin binding. 
6.3 Φ-Value Analysis 
Φ-value analysis is a protein engineering technique, developed by the Fersht Lab, for analysing the 
transition state of protein folding (Matouschek et al., 1989; Fersht, Matouschek and Serrano, 1992; 
Fersht and Sato, 2004). The technique involves measuring the effect of a mutation on both the rate 
of folding (kfold) and equilibrium stability (Kd), calculating the Gibbs free energy of the transition 
states and native states, relative to the denatured state, (Equations 6-3 and 6-4 respectively) for 
both the wild-type and variant, and calculating the ratio of the difference between the two 
(Equation 6-5). 
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∆𝐺‡−𝐷  = 𝑅𝑇𝑙𝑛(𝑘𝑓𝑜𝑙𝑑)                                                             [6-3] 
∆𝐺𝑁−𝐷 = −𝑅𝑇𝑙𝑛(𝐾𝑑)                                                             [6-4] 











                                                       [6-5] 
Typically Φ-values fall between 0 and 1, where 0 means that the mutation has no effect on the 
energy of the rate-limiting transition state, i.e. that that region is unstructured in the transition 
state, and 1 means that the mutation has an equal effect on the energy levels of the rate-limiting 
transition state and the folded state, i.e. that that region is fully formed in the transition state. An 
intermediate value is generally interpreted as the proportion of the native contacts that that 
residues forms, which are formed in the rate-limiting transition state, i.e. Φ = 0.3 is interpreted as 
30% of native state contacts are already formed in the rate-limiting transition state.  
Non-classical Φ-values, Φ > 1 or negative Φ, have also been reported. Φ > 1, where the energy of 
the transition state is perturbed more than that of the native state, is usually attributed to the 
formation of transient contacts in the rate-limiting transition state that are not present in the native 
state. These are most often seen for charged residues that form few contacts in the native state and 
are instead solvent exposed. Negative Φ-values arise from the rare occasion where a mutation 
Figure 6-8 – Free energy diagram of a protein folding reaction. A free energy diagram showing the relative energy levels 
of the denatured (D), native (N) and rate-limiting transition state (‡) of both a wild-type protein, and the same protein 
with a destabilising mutation. The denatured states of both proteins have been overlaid for clarity. 
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stabilises the rate-limiting transition state but destabilises the native state, or vice versa. These are 
usually due to the elimination or introduction of a steric clash, electrostatic repulsion or hydrophilic-
hydrophobic clash that occurs in one state but not the other, and are nearly impossible to interpret 
without further contextual information.  
An analogous approach can be used for protein-protein and protein-ligand interactions, substituting 
the change in rate of complex formation, ΔΔG0‡, and complex stability, ΔΔG0, for protein folding rate 
(ΔΔG‡-D) and protein stability respectively (ΔΔGN-D). I applied this approach to my alanine scan 
variants however, it is generally required that ΔΔG0‡ and ΔΔG0 be calculated separately using 
independent kinetic and equilibrium experiments. As I was unable to obtain meaningful results from 
my equilibrium binding experiments i.e. fluorescence anisotropy titration experiments (see Section 
4.5), I was not able to calculate Φ-values for my alanine scan variants in the above way. Instead I 
have substituted my apparent Kd,kin for the Kd,eq to obtain estimates for the Φ-values.  
Fersht and Sato (2004) suggest that Φ-values require a ΔΔGN-D > 0.6 kcal mol-1 (or ΔΔG0 in this case) 
in order to be considered non-artefactual. From this we can see that three of the residues chosen, 
L12, N15 and E38, cannot be analysed in this way and K45 should also be excluded (see Table 6-4). 
However, as the value for K45 is on the borderline, and this analysis is only qualitative, I have 
included it in this analysis.  
Table 6-4: Φ-value analysis of the alanine scan constructs 
Construct kon (x107 M-1 s-1) ΔΔG0‡ (kcal mol-1) Kd,kin (pM)* ΔΔG0 (kcal mol-1)* Φ* 
“WT” 7.33 ± 0.14 - 7.8 ± 0.6 - - 
L12A 7.19 ± 0.13 0.01 ± 0.01 13.6 ± 1.1 0.32 n.d. 
N15A 6.25 ± 0.23 0.09 ± 0.02 7.1 ± 0.4 -0.06 n.d. 
E17A 6.30 ± 0.42 0.09 ± 0.04 141.3 ± 10.5 1.66 0.05 
I19A 7.04 ± 0.52 0.02  ± 0.04 
234.7 ± 20.0† 1.95† 0.01† 
156.7 ± 11.6‡ 1.71‡ 0.01‡ 
F21A 4.82 ± 0.17 0.24 ± 0.02 535.0 ± 19.1 2.42 0.10 
E38A 6.20 ± 0.19 0.10 ± 0.02 8.7 ± 0.8 0.06 n.d. 
L41A 5.95 ± 0.24 0.12 ± 0.03 1668.7 ± 72.9 3.07 0.04 
V44A 5.05 ± 0.46 0.21 ± 0.05 1469.6 ± 135.6 3.00 0.07 
K45A 10.31 ± 0.19 -0.20 ± 0.01 21.3 ± 0.5 0.57 -0.34 
L48A 5.67 ± 0.60 0.15 ± 0.06 23.2 ± 2.5 0.62 0.24 
* These values are qualitative as they are calculated for Kd,kin rather than Kd,eq as intended. 
† calculated from Kd,kin using fluorimeter 
‡ calculated from Kd,kin using stopped flow 
Overall we see that the majority of the residues tested (see Table 6-4) have yet to form bonds to β-
catenin in the rate-determining transition state (Φ ≈ 0) with the C-terminal-most residue, L48, having 
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some partially formed bonds to β-catenin at this point. K45 is special in that it has a negative Φ-value 
as a result of being faster to form the TCF7L2-β-catenin complex than the pseudo wild-type 
construct.  
6.4 Discussion 
Alanine scans are used extensively in biophysical studies, for investigating both protein folding and 
protein-ligand interactions. They allow us to resolve the forces that drive the formation of a specific 
protein’s shape or complex’s structure and to understand how specific dysfunctions may arise, as 
well as enabling us to make rational choices with predictable outcomes when manipulating them. 
Understanding the kinetic pathways between folded and unfolded, or bound and unbound, has 
historically been a much more difficult process. Polypeptide chains sample a vast amount of 
conformational space in the transition from unfolded to folded or un-bound to bound state. This 
reaction often contains a number of energy maxima and higher energy minima which are transient 
and do not exist long enough to study them directly. Since its conception in the early 90’s, Φ-value 
analysis has allowed us to describe the slowest-forming (rate-limiting) transition state and from 
there, we can predict the likely structures that would form between it and the native or denatured 
state and thereby visualise the other transition states along a folding pathway. 
From the alanine scan we can see that, once again, each of the mutations has little effect on 
association rate (see Table 6-2), and for most of the mutations the change is less than those seen for 
the ensemble binding variants in Chapter 5. This is expected, as the majority of the residues tested in 
this chapter are hydrophobic and longer-range electrostatic interactions tend to drive protein-ligand 
association, as opposed to shorter-range hydrophobic interactions seen in protein folding 
(hydrophobic collapse). That being said, three residues stand out from the others as being worthy of 
note: F21, V44 and K45. 
K45 is interesting, as it is the only variant tested that resulted in an increase in the association rate, if 
only a small one. It is also the only positively charged residue tested in this manner so it is easy to 
speculate that the cause of the increased association rate is the removal of an electrostatic 
repulsion. Indeed, when we examine the coulombic surface of β-catenin we can see that the groove 
into the C-terminal α-helix binds is flanked by multiple positively charged residues (see Figure 6-9). 
Further inspection of the three crystal structures of the TCF7L2-β-catenin complex shows that, when 
bound, TCF7L2 K45 does not form a more common salt bridge to a negatively charged residue on β-
catenin, but forms two, more unusual, cation-π interactions with two buried histidine residues: 
histidine-219 and histidine-260. Due to their buried nature, these cation-π interactions are unlikely 
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to provide a significant long-range attractive force, so by mutating K45 to alanine no attractive 
interaction is lost, but the repulsive interactions are reduced. Hence the association rate constant 
increases. 
It is a bit more difficult to explain the effect of the V44 and F21 variants on the association rate 
constant. V44 is a bulky β-branched hydrophobic residue so loss of long-range electrostatic 
interactions on mutation to alanine is not a factor. It could be that steric hindrance from V44 limits 
the conformational freedom of unbound TCF7L2 increasing the likeliness of it being in a more 
favourable β-catenin binding confirmation. This could indicate that the α-helix is pre-formed before 
the rate-limiting transition state, but we do not have enough evidence to support that conclusion. Of 
note is the fact that V44 is immediately adjacent to K45, whose presence has a retarding effect on the 
association rate. It could also be that the bulkiness of V44 forces K45 to adopt less disfavourable 
conformations and by mutating to it to alanine, it removes this interaction.  
For the F21 variant it is less clear why there is a comparatively large effect on association rate but it is 
likely due to this residue’s interaction with arginine-386 on β-catenin. In all three crystal structures, 
F21 forms an interaction with this arginine that can be considered both a π-stacking interaction and a 
cation-π interaction and is likely a major factor in how much F21 contributes to TCF7L2-β-catenin 
binding (see Figure 6-10). While cation-π interactions are not as effective at longer ranges as 
electrostatic interactions are, it is likely that arginine-386 does provide an attractive force on F21, 
Figure 6-9 – The coulombic surface of β-catenin. The surface of β-catenin coloured by coulombic charge, with regions of 
positive charge coloured blue and regions of negative charge coloured red. The area circled in green indicates the groove 
into which the C-terminal helix of TCF7L2 binds. TCF7L2 residues V44 and K45 dock into the small pocket within the 
highlighted area. Structure image was created using UCSF Chimera from PDB ID 2Z6H  
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hence mutating F21 to alanine has an effect on association, unlike the buried histidines which 
interact with K45. 
Unlike the association rate constants, the dissociation rate constants were significantly more 
perturbed in the alanine scan, with changes observed by as much as two orders of magnitude from 
wild-type (see Table 6-1). We can see that those residues which vary the most significantly between 
the three crystal structures i.e. L12, N15 and E38, perturb dissociation rate the least. This makes sense 
because if these residues are seen varying between structures, it implies their interactions are 
weaker and more transient, hence the small increase in dissociation rate. Conversely, the 
hydrophobic residues i.e. I19, F21, L41 and V44, resulted in the largest increases in the dissociation rate 
constants, implying that these residues form very strong interactions with β-catenin residues. This is 
reflected by these residues being invariant between crystal structures.  
Mutating E17 to alanine also has a significant effect on dissociation, unlike the other negatively 
charged residues tested (E38 and those from Chapter 5). This may be because there is a specific 
positively charge pocket into which E17 can dock, and form specific salt bridges to β-catenin residues 
arginine-469, histidine-470 and lysine-508. We can also see that the neighbouring residue, D16, sits in 
an adjacent, deeper, more positively charge pocket (see Figure 6-11). I had opted not to test this 
residue as other papers have shown that the equivalent of this interaction has a very significant 
effect on β-catenin’s other binding partners, and from this we can see why. 
The I19A mutation invokes a lot of discussion. The major phase dissociation rate ended up being one 
order of magnitude different from the wild-type with a half-life of approximately 60 s. This was fast 
enough to allow the recommended ten half-lives to be recorded on the stopped flow (the upper 
Figure 6-10 – Rotation of Figure 6-9 to show phenylalanine-21 binding pocket. The same surface of β-catenin as seen in 
Figure 6-9, but rotated to show the F21 binding region. The area circled in orange indicates pocket into which F21 binds 
along with β-catenin arginine-386 to which F21 bonds. Structure image was created using UCSF Chimera from PDB ID 2Z6H.  
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time limit for that machine being 600 s), while at the same time slow enough to be accurately 
captured on the fluorimeter, which can take a reading every 3 s (20 points per half-life). 
The fact that both techniques produce near identical koff,major values but different koff,minor values, one 
an order of magnitude faster and the other an order of magnitude slower than koff,major, strongly 
indicates the existence of a third phase of dissociation (see Table 6-1). Then when these traces were 
fitted to a three phase decay it was found that the two techniques produced two phases that were 
similar between the two techniques and each had a unique third phase, giving us four distinct 
phases (see Table 6-3). Neither data set could be fit to a four phase decay. This is likely due to the 
difference in time scale for the techniques and the difference in magnitude of the phases. The four 
phases of approximately 0.5, 0.075, 0.01 and 0.003 s-1 have corresponding half-lives of 1.4, 9.2, 69 
and 230 s respectively. The fastest phase is too fast to accurately captured on the fluorimeter, which 
takes a reading every 3 s, and the second fastest phase would not be described particularly 
accurately, as is demonstrated in the comparatively high error in the value. Conversely the slowest 
phase is too slow to be able to capture ten half-lives on the stopped-flow, with a maximum 
recording time of 600 s, and is not quite able to capture ten half-lives of the second slowest phase. 
These additional dissociation phases are not unique to the I19A S31C variant; a similar observation 
can be made for the dissociation trace for the F21A S31C variant too. When the stopped flow 
dissociation data are fit with a two-phase exponential this gives a major slow phase (80%) of 25.8 ± 
0.2 x10-3 s-1 and a minor fast phase (20%) of 423 ± 15 x10-3 s-1. But when these data were fit to a 
three-phase decay a major slow phase (66%) of 20.3 ± 0.2 x10-3 s-1, a minor middle phase (22%) of 
91.8 ± 5.9 x10-3 s-1, and a minor fast phase (12%) of 794 ± 68 x10-3 s-1 were produced. Again these 
data could not be fit to a four-phase decay. This trend in rate constants is similar to those of the 
Figure 6-11 – Rotation of Figure 6-9 to show glutamate-17 and aspartate-16 binding pockets. The same surface of β-
catenin as seen in Figure 6-9, but rotated to show the E17 & D16 binding region. The area circled in yellow indicates the 
positively charge pocket into which E17 binds and the red indicates the positively charge pocket into which D17 binds. 
Structure image was created using UCSF Chimera from PDB IDs 2Z6H.  
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stopped-flow dissociation traces of the I19A S31C construct. In contrast, the stopped flow 
dissociation traces for the L41A S31C and V44A S31C constructs fit best to a two-phase exponential 
and could not be fit with a three-phase exponential. 
It is curious that three- or four-phase decays can be observed only for the I19A S31C and F21A S31C 
constructs and not for the other fast-dissociating variant constructs. The fact that the mutations that 
show this behaviour are located in the N-terminal binding region and those that do not are located 
in the C-terminal binding region, suggests this phenomenon might be a unique property of the N-
terminal binding region. If so, then a potential reason for this behaviour could be the neighbouring 
variable region, and what is being observed might be multiple conformational rearrangements of the 
ensemble binding region, as several of the more highly populated conformations are also perturbed 
by mutations within the N-terminal binding region.  
The half-life of the major phase of the F21A S31C construct is 27 s which I believe would be slow 
enough to be accurately captured on the fluorimeter (nine points per half-life). If there is a fourth 
phase then I would expect to see a two-phase decay, with a major fast phase with a rate constant 
similar to the major phase obtained from fitting the stopped flow dissociation traces, and a minor 
slow phase. Similarly the half-life of the major phase of the E17A S31C construct is 78 s, which may 
be slow enough that it can be fitted accurately from a stopped flow trace. If this four-phase theory is 
true I would expect to see a three-phase decay with a major slow phase and minor middle and fast 
phases. Unfortunately I was unable to perform these experiments due to time constrains. 
The trend in Kd,kin is that the C-terminal region of TCF7L2 appears to be contributing more energy 
towards the TCF7L2-β-catenin interaction than the N-terminal region. However, due to the 
invariance in association rates constant between alanine variants, the trends in Kd,kin are a reflection 
of the trends seen in the major dissociation rate constants. As a result of this, when estimating the 
Φ-values as I have done, we see that most of the residues tested that fulfil the recommended ΔΔGN-D 
(ΔΔG0) > 0.6 kcal mol-1 have Φ-values close to zero, i.e. essentially unformed in the rate-determining 
transition state. The exceptions are K45 which has a negative Φ-value and L48 for which Φ ≈ 0.25. 
The negative Φ-value for K45 is much more difficult to interpret, as the magnitude of ≈ 0.35 could be 
an artefact as a consequence of the negative ΔΔG‡-D. If the ΔΔG‡-D of -0.2 kcal mol-1 was the sum of a 
0.2 kcal mol-1 loss of favourable interactions plus a 0.4 kcal mol-1 loss of disfavourable interactions, 
then the magnitude of all changes on mutation to alanine, is 0.6 kcal mol-1. This would then give Φ ≈ 
1. 
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Φ ≈ 0.25 compared to ≈ 0 for most of the other residues, suggests that L48 makes contact with β-
catenin at an earlier stage in the association pathway that the other residues. This is suggestive of a 
“zipping up” binding mechanism, where the C-terminal region of the long, string-like TCF7L2 binds to 
β-catenin first and the remaining residues follow in succession as the enforced proximity promotes 
binding. Also of note is that the estimated Φ-values are not all zero across the length of the C-
terminal α-helix, suggesting the α-helix is not yet formed in the rate-determining transition state. 
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Chapter 7 - Conclusions 
Many of the diseases that are the most resistant to treatment are challenging because of the 
complexity of their underlying biochemical and pathological processes. Diseases like cancer and 
Parkinson’s are difficult to treat as there are multiple pathways that can lead to the disease. In this 
Thesis I aimed to provide new information about the canonical Wnt signalling pathway, which 
underlies both these diseases. 
The gene PARK8, which encodes for the protein Leucine-rich repeat kinase 2 (LRRK2), is one of just a 
small number of genes with a demonstrable link to Parkinson’s disease (Drolet, Sanders and Kern, 
2011). Even though this gene accounts of only 5% of familial and 3% of sporadic Parkinson’s disease 
cases (Tan and Jankovic, 2006), it is still the highest single attributable cause of Parkinson’s disease, 
and therefore represents a major target for the treatment of the disease. 
Despite years of intensive study, LRRK2 has proved to be an elusive target. It has been shown to 
interact with a wide variety of intracellular partners including those involved in cytoskeleton 
dynamics, mitochondrial homeostasis, the MAPK/ERK pathway, and the canonical Wnt signalling 
pathway (see Section 1.4, Kang and Marto (2017)). Yet, without any concrete structural data for the 
LRRK2 protein further, information about the nature of these interactions will be difficult to obtain. 
In this Thesis I attempted structural studies of the LRRK2 protein domains, based on the predictions 
of Mills et al. (2012). Mills et al. predicted through homology modelling, the existence of four 
tandem repeat domains in the unsolved regions of LRRK2. This may represent a significant finding as 
tandem repeat domains typically facilitate protein-protein interactions by providing a stable and 
specific architecture for other protein partners to interact with (Grove, Cortajarena and Regan, 
2008). Unfortunately, after a year of using a variety of different approaches I was unable to solubly 
express these domains using recombinant expression in E. coli. This in no way disproves the 
predictions of Mills et al., only that the approach I took in trying to isolate the individual domains 
was not appropriate. Other research groups around the world have been able to express full-length 
human LRRK2 primarily in human cell lines; however expression in human cell lines does not tend to 
produce proteins in the quantities required for the biophysical assays I had intended and so this 
project was brought to a conclusion. 
The other focus of this Thesis is the interaction of β-catenin with the transcription factor TCF7L2. As 
the signal transducing species in the canonical Wnt signalling pathway, β-catenin plays an important 
role in both embryonic development and the maintenance of adult tissues, and consequently its 
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dysfunction has been implicated in a wide range of cancers (MacDonald, Tamai and He, 2009). It is 
therefore an attractive target in “the fight against cancer”. However as part of its role in the 
canonical Wnt signalling pathway, as well as its role at adherens junction, β-catenin interacts with a 
larger number of protein partners, many of which share the same binding epitope, i.e. the inner 
groove of the ARM repeat superhelix. This feature makes it a challenging target for the development 
of therapeutic agents, as disruption of one interaction may have undesirable side-effects as a result 
of disrupting other interactions. The research I have conducted and presented here is part of a larger 
ongoing project in the Itzhaki group to understand the mechanism of the interactions of β-catenin 
with its multiple binding partners, with Dr S.D. Dunbar focusing on β-catenin’s interactions with Axin 
and E-cadherin, and Dr P.J.E. Rowling focusing on the APC-β-catenin interactions.  
When I began this project, there existed three unique crystal structures of TCF7L2 bound to β-
catenin (Graham et al., 2001; Poy et al., 2001; Sampietro et al., 2006), which differed in terms of 
which glutamate residue (E24 or E29) of TCF7L2 formed a salt bridge with the lysine-312 of β-catenin. I 
showed that mutating these glutamate residues to alanine, as well as other negatively charged 
residues in that region, had a negligible effect on the association and dissociation kinetics, at a 
physiologically relevant osmolarity (Section 5.4). However, in later experiments (Section 5.5) 
significant differences were seen in the dissociation kinetics between the pseudo wild-type construct 
(“WT” S31C) and the construct with five negatively charged residues mutated to alanine (XXXXX 
S31C) at higher osmolarities.  
These results imply that this region of TCF7L2 (residues K22 to D39), which I refer to as the “variable” 
region, does interact with β-catenin but, at the physiologically relevant osmolarity under which I first 
studied it, these interactions make little contribution to the overall binding affinity. The simplest 
conclusion that can be drawn from these data is that the differences that are visible in the three 
crystal structures are consequence of the different conditions in which the proteins were 
crystallised, including varying osmolarity, which seems to have a significant effect on this region and 
is therefore likely reflected in the observed structures (Das and Pappu, 2013). However, as I already 
noted in Section 5.5, this does not mean that these are not real structures that TCF7L2 is capable of 
adopting when in complex with β-catenin in solution, but that these structures are in constant flux 
and these observed crystal structures are snapshots of a dynamic system. 
Charge appears to play a significant role in β-catenin’s binding to its other partners as well. For both 
APC and E-cadherin, phosphorylation significantly increased their binding affinities for β-catenin 
(310-fold and 880-fold respectively Choi, Huber and Weis (2006)). Conversely, LEF1 which has higher 
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homology with TCF7L2 then APC or E-cadherin, can also be phosphorylated in vivo but does not gain 
increased binding affinity for β-catenin (Sun and Weis, 2011).  
When we examine the crystal structures of each of these partners (1TH1, Xing et al., (2004), 3IFQ, 
Choi et al., (2009), and 3OUJ, Sun and Weis, (2011) respectively) we get a mixed picture. E-cadherin, 
which has the greatest increase in binding affinity, is phosphorylated at three residues, in equivalent 
positions to residues E26, E28 and the other within the C-terminal helix of TCF7L2. APC, which also 
gains a significant increase in affinity, is phosphorylated at five residues, one in an equivalent 
position to residue E17 and four within the C-terminal helix of TCF7L2. However LEF1 is 
phosphorylated at just one residue, in an equivalent position to residue A37 which doesn’t increase 
the binding affinity significantly. These data suggest that it is phosphorylation within the equivalent 
of the C-terminal helix that results in the increased affinity, not the variable region. This may account 
for the change in kinetics I observed when I tried labelling TCF7L2 at position S46.   
I next investigated the contribution of the other TCF7L2 residues to the TCF7L2-β-catenin binding 
interaction and kinetics by means of an alanine scan (Chapter 6). The collected equilibrium data from 
the four sets of alanine scans, three previously published (Omer et al., 1999; Fasolini et al., 2003; 
Gail, Frank and Wittinghofer, 2005) and my own, are shown in Table 7-1. For ease of comparison 
between data sets the ratio between the values obtained for the alanine scan variants with their 
respective wild-type constructs has been calculated. 
From both my own alanine scans and those from the literature we can see a trend in the residues 
(see Table 7-1). There are two regions of TCF7L2, which I will call the N-terminal binding region 
(residues N16 to F21) and the C-terminal binding region (residues L41 to L48) that contribute 
significantly more to the binding affinity than other regions and these are the regions that are the 
most similar between crystal structures (see Figure 7-1). Targeting these regions in particular may 
prove to be a good starting point for the rational design of novel therapeutic peptides or 
Figure 7-1 – The three regions of the TCF7L2. Cartoon diagrams of the three crystal structures of TCF7L2 in complex with 
β-catenin with the three regions of TCF7L2: the variable domain (V), and highlighted. (A), (B) and (C) are based on the 
crystal structures obtained by Poy et al., Graham et al. and Sampietro et al. respectively (see Chapter 4). For all three 
structures the N-terminal binding domain (N) and the C-terminal binding domain (C) are very similar, but the variable 
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peptidomimetic drugs that target the TCF7L2-β-catenin interaction. 
Table 7-1: Comparison of literature alanine scans and my own alanine scan data. 
Data Set My Data Omer et al.1 Fasolini et al.2 Gail et al.3 
Construct 1-54 S31C 1-100 1-56 1-53 
Method Kinetics ELISA ITC 
Fluorescence 
Polarisation 
Variant Kd,kin (pM)* Ratio Kd,eq (pM) Ratio Kd,eq (pM) Ratio Kd,eq (pM) Ratio 
Wild-type 7.8 ± 0.6 1.0 23 ± 3 x103 1.0 3.6 ± 1.9 x103 1.0 840.0 ± 180 1.0 
D10A - - - - 2.2 ± 1.2 x103 0.6 - - 
D11A - - - - 20 ± 40 x103 5.6 - - 
L12A 13.6 ± 1.1 1.7 - - - - 820.0 ± 130 1.0 
G13A - - - - - - 520.0 ± 85 0.6 
N15A 7.1 ± 0.4 0.9 - - - - - - 
D16A - - Complete Loss n/a 143 ± 41 x103 39.7 1400.0 ± 97 1.7 
E17A 141.3 ± 10.5 18.1 390 ± 80 x103 17.0 - - 21 ± 5.6 x103 25.0 
L18A - - - - 3.7 ± 2.1 x103 1.0 12 ± 2.6 x103 14.3 
I19A 234.7 ± 20.0 30.0 - - 3.7 ± 1.1 x103 1.0 31 ± 3.2 x103 36.9 
F21A 535.0 ± 19.1 68.4 - - 1.9 ± 0.5 x103 0.5 220 ± 24 x103 261 
D23A 5.7 ± 0.4 0.7 - - 2.2 ± 0.6 x103 0.6 1.8 ± 0.6 x103 2.1 
E24A 8.3 ± 0.7 1.1 - - 12.5 ± 1.6 x103 3.5 - - 
E26A 8.5 ± 0.6 1.1 - - - - - - 
E28A 8.5 ± 0.8 1.1 - - 2.6 ± 0.6 x103 0.7 - - 
E29A 15.6 ± 1.4 2.0 - - 2.9 ± 1.6 x103 0.8 - - 
N34A - - - - 3.4 ± 1.0 x103 0.9 660.0 ± 310 0.8 
E38A 8.7 ± 0.8 1.1 - - - - - - 
D40A - - - - 9.1 ± 6.6 x103 2.5 - - 
L41A 1668.7 ± 72.9 213 - - 39 ± 44 x103 10.7 250 ± 12 x103 297 
V44A 1469.6 ± 135.6 187 - - 48 ± 23 x103 13.2 - - 
K45A 21.3 ± 0.5 2.7 - - 4.5 ± 1.4 x103 1.3 - - 
S46A - - 12 ± 2 x103 0.5 - - - - 
S47A - - 20 ± 2 x103 0.9 - - - - 
L48A 23.2 ± 2.5 3.0 4 ± 0.5 x106 173 - - 220 ± 22 x103 261 
V49A - - - - - - 7.0 ± 7.3 x103 8.3 
E51A - - - - - - 2.5 ± 0.4 x103 3.0 
E24A E29A 6.9 ± 0.6 0.9 - - - - - - 
XXXXX 6.9 ± 0.6 0.9 - - - - - - 
∗  𝐾𝑑,𝑘𝑖𝑛 =  𝑘𝑜𝑓𝑓,𝑚𝑎𝑗𝑜𝑟 𝑘𝑜𝑛⁄  
1 (Omer et al., 1999); 2 (Fasolini et al., 2003); 3 (Gail, Frank and Wittinghofer, 2005) 
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The trends in the alanine scans suggest that TCF7L2 binds to β-catenin through an avidity binding 
mechanism (Olsen, Teilum and Kragelund, 2017) with the two distinct binding regions (the N- and C-
terminal binding regions), linked by a disordered linker, binding to two corresponding sites on β-
catenin. This model would explain the apparent complexity of the binding kinetics.  
For alanine variants in the C-terminal binding region, the dissociation appeared to be biphasic, which 
could be explained as the sequential dissociation of the two binding regions (see Figure 7-2a), with 
binding region one (BD1) always observed dissociating before binding region 2 (BD2). However the 
alanine variants in the N-terminal region appeared to produce a four-phase dissociation. A possible 
explanation for this is an additional alternative dissociation pathway in which BD2 now dissociates 
before BD1, giving two additional observable phases (see Figure 7-2b).  
It is likely that this second pathway was not sufficiently populated to be detected for the wild-type 
construct, due to the energetics involved, and that perturbation of the binding interaction by 
mutating to alanine allowed flux through this second pathway. This therefore implies that it is the C-
terminal binding region (41-48) which dissociates first, followed by N-terminal binding region (16-
21). Mutations in the N-terminal then weaken the binding of that region, accelerating its dissociation 
and allowing flux through the second pathway. This is consistent with alanine variants in the C-
terminal region having a greater effect on the dissociation rate constant in general than the N-
terminal alanine variants. 
β-catenin β-catenin β-catenin 











Figure 7-2 – The proposed mechanism of TCF7L2-β-catenin complex dissociation. (A) the sequential dissociation pathway 
for the two TCF7L2 (red) binding regions from β-catenin (cyan), in which one region always dissociates before the other 
region. (B) the branched dissociation for the two TCF7L2 binding regions from β-catenin, in which either of the two can 
dissociate first. 
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When we look at the crystal structures of β-catenin binding to its binding partners we can see that 
each partner binds to a subset of four distinct regions on β-catenin (see Figure 7-3). The first, the N-
Cap region, comprises the first ARM repeat as well as the capping N-helix which is present in full 
length β-catenin (Xing et al., 2008) but is not present in the Weis construct used in this study. Second 
is the “phosphorylation” region, which includes ARM repeats two to four and is where the C-
terminal binding region of TCF7L2 binds. This is where the phosphorylated residues of phospho-E-
cadherin and phospho-APC bind. Next is the lysine button region, composed of ARM repeats five to 
ten which includes the lysine buttons, lysine-312 and lysine-435. Finally there is the C-cap region 
comprising the eleventh and twelfth ARM repeats and the capping C-helix which is also not present 
in the Weis construct. 
Whether the two-site avidity model for binding can be applied to all of β-catenin’s binding partners 
has yet to be determined. I would speculate, based on their sequence and structural homology, that 
the other members of the TCF/LEF family of the transcription factors (TCF7, LEF and TCF7L1) might 
exhibit a similar binding mechanism. The other binding partners are harder to predict. It is likely that 
two-site avidity mechanisms require a disordered linker of an appropriate length, such as the 
variable region of TCF7L2. In Dr. Rowling’s study of the APC repeat 3 binding to β-catenin she found 
that association and dissociation were single phase. However when she inserted an 18-residue 
disordered linker in her APC construct, in an equivalent position to the TCF7L2 variable region, she 
found that association became two phase. These studies are currently ongoing and unpublished.  
Another curiosity is that although there seems to be this multi-phasic dissociation, association 
seemed to be exclusively single phase. While the association traces could also be fit with a two 
phase exponential decay, there was no consistency in the second association rate constants phases 
(see Section 4.5). However when testing the “WT” S20C construct there appeared to be a different 
association phase that was difficult to distinguish due to a poor signal-to-noise ratio. This could be a 
second association phase that is just not observable for the “WT” S31C and “WT” S46C constructs 
due to the relative intensities of the signals. Similar to the two phase dissociation, this second 
association phase could be due to the sequential association of the two binding regions. 
In summary it appears that, due to its intrinsically disordered nature, the TCF7L2-β-catenin kinetics 
are very complex. My findings demonstrate a fast association combined with a very slow, multi-
phasic dissociation resulting in a more tightly bound complex than has previously been suggested. 
This very slow dissociation is likely to confound some equilibrium measurements of complex 
stability, particularly those that rely on titration (e.g. ITC), as the reaction may not have the 
necessary time to reach equilibrium before the system is perturbed again. Indeed this effect can be 
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Chapter 7 - Conclusions 132 
 
seen from the differences in wild-type complex stability between studies (see Table 8-1, Omer et al., 
1999; Fasolini et al., 2003; Gail, Frank and Wittinghofer 2005). My findings also suggest that the 
TCF7L2-β-catenin binding interaction follows a two-site avidity binding mechanism which future 
studies will need to account for. 
Figure 7-3 – The binding regions of β-catenin: The superposition of the crystal structures of β-catenin in complex with its 
binding partners as previously shown in Section 1.5.2. The four proposed binding regions have been highlighted, 
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7.1 Unfinished Work 
There are also a number of experiments which I had begun working on which I was unable to 
complete due to time constraints. First I began investigating a way of actually forcing TCF7L2 
formation of the variable α-helix seen only in Graham et al.’s structure, as well as attempting to 
determine the extent to which the C-terminal α-helix is pre-formed, by means of peptide stapling. 
Peptide stapling is the process of macrocyclising a peptide via unnatural amino acid side chains, 
typically across one face of an α-helix (Walensky and Bird, 2014). This technique has even be 
previously used in targeting β-catenin although never using TCF7L2 (Grossmann et al., 2012; Takada 
et al., 2012).  
7.1.1 Peptide Stapling 
Previous studies targeting β-catenin used a simple hydrocarbon staple formed from a ruthenium-
catalysed (Grubbs’ catalyst) ring-closing metathesis (RCM) reaction of two alkene containing side 
chains (see Figure 7-4a). However the hydrocarbon staple is quite hydrophobic which can result in a 
change in binding conformation to compensate for this new interaction, as well as reduced 
solubility. Previous experiments with stapled peptides in our lab have used click chemistry (Kolb, 
Finn and Sharpless, 2001) as a method for forming a peptide staple (Guttenplan et al., 2017; Xu et 
al., 2017). This process uses the Copper-catalysed azide-alkyne cycloaddition (CuAAC) reaction 
described by Himo et al. (2005) to form a double-clicked staple between two azide containing 
unnatural amino acid residues and a dialkyne linker (see Figure 7-4b). This has the advantage over 
RCM of forming two, more soluble triazole rings instead of an alkene as well as allowing additional 
functionalisation via the linker (Dr. Xu added a cell-penetrating peptide tag to facilitate studies in 
vivo).  
After careful consideration of the crystal structures and following Dr. Xu’s recommendations, I opted 
for two i to i+7 staples between R39 and S46 for the C-terminal α-helix and between D23 and K30 for 
the variable α-helix. Both of these stapling positions correspond to the solvent-exposed face of their 
respective α-helices, and the chosen residues make no interactions with β-catenin in their helix 
forms and so these are sterically unhindered positions where the introduction of a staple should 
have no impact on binding affinity. For these staples I will use azidohomoalanine (aha) as the azide-
containing, unnatural amino acid component and 3,5-diethynylbenzoic acid as the dialkyne 
containing linker. 
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7.1.2 Incorporation of Unnatural Amino Acids using Methionine Auxotrophs 
In order to facilitate peptide stapling, I used a method of incorporating the unnatural amino acid 
similar to that used by Plückthun’s group for the bioconjugation of an ANK repeat protein (Simon, 
Zangemeister-Wittke and Plückthun, 2012). This method takes advantage of the fact that the E. coli 
methionyl-tRNA synthetase is promiscuous and can substitute a number of structural analogues for 
methionine, including the click-useful amino acids: azidoalanine, azidohomoalanine and 2-amino-5-
hexynoic acid (Kiick et al., 2002). When combined with a methionine auxotrophic strain of E. coli (I 
used B834(DE3) cells, see Section 2.1.1), proteins can be expressed containing the desired unnatural 
amino acid in place of methionine residues. 
In order to utilise this method I created the M1L D23M K30M S31C mutational variant construct via a 
series of SDMs (see Appendix A, Section A.3.5), hereafter referred to as the CLICK31 construct. This 
construct was made in the His-tagged vector (pRSET) instead of the GST-tagged vector (pRSET-GST), 
as the GST-fusion tag contains a number of structurally significant methionine residues that would 
disrupt its ability to function as a purification tag as well as unnecessarily consuming the unnatural 
amino acid. 
The CLICK31-pRSET was transformed into B834(DE3) cells, as described in Section 2.2.4, except 250 
µl of SOC medium was used instead of 200 µl of 2xYT medium in the outgrowth step. After overnight 
incubation a single colony was picked and inoculated into a 1:10 started culture (200 ml) comprised 
of fresh 2xYT medium, supplemented with 100 mg l-1 amp and an additional 1% (w/v) glucose, and 
grown overnight at 37°C in a shaking incubator. 
The 1:10 started culture was inoculated into fresh 2xYT medium (2 l), supplemented with 50 mg l-1 
amp and 1% (w/v) glucose and incubated at 37°C in a shaking incubator until reaching OD600 = 0.6 (3-
Figure 7-4 – The mechanisms of peptide stapling reactions. (A) and (B) show the reaction mechanisms for ring-closing 
metathesis (RCM) and copper-catalysed azide-alkyne cycloaddition (CuAAC) reactions respectively. RCM is a common 
method of stapling peptides, whereas the Itzhaki lab favours CuAAC. (A) and (B) were recreated from Fürstner and 
Langemann (1996) and Worrell, Malik and Fokin (2013) respectively. 
A B 
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4 hrs). This procedure ensured there was a sufficient cell mass for protein production. The cells were 
then harvested as described in Section 2.3 and the supernatant media discarded. The cell pellet was 
then washed three times by resuspending in ice-cold 1x PBS, harvesting then discarding the 
supernatant. This was to remove any residual 2xYT media. The cell pellet was then resuspended and 
divided up in fresh SelenoMet™ medium (2 l) supplemented with 50 mg l-1 amp and 50 mg l-1 
azidohomoalanine hydrochloride (equivalent to 40 mg l-1 of the free amino acid), and incubated at 
37°C in a shaking incubator for 30 min prior to being induced with 1 mM IPTG. This delay between 
resuspension and inducement is to restart cell division and to deplete internal stores of methionine 
whilst minimising catabolic recycling of methionine. The cells were grown at 30°C for a maximum 4 
hrs before being harvested and the pellet frozen for later. 
Unfortunately, when the cell pellet was lysed and the protein purified in the usual way (as described 
in Section 2.5), only unusably small amounts were obtained which were then lost on the G75 
column. Due to the cost of the unnatural amino acids, as well as constraints on time, this approach 
was dropped in favour of a new approach: solid-phase peptide synthesis combined with native 
chemical ligation. 
7.1.3 Solid-Phase Peptide Synthesis and Native Chemical Ligations 
Solid-phase peptide synthesis (SPPS) was first pioneered in the 1960’s (Merrifield, 1963) and has 
subsequently become the preferred method of abiologically synthesising peptides. In recent years, 
this previously time consuming process has been automated and commercialised, providing and 
alternative method of producing peptides and protein fragments longer than ten residues. However, 
even with the aid of automation, constructs longer than ≈ 35 residues are difficult to synthesise due 
to problems with the coupling reaction not proceeding to 100% completion, reducing the overall 
efficiency. For my 56 residue TCF7L2 constructs this presents a problem, but one that could be easily 
overcome using native chemical ligation. 
Native chemical ligation (NCL) is chemo- and regio-selective reaction for joining two unprotected 
peptide fragments together into a single polypeptide chain (Dawson et al., 1994), fragments that can 
be made using SPPS. This versatile technique has been used in the past to synthesise whole proteins 
from fragments containing unnatural amino acids modifications (Qi et al., 2015) or other natural 
modifications like glycosylation (Wang et al., 2013).  
The reaction requires that the N-terminal peptide (peptide 1) to have its C-terminus modified with a 
thioester, a process that can be achieved easily when cleaving from the resin if the fragment was 
made using SPPS, and for the C-terminal peptide (peptide 2) to have a cysteine as its N-terminal-
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most residue. This cysteine residue undergoes a reversible transthioesterification reaction with the 
C-terminal thioester followed by an irreversible S to N acyl shift to the N-terminus of peptide 2 (see 
Figure 7-5). Because the initial transthioesterification reaction is fully reversible, any cross reactions 
with other cysteine residues, or thiol containing modifications, cannot proceed and so reverse until 
the desired reaction and irreversible acyl shift occur, yielding only the desired product. 
By combining these two techniques I was able to adopt a modular approach and would be able to 
create TCF7L2 constructs that are click-able at the C-terminal α-helix, the variable α-helix or both. I 
designed four peptides to be synthesised by SPPS: click-able (1c) and wild-type (1wt) versions of 
residues 1-30 (including an N-terminal gly-ser- for consistency with my previous findings); and click-
able (2c) and wild-type (2wt) versions of residues 31-54 with the S31C mutation, enabling both NCL 
and fluorescein maleimide labelling (see Appendix A, Section A.3.5). 1c and 2wt could be combined to 
create a construct that was staple-able across the variable α-helix, 1wt and 2c to make one staple-
able across the C-terminal α-helix, and 1c and 2c to make the double stapled construct. NCL is 
permissive enough that it can be performed on peptides that have already been macrocyclised, 
which would allow the creation of the double stapled construct without fear of cross reactions.  
However due to time constraints I was unable to synthesise these constructs. With the C-terminal α-
helix, if this helix is fully formed prior to TCF7L2-β-catenin binding then I would expect there to be 
little change in the association and dissociation profiles. However if it is not pre-formed, I would 
Figure 7-5 – The mechanism of native chemical ligation. Image provided by Wikimedia commons. 
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expect an increase in the association rate constant as a number of key residues are now pre-
positioned to more easily form complex contacts. I would also predict a decrease in dissociation rate 
constants as the conformational flexibility of this region would be reduced and, in order to 
dissociate, the contacts of this region would need to be broken simultaneously rather than 
sequentially. It might also be the case that one of the observed dissociation phases is due to the 
unravelling of the C-terminal α-helix. Stapling this α-helix would restrict this unravelling, in which 
case I would predict one of the dissociation phases to no longer be observed. Predicting the effect of 
stapling the variable α-helix is more difficult given that what I found was that entire region seemed 
to contribute very little to binding (see Chapter 5). But I would predict that what would happen is a 
decrease in both association and dissociation rates, similar to those seen for the XXXXX S31C 
construct. 
I would still need to test the effect of the staple on α-helical propensities of the stapled regions. α-
helical structure can be measured by circular dichroism (CD) spectroscopy, and is characterised by a 
local minima in ellipticity at 222 nm (θ222) and can also be induced by adding TFE to the solution 
(Jasanoff and Fersht, 1994).  
I did test the α-helical propensity of the wild-type construct (TCF7L2 (1-54)) during the method 
devolopment and found that this construct showed a very small amount of α-helical structure at 0% 
TFE which increased to an apparent plateau above 45% TFE (see Figure 7-6). At the time, further CD-
based experiments were disregarded as any CD-signal changes that might be generated by TCF7L2 
would likely be masked by the signal from β-catenin (which contains 36 long α-helices).  
Figure 7-6 – α-helicity test of the TCF7L2 (1-54) construct. (A) shows how the CD spectra between 200 and 260 nm changes 
with increasing TFE concentration and (B) highlights how the minima at 222 nm changes with TFE concentration. Absorbance 
at 222 nm is known to be linear with α-helix content and (B) shows the expected sigmoidal curve as % helical content 
increases from 0 to 50% TFE. CD spectra were recorded on a Chirascan™ spectropolarimeter (Applied Photophysics) using a 
cell of pathlength 1 mm. This experiment was performed in 25 mM potassium phosphate pH 6.0, 75 mM NaCl and 1 mM DTT 
with between 5 and 50% (v/v) TFE at 25°C. Final concentration of TCF7L2 (1-54) was 10.3 µM. 
A B 
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However changes in α-helical propensity on stapling could be determined by performing similar 
experiments on the 1c and 2c NCL fragments before and after a successful click reaction. If the staple 
has the expected effect on α-helical propensity, I would expect to see a smaller magnitude change in 
θ222, reaching a similar final θ222, after stapling than before stapling, and if the stapling has no effect 
then I would expect the pre-stapling spectra and the post-stapling spectra to be identical. If it is the 
case that the helix is preformed, as may be the case for the C-terminal helix (2c), then I would expect 
there to be little to no change on addition of TFE and the before stapling spectra and the after 
stapling spectra to be identical. 
7.1.4 Truncated Constructs, Tethered Constructs and Avidity 
In order to investigate the proposed two-site avidity model I designed a series truncated TCF7L2 
constructs representing these separate regions to test, with the intension of subsequently re-
attaching the two domains with various other unnatural likers, e.g. various lengths of PEG or 
polyalanine, to determine the contribution of the variable region to binding beyond simply being a 
tether. 
One of these constructs, the “WT” S31C (1-32) construct, was made by RTH PCR in both the pRSET 
and pRSET-GST vectors. However the his-tagged construct did not express well, and the GST-tagged 
construct did not cleave efficiently with thrombin. Instead the “WT” S31C (1-31) construct was 
successfully made using SPPS, which also served as a practice run at using the peptide synthesiser 
before using unnatural amino acids. However, again due to time constraints, this construct was 
never tested. 
In Omer et al.’s original paper on TCF7L2-β-catenin binding (Omer et al., 1999), they also studied a 
range of truncated constructs of TCF7L2. They tested a TCF7L2 construct composed of residues 1-30 
which had a Kd 400 times higher than a construct composed of residues 1-53 (6 ± 2.4 µM compared 
to 15 ± 6 nM), which is comparable to my wild-type TCF7L2 (1-54) construct. They also tested TCF7L2 
constructs composed of residues 38-54, 30-100 and 20-100 and saw no significant binding from any 
of these constructs, although a 12-100 construct did have a Kd of 85 ± 8 nM, 6 times that of their 1-
53 construct. They also tested a 1-42 construct with a Kd of 9 ± 1.1 µM, not significantly different 
from their 1-30 construct. Taken together, their data further support the idea that the variable 
region contributes little to binding and is merely acting as a tether between binding regions. 
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7.2 Future Work 
The biggest issue during this study was the lack of a reliable method for determining the equilibrium 
dissociation constant, Kd,eq. While my Kd,eq (28 nM), as determined by ITC, was consistent with 
previously reported Kd,eqs (15 ± 3 nM), the calculated kinetic dissociation constant,  Kd,kin, was three 
orders of magnitudes lower than expected (7.8 ± 0.6 pM). When I tried to determine Kd,eq using an 
alternative method, i.e. fluorescence anisotropy titration, I was unable to produce a consistent value 
(see Section 4.6). However when we compare the Kd,eqs for wild-type constructs from different 
alanine scans from the literature, each of which uses a different technique to determine Kd,eq, we can 
see that there is a difference of one order of magnitude between each of the data sets (see Table 7-
1). This inconsistency suggests that this issue is more complex than it first appears. 
A more reliable method of determining Kd,eq is required. I have previously suggested in Section 4.8 
that the incredibly long dissociation times of the TCF7L2-β-catenin complex may be responsible for 
the inconsistency between my own and literature equilibrium binding data, and my kinetic binding 
data. The simplest and likely most reliable way of determining Kd,eq which can account for the long 
dissociation time would be a plate-based direct or competition fluorescence polarisation assay as 
the plate can be prepared then incubated for an appropriate amount of time prior to reading.  
A direct fluorescence polarisation assay can be achieved using a serial dilution of β-catenin to which 
a fixed known concentration of labelled-TCF7L2 is added then incubated before reading. The Kd,eq 
can be calculated from this assay using the polarisation, accounting for ligand depletion equation 
(Equation 2-8). Competition assays would involve adding a fixed known concentration of pre-
complexed labelled-TCF7L2 and β-catenin to a serial dilution of the competitor variant that was 
being tested. These data can be fit with the equations described in Wang (1995) to determine the 
Kd,eq of the competitor variant. 
These two methods have been successfully used by other members of the Itzhaki Lab in the past and 
have been used by Dr. Dunbar to study the interaction between a stapled axin construct and β-
catenin. I had previously considered using these methods however I decided to use polarisation 
titration instead as plate-based assays used large amounts of β-catenin. Dr. Dunbar herself only 
performed a few such experiments.  
Further research into the multi-phasic dissociation is also necessary. As I mentioned in Section 6.4, 
the only construct for which I observed four dissociation phases was the I19A S31C construct. This 
was because the dissociation reaction was such that it could be measured using both stopped-flow 
and time-dependent fluorescence spectroscopy. However, F21A S31C also had dissociation kinetics 
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Chapter 7 - Conclusions 140 
 
that allowed it to be measured using either technique, and it did have a measurable third 
dissociation phase. Additionally the E17A S31C variant also had suitable dissociation kinetics as to be 
measure by either technique. This would be the starting point, but three mutations are not enough 
to strongly support the theory so I would also want to try and test the other residues in that region 
that I did not test (D16, L18, S20 and K22) to see if a similar pattern could be seen for any of them. 
The variable region also warrants further characterisation, particularly residues 23-29. Mutations in 
this region had a negligible impact on complex association and dissociation at physiological salt 
concentrations, however at higher concentrations, they had a much more dramatic effect on the 
kinetics. This suggests a fuzzy mode of binding for this region. Fuzzy complexes can be characterised 
by a number of techniques, primarily NMR, SAXS, and HDX-MS (Sibille and Bernadó, 2012; 
Balasubramaniam and Komives, 2013) of which HDX-MS would be simplest way to investigate this 
system. NMR and SAXS are best used in combination with each other and would be able to provide 
more quantitative data than HDX-MS but are more time-consuming and expensive. HDX-MS would 
be able to give a qualitative measurement which would tell us whether NMR and SAXS were worth 
pursuing. 
In brief; β-catenin would be incubated in D2O for an amount of time such that the solvent exposed 
surface hydrogens can exchange with deuterium, but not buried ones. Then TCF7L2 is added before 
being diluted in H2O to exchange the deuterium back to hydrogen. This reaction is quenched at 
various time points, then digested by protease and the fragments analysed by MS, typically MALDI-
TOF. From this, the rate of exchange for hydrogens in different positions on β-catenin, in the 
presence or absence of TCF7L2, can be determined. Hydrogens that are shielded from the solvent by 
the presence of TCF7L2 should exchange slower as the TCF7L2 would need to dissociate before they 
could exchange and, from this a “protection factor” can be calculated (Balasubramaniam and 
Komives, 2013).  
I would expect the variable region of TCF7L2 to provide less shielding (lower protection factor), if 
any, to the β-catenin hydrogens than the other regions. Assuming there is some protection, the 
effect of osmolarity on this region can be investigated further, as the hydrogen/deuterium exchange 
steps can be performed at various salt concentrations. This approach could potentially also be used 
to investigate the effect of the alanine scan mutational variants on binding, to see whether these 
mutations disrupt binding more locally or more globally across the TCF7L2- β-catenin interface. 
Another aspect that merits investigation is what effect labelling at position 46 has on the observed 
binding kinetics. As I mentioned in Section 4.6, the “WT” S46C and “WT” S20C were created to acts 
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as local reporters of the C- and N-terminal regions respectively. While position 20 was shown to be 
unsuitable for reporting the binding interaction, it would be interesting to see if the two phase/four 
phase pattern in the dissociation kinetics was observed when TCF7L2 is labelled at S46C. For most of 
the alanine variants used in Chapters 5 and 6, I also created plasmids containing the equivalent S46C 
construct, but did not express or purify these constructs due to time constraints. 
In summary there is a lot more still to be learnt about the TCF7L2-β-catenin interaction. Future work 
on this project needs to focus on the development of a more reliable method of determining the 
equilibrium dissociation constant in order to further quantify the kinetics of the binding interaction. 
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Appendix A – DNA and Proteins Sequences 
A.1 LRRK2 
Proposed repeating regions as predicted by (Mills et al., 2012): 
• ARM Domain 
• ANK Domain 
• LRR Domain 
• ROC Domain 
• Kinase Domain 
• WD40 Domain 
        10         20         30         40         50         60         70 
MASGSCQGCE EDEETLKKLI VRLNNVQEGK QIETLVQILE DLLVFTYSER ASKLFQGKNI HVPLLIVLDS 
        80         90        100        110        120        130        140 
YMRVASVQQV GWSLLCKLIE VCPGTMQSLM GPQDVGNDWE VLGVHQLILK MLTVHNASVN LSVIGLKTLD 
       150        160        170        180        190        200        210 
LLLTSGKITL LILDEESDIF MLIFDAMHSF PANDEVQKLG CKALHVLFER VSEEQLTEFV ENKDYMILLS 
       220        230        240        250        260        270        280 
ALTNFKDEEE IVLHVLHCLH SLAIPCNNVE VLMSGNVRCY NIVVEAMKAF PMSERIQEVS CCLLHRLTLG 
       290        300        310        320        330        340        350 
NFFNILVLNE VHEFVVKAVQ QYPENAALQI SALSCLALLT ETIFLNQDLE EKNENQENDD EGEEDKLFWL 
       360        370        380        390        400        410        420 
EACYKALTWH RKNKHVQEAA CWALNNLLMY QNSLHEKIGD EDGHFPAHRE VMLSMLMHSS SKEVFQASAN 
       430        440        450        460        470        480        490         
ALSTLLEQNV NFRKILLSKG IHLNVLELMQ KHIHSPEVAE SGCKMLNHLF EGSNTSLDIM AAVVPKILTV 
       500        510        520        530        540        550        560 
MKRHETSLPV QLEALRAILH FIVPGMPEES REDTEFHHKL NMVKKQCFKN DIHKLVLAAL NRFIGNPGIQ 
       570        580        590        600        610        620        630 
KCGLKVISSI VHFPDALEML SLEGAMDSVL HTLQMYPDDQ EIQCLGLSLI GYLITKKNVF IGTGHLLAKI 
       640        650        660        670        680        690        700 
LVSSLYRFKD VAEIQTKGFQ TILAILKLSA SFSKLLVHHS FDLVIFHQMS SNIMEQKDQQ FLNLCCKCFA 
       710        720        730        740        750        760        770 
KVAMDDYLKN VMLERACDQN NSIMVECLLL LGADANQAKE GSSLICQVCE KESSPKLVEL LLNSGSREQD 
       780        790        800        810        820        830        840  
VRKALTISIG KGDSQIISLL LRRLALDVAN NSICLGGFCI GKVEPSWLGP LFPDKTSNLR KQTNIASTLA 
       850        860        870        880        890        900        910 
RMVIRYQMKS AVEEGTASGS DGNFSEDVLS KFDEWTFIPD SSMDSVFAQS DDLDSEGSEG SFLVKKKSNS 
       920        930        940        950        960        970        980 
ISVGEFYRDA VLQRCSPNLQ RHSNSLGPIF DHEDLLKRKR KILSSDDSLR SSKLQSHMRH SDSISSLASE 
       990       1000       1010       1020       1030       1040       1050 
REYITSLDLS ANELRDIDAL SQKCCISVHL EHLEKLELHQ NALTSFPQQL CETLKSLTHL DLHSNKFTSF 
      1060       1070       1080       1090       1100       1110       1120 
PSYLLKMSCI ANLDVSRNDI GPSVVLDPTV KCPTLKQFNL SYNQLSFVPE NLTDVVEKLE QLILEGNKIS 
      1130       1140       1150       1160       1170       1180       1190 
GICSPLRLKE LKILNLSKNH ISSLSENFLE ACPKVESFSA RMNFLAAMPF LPPSMTILKL SQNKFSCIPE 
      1200       1210       1220       1230       1240       1250       1260 
AILNLPHLRS LDMSSNDIQY LPGPAHWKSL NLRELLFSHN QISILDLSEK AYLWSRVEKL HLSHNKLKEI 
      1270       1280       1290       1300       1310       1320       1330 
PPEIGCLENL TSLDVSYNLE LRSFPNEMGK LSKIWDLPLD ELHLNFDFKH IGCKAKDIIR FLQQRLKKAV 
      1340       1350       1360       1370       1380       1390       1400 
PYNRMKLMIV GNTGSGKTTL LQQLMKTKKS DLGMQSATVG IDVKDWPIQI RDKRKRDLVL NVWDFAGREE 
      1410       1420       1430       1440       1450       1460       1470 
FYSTHPHFMT QRALYLAVYD LSKGQAEVDA MKPWLFNIKA RASSSPVILV GTHLDVSDEK QRKACMSKIT 
      1480       1490       1500       1510       1520       1530       1540 
KELLNKRGFP AIRDYHFVNA TEESDALAKL RKTIINESLN FKIRDQLVVG QLIPDCYVEL EKIILSERKN 
      1550       1560       1570       1580       1590       1600       1610 
VPIEFPVIDR KRLLQLVREN QLQLDENELP HAVHFLNESG VLLHFQDPAL QLSDLYFVEP KWLCKIMAQI 
      1620       1630       1640       1650       1660       1670       1680 
LTVKVEGCPK HPKGIISRRD VEKFLSKKRK FPKNYMSQYF KLLEKFQIAL PIGEEYLLVP SSLSDHRPVI 
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      1690       1700       1710       1720       1730       1740       1750 
ELPHCENSEI IIRLYEMPYF PMGFWSRLIN RLLEISPYML SGRERALRPN RMYWRQGIYL NWSPEAYCLV 
      1760       1770       1780       1790       1800       1810       1820 
GSEVLDNHPE SFLKITVPSC RKGCILLGQV VDHIDSLMEE WFPGLLEIDI CGEGETLLKK WALYSFNDGE 
      1830       1840       1850       1860       1870       1880       1890 
EHQKILLDDL MKKAEEGDLL VNPDQPRLTI PISQIAPDLI LADLPRNIML NNDELEFEQA PEFLLGDGSF 
      1900       1910       1920       1930       1940       1950       1960 
GSVYRAAYEG EEVAVKIFNK HTSLRLLRQE LVVLCHLHHP SLISLLAAGI RPRMLVMELA SKGSLDRLLQ 
      1970       1980       1990       2000       2010       2020       2030 
QDKASLTRTL QHRIALHVAD GLRYLHSAMI IYRDLKPHNV LLFTLYPNAA IIAKIADYGI AQYCCRMGIK 
      2040       2050       2060       2070       2080       2090       2100  
TSEGTPGFRA PEVARGNVIY NQQADVYSFG LLLYDILTTG GRIVEGLKFP NEFDELEIQG KLPDPVKEYG 
      2110       2120       2130       2140       2150       2160       2170 
CAPWPMVEKL IKQCLKENPQ ERPTSAQVFD ILNSAELVCL TRRILLPKNV IVECMVATHH NSRNASIWLG 
      2180       2190       2200       2210       2220       2230       2240 
CGHTDRGQLS FLDLNTEGYT SEEVADSRIL CLALVHLPVE KESWIVSGTQ SGTLLVINTE DGKKRHTLEK 
      2250       2260       2270       2280       2290       2300       2310 
MTDSVTCLYC NSFSKQSKQK NFLLVGTADG KLAIFEDKTV KLKGAAPLKI LNIGNVSTPL MCLSESTNST 
      2320       2330       2340       2350       2360       2370       2380 
ERNVMWGGCG TKIFSFSNDF TIQKLIETRT SQLFSYAAFS DSNIITVVVD TALYIAKQNS PVVEVWDKKT 
      2390       2400       2410       2420       2430       2440       2450 
EKLCGLIDCV HFLREVMVKE NKESKHKMSY SGRVKTLCLQ KNTALWIGTG GGHILLLDLS TRRLIRVIYN 
      2460       2470       2480       2490       2500       2510       2520 
FCNSVRVMMT AQLGSLKNVM LVLGYNRKNT EGTQKQKEIQ SCLTVWDINL PHEVQNLEKH IEVRKELAEK 
   2527 
MRRTSVE 
All constructs include a N-terminal GS due to the thrombin cleavage site 
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All TCF7L2 constructs expressed in E. coli were expressed from vectors containing N-terminal, 
thrombin-cleavable purification tags. The process of cleaving the tag with thrombin leaves behind an 
N-terminal GS- at the beginning of the protein sequence. The constructs produced by peptide 
synthesis had an additional GS- added to the N-terminus of the sequence so their findings would be 
consistent with those obtained for constructs expressed in E. coli. 
A.3.1 Wild-Type TCF7L2 (1-54) 
GSMPQLNGGGGDDLGANDELISFKDEGEQEEKSSENSSAERDLADVKSSLVNESET  












E24A E29A S31C 
GSMPQLNGGGGDDLGANDELISFKDAGEQEAKCSENSSAERDLADVKSSLVNESET 
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XXXXX S31C (D23A E24A E26A E28A E29A S31C) 
GSMPQLNGGGGDDLGANDELISFKAAGAQAAKCSENSSAERDLADVKSSLVNESET 





















A.3.5 Staple-able Constructs 
CLICK31 (M1L D23M K30M S31C) 
GSLPQLNGGGGDDLGANDELISFKMEGEQEEMCSENSSAERDLADVKSSLVNESET 
Native Chemical Ligation Fragments 
1wt – GSMPQLNGGGGDDLGANDELISFKDEGEQEEK 
1c – GSMPQLNGGGGDDLGANDELISFKXEGEQEEX 
2wt – CSENSSAERDLADVKSSLVNESET 
2c – CSENSSAEXDLADVKXSLVNESET 
X = azidohomoalanine 
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A.3.6 Truncated TCF7L2 Constructs 
“WT” S31C (1-32)   
GSMPQLNGGGGDDLGANDELISFKDEGEQEEKCS 
This construct was made accidentally due to poor primer design. The intended construct was the “WT” S31C 
(1-31) construct described below. 
“WT” S31C (1-31) 
GSMPQLNGGGGDDLGANDELISFKDEGEQEEKC 
“WT” S31C (31-54) 
CSENSSAERDLADVKSSLVNESET 
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Appendix B – DNA Primers and Gene Strings 
B.1 LRRK2 
B.1.1 C-terminal ARM Construct Extension 
 
B.1.2 ARM Extension Extending Primers 
Forward: 5’-GGGGCAAGCTTCTGGTGCACCATTCATTTG-3’ 
Reverse: 5’-CCCCCAAGCTTTTATTATTTTGCAAAACAC-3’ 
B.1.3 ANK C-terminal Extension 
 
B.1.4 LRR N-terminal Extension 
 
B.2 TCF7L2 




 “WT” S20C 
Forward 5’-AACTGATCTGCTTTAAAGATGAA-3’ 
Reverse 5’-TTTAAAGCAGATCAGTTCATCAT-3’ 
 “WT” S46C 
Forward 5’-GATGTTAAATGCAGCCTGG-3’ 
Reverse 5’-CCAGGCTGCATTTAACATC-3’ 
B.2.2 Ensemble Binding SDM Primers 
E24A S31C (RTH) 
Forward 5’-CAGGCGAGCAAGAAGAAAAAAG-3’ 
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Appendix B – DNA Primers and Gene Strings 148 
 
Reverse 5’-CATCTTTAAAGCTGATCAGTTCATCA-3’ 
E29A S31C (RTH) 
Forward 5’-CAAAAAGCAGCGAAAATAGCAGC-3’ 
Reverse 5’-CTTCTTGCTCGCCTTCATCTTTA-3’ 


















Both pairs worked 




N15A S31C (RTH) 
Forward 5’-GCGGATGAACTGATCAGCTTTAAAGATG-3’ 
Reverse 5’-TGCACCCAGATCATCACC-3’ 






F21A S31C (RTH) 
Forward 5’-GCGAAAGATGAAGGCGAGCAAG-3’ 
Reverse 5’-GCTGATCAGTTCATCATTTGC-3’ 
E38A S31C (RTH) 
Forward 5’-CGCGTGATCTGGCAGATGTTAA-3’ 
Reverse 5’-CTGCGCTGCTATTTTCG-3’ 
The NGPs of the Canonical Wnt Signalling Pathway Benjamin Martin Smith 
 
Appendix B – DNA Primers and Gene Strings 149 
 






















None of these primer pairs impacts the others so the K1M D23M K30M S31C (CLICK31) construct was made by 
sequential use of these three paris. 
B.3.5 Truncated TCF7L2 Constructs 
“WT” S31C (1-32)   
Forward 5’-GAAAAATGTAGCTAATAAAGCAGCGCAGAACG-3’ 
Reverse 5’-GCTGCTTTATTAGCTACATTTTTCTTCTTGCTCG-3’ 
This construct was made accidentally due to poor primer design. The intended construct was the “WT” S31C 
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